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 Disease progression of primary pneumonic plague is biphasic, consisting of a pre-
inflammatory and a pro-inflammatory phase. Most lung pathogens induce a measureable 
inflammatory response within a few hours of infection, but Yersinia pestis is strikingly 
different: the first 36 hours of infection are characterized by rapid bacterial replication in 
the lung without generating appreciable levels of proinflammatory cytokines/chemokines, 
histological changes in infected tissue or outward disease symptoms. The ultimate goal of 
this thesis was to understand the processes that contribute to the pre-inflammatory phase 
of disease.  
 Upon inhalation of infectious droplets, Y. pestis can interact with a myriad of 
different cell types, but the initial bacterial / host cell interactions during pulmonary 
infection are largely uncharacterized. I found that Y. pestis cannot be lavaged from the 
lung during the initial stages of infection but is freely lavageable during the later stages of 
infection, indicating that Y. pestis adheres tightly to lung tissues during the pre-
inflammatory phase of disease. Although recent studies have implicated Ail as the Y. 
pestis adhesin that mediates this interaction, my data suggest that Ail acts to stabilize the 
outer membrane, and the loss of Ail alters other outer membrane proteins. Interestingly, 
the reintroduction of two major Yersinia adhesins, yadA and inv, into Y. pestis reduces the 
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virulence of Y. pestis in both bubonic and pneumonic animal models of infection, 
offering an explanation as to why these genes were lost during the course of Y. pestis 
evolution.  
 I also developed a negative selection screen termed transposon site hybridization 
(TraSH) to identify bacterial factors required for the two different phases of Y. pestis 
pulmonary infection. I validated the technique by defining the essential genes for Y. 
pestis viability, which largely coincided with essential genes found in Escherichia coli. 
However, I was unable to identify any known virulence factors using TraSH following an 
intranasal infection, including genes involved in the Ysc type-three secretion system 
(T3SS), which are known to be essential for pulmonary infection, suggesting that there is 
global trans-complementation of attenuated mutants by wild-type Y. pestis. 
 Finally, using a co-infection model of pneumonic plague, I discovered that Y. 
pestis quickly creates a localized, dominant anti-inflammatory state that allows for the 
survival and rapid growth of both itself and normally avirulent organisms. In contrast, Y. 
pseudotuberculosis, the relatively recent progenitor of Y. pestis, and K. pneumoniae, 
another highly virulent lung pathogen, show no similar trans-complementation effect, 
which is unprecedented among other respiratory pathogens. Both the unbiased negative 
selection screen using a vast pool of Y. pestis mutants (TraSH) and the co-infection 
experiments revealed no selection against any known virulence genes, demonstrating the 
transformation of the lung into a globally permissive environment during the pre-
inflammatory phase of pneumonic plague that allows not only wild-type Y. pestis to 
proliferate rapidly in the lung, but other microbes as well. 
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“How many valiant men, lovely ladies and handsome youths whom even Galen, 
Hippocrates and Aesculapius would have judged to be in perfect health, dined with their 
family, companions and friends in the morning and then in the evening with their 
ancestors in the other world?” 
 
Boccaccio, G. (est. 1353) The Decameron - Introduction, trans. David Burr, unpublished. 
Used with permission. 
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Yersinia pestis: A historical perspective 
In October 1347, Genoese trading ships put in at Messina Harbor in Sicily, Italy 
with crews of dead and dying men. The ships had come from the Black Sea port of Caffa 
(currently Feodosiyia) in the present day Ukraine. The diseased sailors had unfamiliar 
black swellings about the size of an egg in their groins and armpits. Blood and pus oozed 
from these swelling, and boils and black patches quickly formed on the rest of their 
bodies. The afflicted suffered severe pain and died soon after their symptoms became 
apparent. Before long, other sailors and merchants in Sicily contracted similar symptoms 
and also started dying. As the disease spread through the town, other symptoms appeared, 
a continuous fever and bloody sputum, along with the swellings. These new victims 
sweated profusely and coughed uncontrollable and died soon after becoming sick, often 
within three days or less, sometimes even within 24 hours (Tuchman, 1978). The disease 
quickly spread along trade routes and within three years had spread to the entire “known 
world”, leaving so much death and despair in its wake that people lamented that “this is 
the end of the world” (Tuchman, 1978). 
This disease was plague, manifest in two of its forms: bubonic plague and 
pneumonic plague. Yersinia pestis, the etiological agent responsible for plague, is 
estimated to have killed more than 200 million people worldwide, although many 
estimates put the death toll significantly higher (Perry and Fetherston, 1997). Although 
there are numerous references to “plagues” in many ancient texts that may be attributable 
to Y. pestis, the first great plague pandemic, termed the Justinian Plague, arrived in the 
Byzantine Empire from East Africa and Egypt in 541 A.D. during the reign of Emperor 
Justinian I. The initial epidemic ravaged Constantinople from 541 to 544 A.D. and quickly 
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spread throughout the Middle East and Mediterranean regions. Additional eight- to 
twelve-year cyclic epidemics lasted until 700 A.D., gradually spreading from region to 
region until the plague had overrun North Africa, Europe, central and southern Asia and 
the Middle East. Although the starvation and political unrest that followed each plague 
epidemic likely played some role, from 541 to 700 A.D., 50% to 60% of the population in 
these areas had been lost, making the Justinian Plague one of the greatest plagues in 
history (Russell, 1976).       
 Over the next 600 years, periodic plague epidemics still occurred in central and 
southern Asia, whereas Europe largely avoided major plague epidemics. However, that 
changed when the Genoese trading ships introduced plague into Sicily in 1347 and 
ushered in the start of the second plague pandemic. The first epidemic (1347 to 1352 A.D.), 
appropriately known as the Black Death, killed an estimated 18 to 27 million Europeans 
or an estimated one-third of Europe’s population. The death toll was just as great 
throughout Asia, where an estimated 65 million people are thought to have died directly 
or indirectly from plague during this same epidemic (McNeill, 1976; Twitchett, 1979). 
Cyclic epidemics, lasting anywhere from two to twenty years, and the resulting chronic 
depopulation continued to overwhelm Europe until the end of the 1600’s and eventually 
resulted in many of social, political, economic, religious and even educational changes of 
the Middle Ages (Defoe and Hurlbut, 1895; Gottfried, 1983; Tuchman, 1978). Various 
theories have been presented as for the decline of both the first and second pandemics, 
including changes in public health policy (better use of quarantine both within and 
between population centers), weather (droughts), rodent populations and even with Y. 
pestis itself (Haensch et al., 2010; Perry and Fetherston, 1997; Slack, 1989; Stenseth et 
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al., 2006; Tuchman, 1978). However, none of these theories alone can account for the 
decline.  
 The third and ongoing pandemic is believed to have started in the Chinese 
province of Yünnan in 1855. Troop traffic from a war between provinces eventually 
spread the disease to the southern coasts of China, reaching Hong Kong and Canton in 
1894. By the turn of the century, steamships and trading vessels had disseminated the 
plague throughout the world, including to the United States and other parts of the New 
World for the first time. During the height of the pandemic, over a million people were 
dying each year in India alone, and an estimated 15 million people worldwide have died 
since the pandemic began (Echenberg, 2002). This current pandemic is in decline thanks 
to improved health policy and the advent of antibiotics. However, stable enzootic foci are 
still found on every major continent except Australia and Europe (Perry and Fetherston, 
1997). 
  The infectious source of the plague was unknown until June 1894 when Louis 
Pasteur suggested that a young medical physician, Alexandre Yersin, go to Hong Kong to 
investigate the current plague outbreak. In a makeshift laboratory at the end a hallway 
just inside the morgue, Yersin was able to isolate Y. pestis from fluid aspirated from 
buboes of a patient who had recently died of the plague. He also injected the same fluid 
samples into guinea pigs, which subsequently died, and found that their organs were 
teeming with the same microorganism isolated from the deceased patient. The knowledge 
that rats had long been associated with the plague and his own observations with guinea 
pigs lead Yersin to correctly conclude that this microorganism, which infects both rats 
and humans, caused the plague (Gross, 1995). Although Shibasaburo Kitasato also 
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reported having isolated the plague microorganism during the same time frame, 
descriptions of his isolate, which were also isolated from a patient who died of the plague, 
resemble that of a contaminating pneumococcus more than Y. pestis (Perry and 
Fetherston, 1997).   
Epidemiology of Y. pestis 
The exact route of transmission between rats and humans remained elusive until 
Paul-Louis Simond, a French colonial Army physician sent by Pasteur to continue 
Yersin’s work in Indochina in 1897, observed that humans seemed to only contract the 
disease when they came into contact with recently dead warm rats but not with dead cold 
rats. He postulated that the fleas (Xenopsylla cheopis), which leave dead rats when they 
become cold, might be responsible for the transmission between rats and humans. Upon 
microscopically examining the fleas, he observed the plague bacterium in the digestive 
tract of the fleas. Using an ingenious series of experiments involving suspending 
uninfected rats in cages over plague infected rats with or without fleas, Simond was able 
to conclude that fleas could transmit plague between hosts (Fig. 1-1) (Gross, 1995). 
Masanori Ogata is also credited with independently discovering the role of fleas in plague 
transmission that same year. Currently, there are over 30 species of fleas worldwide that 
are capable of transmitting Y. pestis between hosts (Perry and Fetherston, 1997).  
Plague is a zoonotic disease, and although rats, both the urban rat Rattus rattus 
and the domestic rat Rattus norvegicus, were the major reservoirs during the first two 
pandemics and beginning of the third pandemic, the majority of human plague cases 
today are the result of cross-infections from other wild rodents such as prairie dogs, 
squirrels and marmots or larger mammals that have become infected such as cats (Perry 
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and Fetherston, 1997). To date, Y. pestis has been associated with over 200 species of  
rodents worldwide, and its ability to infect arthropod vectors (fleas) and use them as a 
vehicle of transmission between susceptible hosts is unique among the 
Enterobacteriaceae (Hinnebusch, 1997). Human outbreaks therefore are often proceeded 
by epizootic outbreaks, especially in places where plague is still endemic, including 
Madagascar, eastern and southern Africa, Southeast Asia, the western United States, 
Mongolia and northern China, Russia and central Asia. Currently, there are 
 
 
 
Figure 1-1: Transmission pathways for Y. pestis. This diagram describes the three 
major routes of transmission of Y. pestis between rodent and human hosts: 
bubonic, septicemic and pneumonic. Figure courtesy Neal R. Chamberlain, Ph.D., 
A.T. Still University/KCOM; adapted with permission (Chamberlain, 2004), subject 
to copyright restrictions. 
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approximately 2000 cases of plague reported to the World Health Organization (WHO) 
each year (WHO, 1999). WHO has also recently classified Y. pestis as a re-emerging 
disease after outbreaks in India, Malawi, Mozambique and east Africa (Schrag and 
Wiener, 1995). 
During the 1910 Manchurian outbreak, Wu Lien-teh and Richard P. Strong noted 
that the sick plague patients arriving the hospital wards showed no signs of the classical 
bubonic plague. They also could find no evidence of the involvement of rats or fleas in 
this outbreak. Since the unresolved issue of transmission was critical in controlling the 
outbreak, both Strong and Wu independently performed a series of experiments where 
they held culture plates at certain distances from couching or breathing patients and 
found the bacteria could be spread via coughing (respiratory droplets). They were able to 
recognize and describe the pneumonic form of plague transmission and helped institute 
the use of protective measures to protect against its spread. Much of the epidemiology 
and human pathology of pneumonic plague we have today is a result of their work during 
this epidemic (Chernin, 1989; Wu, 1995). Although the pneumonic form of transmission 
is still seen during isolated outbreaks today, it is very rare.  
Clinical manifestations of Y. pestis infection 
 Human infection with Y. pestis is usually manifest as one of three clinical 
syndromes: bubonic, septicemic or pneumonic. As previously mentioned, the majority of 
cases are either bubonic or septicemic (Crook and Tempest, 1992), which result from the 
bite of a Y. pestis-infected flea. The clinical symptoms of bubonic plague include fever, 
chills, weakness, headache and swollen, tender lymph nodes (lymphadenopathy, i.e., 
buboes), which generally appear after a two- to eight-day incubation period. Buboes 
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result from unchecked bacterial growth in the regional draining lymph node and are most 
commonly associated with the inguinal and groin femoral lymph nodes. Bubonic plague 
is fatal in 40% to 60% of cases if left untreated.  
Bacteremia, either directly from a flea bite (primary septicemic plague) or 
secondarily from an infected lymph node or lung (secondary septicemic plague), can lead 
to shock, bleeding from bodily orifices and/or death and blackening of tissues (gangrene) 
in a patient’s extremities. The gangrene associated with septicemic plague inspired the 
nickname the Black Death during the 14th-century pandemic (Perry and Fetherston, 1997). 
Primary septicemic plague occurs in approximately 10% to 25% of plague cases and is 
characterized by patents with positive blood cultures but who lack a lymphadenopathy 
and pneumonia (Sebbane et al., 2006). Both primary and secondary septicemic plague are 
clinically similar to most bacterial septicemias, commonly resulting in coagulopathy, 
meningitis and multi-organ failure. Septicemic plague is 100% fatal if not treated and 
30% to 40% fatal even when treated with antibiotics (Perry and Fetherston, 1997).  
The third manifestation of plague is primary pneumonic plague, which occurs 
when an individual inhales infectious respiratory droplets that are normally produced 
from humans or animals in the late stages of pneumonic plague by coughing. Conversely, 
secondary pneumonic plague develops as a complication of bubonic or septicemic plague 
when the infection disseminates to the lungs. Most naturally occurring cases of primary 
pneumonic plague are believed to have initiated from a case of secondary pneumonic 
plague, which occurs in approximately 12% of patients (Doll et al., 1994). Although it is 
the least common form of the disease, pneumonic plague is the most rapidly progressing 
and most fatal form of plague. Primary pneumonic plague in humans begins as a 
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bronchopneumonia that is characterized by numerous bacteria and proteinaceous 
effusions in the small airways. The pneumonia then spreads rapidly, becoming lobar then 
multilobar within a few hours. Gross examination of the lungs reveals fluid in the upper 
and lower airways, fibrinous pleuritis, serosanguineous pleural effusions and 
hemorrhagic foci in the mediastinum. Histologic and microscopic examination of lung 
tissue reveals an acute pneumonia characterized by pulmonary alveolar flooding, 
pulmonary congestion and hemorrhaging, necrohemorrhagic foci, mediastinitis and 
extracellular bacteria in the alveoli but rarely seen in the interstitum (Davis et al., 1996; 
Guarner et al., 2002). Complete loss of alveolar architecture in necrotic foci, extensive 
neutrophilic infiltrate and fibrin deposition also occur (Doll et al., 1994; Werner et al., 
1984). Death is normally due to respiratory failure and shock within four days post-
infection. Pneumonic plague is 100% fatal if not treated within 24 hours from the onset of 
symptoms. Studies using non-human primates as a model of primary pneumonic plague 
show very similar gross and microscopic pathology (Davis et al., 1996; Finegold, 1969). 
The mouse model of primary pneumonic plague infection also shows many of the same 
pathological features that have been seen in humans, non-human primates and cats 
(Chmura et al., 2003; Davis et al., 1996; Eidson et al., 1991; Finegold, 1968; Watson et 
al., 2001; Welkos et al., 2002; Welkos et al., 1997). 
Biological warfare has been waged intermittently for more than 2500 years. The 
use of the Y. pestis as an agent of biowarfare is almost as old as the organism itself, 
although the techniques used to deliver and weaponize it have varied through the ages. 
They have gradually evolved from catapulting plague victims into besieged cities and 
dropping clay pots filled with infected fleas and flour (to attract rats) to more specialized 
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weapon systems (Robertson and Robertson, 1995). Three major attributes of Y. pesits 
contribute to fears of its intentional release as a weapon of bioterrorism: its well-
documented pandemic capacity, its ability to be transmitted via aerosolized droplets and 
its significant morbidity and mortality in humans (Inglesby et al., 2000). The isolation of 
multiple Y. pestis strains that have developed antibiotic resistance further emphasizes that 
Y. pestis remains a threat to public health (Galimand et al., 2006; Galimand et al., 1997; 
Guiyoule et al., 2001). The Centers for Disease Control and Prevention (CDC) in the 
United States has therefore classified Y. pestis as a Category A Select Agent.  
Molecular microbiology of Y. pestis 
There are three Yersinia species that are pathogenic to humans, Y. pestis, Y. 
enterocolitica and Y. pseudotuberculosis. Yersinia species are facultative anaerobic, 
Gram-negative bacilli or coccobacilli. Although all three species are lymphotropic, Y. 
enterocolitica and Y. pseudotuberculosis are typically food-borne pathogens that cause a 
self-limiting limiting gastroenteritis that ranges from acute enteritis to mesenteric 
lymphadentitis (Cover and Aber, 1989; Huang et al., 2006). All three species have an 
extended temperature growth range, 4°C to ~40°C, but grow optimally at 28°C. Y. 
enterocolitica and Y. pseudotuberculosis have an environmental niche, whereas Y. pestis 
is an obligate pathogen with limited abilities to survive outside its hosts. Y. pestis is 
auxotrophic for a number of nutritional requirements including several amino acids, 
biotin, thiamine, pantothenate, glutamic acid and other additional requirements that are 
only necessary for growth at 37°C. Several additional genomic lesions in metabolic genes 
alters carbon utilization in Y. pestis, which has been postulated as a mechanism of 
immune avoidance as many secondary bacterial metabolites are known pattern-associated 
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molecular patterns (PAMPs) recognized by the immune system (Brubaker, personal 
communication; Perry and Fetherston, 1997).  
Currently, there are three recognized biotypes (or biovars) of Y. pestis (antiqua, 
medievalis and orientalis) based on their ability to convert nitrate to nitrite and to ferment 
glycerol. Another biovar, microtus, has recently been proposed based on a phylogenic 
analysis of the genes necessary for these processes (Song et al., 2004; Zhou et al., 2004). 
Genome sequences are available for representatives of each biovar and show some level 
of heterogeneity and genome rearrangement between biovars and even between strains 
within a given biovar (Chain et al., 2006; Deng et al., 2002; Eppinger et al., 2010; Garcia 
et al., 2007; Morelli et al., 2010; Parkhill et al., 2001). Despite the heterogeneity, 
previous studies have shown that the different biovars, with the exception of microtus, do 
not significantly differ in their degree of virulence (Brubaker, 1991). Speculation based 
on the current geographical distribution patterns of descendant linages and historical 
records has suggested that the biovar antiqua was mainly responsible for the first major 
pandemic, the biovar medievalis for the second pandemic and the biovar orientalis for the 
third and ongoing pandemic (Achtman et al., 2004). However, resent molecular data from 
suspected plague cases from both the first and second pandemic suggest that all three 
pandemics were caused by orientalis-like Y. pestis strains (Drancourt et al., 2004). 
The genome of Y. pestis CO92 (the biovar orientalis strain most commonly used 
in the Goldman Lab) consists of a 4.65-megabase chromosome and 3 plasmids, pPCP1 
(9.6 kilobases, kb), pCD1 (70 kb) and pMT1 (110 kb) (Parkhill et al., 2001).  Strong 
molecular evidence indicates that Y. pestis is a recently evolved clone of Y. 
pseudotuberculosis that may have originated in eastern Asia between 1500 and 20,000 
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years ago (Achtman et al., 2004; Achtman et al., 1999; Chain et al., 2004; Morelli et al., 
2010). Indeed, the genomes of the two species are greater than 90% identical on average 
(some strains have an even greater percent identity), and their 16S rDNA nucleotide 
sequences are 99.7% identical (Chain et al., 2004). Y. pestis has ~146 pseudogenes 
compared to Y. pseudotuberculosis, some of which, when restored, have detrimental 
effects on virulence in either the mammalian host or the flea (Bobrov et al., 2011; Casutt-
Meyer et al., 2010; Chain et al., 2004; Hinnebusch, 1997; Rosqvist et al., 1988).  
Indeed, evolutionarily recent adaptions in the Y. pestis genome are thought to 
have produced a pathogen that can be transmitted by different routes of infection, i.e., via 
arthropod vectors and human-to-human transmission via the aerosolization of respiratory 
droplets. Many of these same adaptations are thought to have substantially increased the 
virulence of Y. pestis towards its mammalian host. Although Y. pestis has also acquired 
two additional plasmids, pPCP1 and pMT1, that are required for full virulence, the 
presence of these plasmids alone cannot account for the markedly different clinical 
manifestations of these two nearly identical organisms (Chain et al., 2004; Pouillot et al., 
2005). 
Evolutionarily speaking (Gould and Lewontin, 1979), the highly virulent nature of 
plague may be due to the high levels of bacteremia (≤106 bacteria per milliliter blood) 
required to efficiently infect a flea (Hinnebusch, 1997). Y. pestis infects fleas poorly and 
is not readily transmitted back into its mammalian host after blockage of the flea 
proventriculus, dictating that a high level of bacteremia needs be established from a very 
low inoculum to maintain the natural transmission cycle. This situation favored the 
emergence and continued selection of a hypervirulent clone of Y. pestis that is able to 
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cause the high degree of severity associated with disease (Hinnebusch, 1997; Lorange et 
al., 2005). Many of the evolutionary adaptations that changed a common enteric 
pathogen into a highly virulent pathogen are still unappreciated, and in depth comparative 
studies between Y. pestis and Y. pseudotuberculosis are necessary to gain a greater 
understanding of the pathogenic nature of Y. pestis.     
Known virulence factors of Y. pestis 
Even with the long history of this disease, relatively little is known about the 
pathogenesis of plague at the molecular level (Brubaker, 1991). Although there has been 
an increase in the amount of funding directed towards biodefense research and a 
subsequent increase in the number of publications related to Y. pestis pathogenesis, the 
majority of these studies have focused on only three virulence factors, albeit the three 
most predominant virulence factors: the Ysc-Yop type-three secretion system (Ysc-Yop 
T3SS) encoded on pCD1, the pgm locus encoded on the chromosome and the 
plasminogen activating protease Pla encoded on pPCP1. Other isolated studies have 
helped us gain insights into several other bacterial virulence factors although their 
mechanisms of action in vivo still need to be elucidated further.  
All three Yersinia pathogenic to mammals harbor a nearly identical virulence 
plasmid that encodes the Ysc-Yop T3SS, designated pCD1 in Y. pestis and pYV in Y. 
enterocolitica and Y. pseudotuberculosis. The Ysc-Yop T3SS is absolutely essential for Y. 
pestis to cause disease in its mammalian host (Fig. 1-2). The Ysc-Yop T3SS consists of a 
needle apparatus whose basal body shares very high levels of homology with the basal 
body of flagellar apparatuses. The translocon, which is formed at the tip of the needle by 
yopD, yopB and lcrF, mediates the formation of a pore through which the effector 
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proteins (Yersinia outer membrane proteins or Yops) enter the host cell directly from the 
bacterial cytoplasm (Cornelis, 2000; Cornelis, 2002; Costa et al., 2010; Mueller et al., 
2005). Recent studies have also suggested that direct cytosol-to-cytosol translocation is 
not absolutely necessary (Akopyan et al., 2011); however, this study fails to address the 
role of Pla (discussed below) in extracellular Yop cleavage or recent evidence that needle 
length is important in the translocation process (Mota et al., 2005; Pouillot et al., 2005).  
The processes regulating translocation are not well understood; however, in vitro 
secretion of Yops can be achieved artificially by growing Yersinia under Ca++ limiting 
 
 
Figure 1-2: Y. pestis kinetics of pulmonary infection. The kinetics of infection for 
C57BL/6 mice intranasally inoculated with 104 wild-type (A) or pCD1- (B) Y. pestis. 
Colony-forming units (CFU) per tissue were determined at various time points of 
infection for lungs and spleen for both strains. Figure courtesy William E. Goldman, 
Ph.D. (Lathem et al., 2005), subject to copyright restrictions.  
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conditions, which also results in a bacterial growth restriction termed the low-calcium 
response (LCR). In vivo translocation of Yops into host cells is mediated through contact 
with the host plasma membrane (Pettersson et al., 1996; Rosqvist et al., 1994) and is 
tightly controlled by multiple feedback mechanisms from both inside the bacterium and 
the host cell (Cornelis, 2002; Dewoody et al., 2011; Pettersson et al., 1996). The 
translocated effector proteins (YopE, YopH, YopJ/YopP, YopK, YopM, YopO/YpkA 
and YopT) have been extensively studied both in vitro and in vivo and are known to alter 
the host cell cytoskeleton, inhibit phagocytosis, inhibit platelet aggregation and inhibit 
the production of proinflammatory cytokines. The cumulative effect of their individual 
actions results in an inhibition of host immune responses (Cornelis, 2002). 
Although many of the known virulence factors are found on the three virulence 
plasmids, there are also several chromosomally encoded virulence factors (Perry and 
Fetherston, 1997). The most extensively studied of these factors are encoded in the pgm 
locus, a ~102kb region of DNA bounded by repeated copies of IS100, which are thought 
to allow for loss of the pgm locus by homologous recombination (Fetherston et al., 1992). 
Although other genes within the pgm locus may contribute to infection, the locus can be 
subdivided into two distinct phenotypic regions (Jenkins et al., 2009; Perry and 
Fetherston, 1997; Pujol et al., 2005). The first region contains the hms genes, which are 
responsible for the production of a poly-β-1,6-N-acetyl-glucosamine extracellular 
polysaccharide matrix that is essential for biofilm formation (Lillard et al., 1997). 
Polysaccharide production also produces a red pigmentation phenotype when Y. pestis is 
grown at 26°C on agar plates containing Congo red dye. Efficient Y. pestis biofilm 
formation is responsible for blockage of the flea proventriculus but is not required for 
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mammalian infection; however, its overproduction can be detrimental to mammalian 
infection (Bobrov et al., 2011; Hinnebusch, 1997; Hinnebusch et al., 1996).   
The second region has a high G+C content and is therefore considered to be a 
high pathogenicity island (HPI). The HPI encodes for proteins used in the synthesis and 
utilization of the siderophore yersiniabactin. Mutants that prevent yersiniabactin 
production or utilization are severely attenuated in the subcutaneous route of infection 
due to the inability of HPI mutants to acquire iron (Bearden et al., 1997). This defect can 
be overcome by simultaneously injecting iron sulfate during subcutaneous inoculation 
with the bacteria or into the mouse peritoneally, demonstrating one mechanism Y. pestis 
uses to overcome nutritional immunity (Perry and Fetherston, 1997; Weinberg, 1975). 
However, during pneumonic plague, the virulence defects of strains lacking the pgm 
locus cannot be fully explained by the loss of yersiniabactin production or utilization, 
suggesting that additional factors encoded on the pgm locus are involved in pathogenesis 
(Fetherston et al., 2010; Lee-Lewis and Anderson, 2010).       
The small plasmid pPCP1 is unique to Y. pestis and encodes the genes for the 
plasminogen activator protease (pla), the bacteriocin pesticin (pst) and a pesticin 
immunity protein (pim). Pla is an omptin cysteine protease that is not required for 
bacterial replication at the site of a subcutaneous inoculation but is important in bacterial 
dissemination, presumably because of its ability to cleave plasminogen into plasmin, 
which then digests fibrin clots that restrict bacterial dissemination (Sodeinde et al., 1992; 
Welkos et al., 1997). Conversely, during pneumonic plague, Pla is required for bacterial 
replication and subsequent pathology in the lungs but not for bacterial dissemination 
(Lathem et al., 2007). Pla has also been shown to act as an adhesin/invasin to tissue 
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culture cells when expressed in E. coli; however, Y. pestis strains that lack Pla do not 
show a decrease in adherence or invasion into tissue culture cells, and its role as an 
adhesin has yet to be demonstrated in vivo (Kienle et al., 1992; Lähteenmäki et al., 2001). 
Identifying the protease substrates of Pla in vivo will be essential in determining its role 
in pathogenesis. 
The plasmid pMT1 encodes the genes for the F1 antigen (caf1) and murine toxin 
(ymt). Caf1 forms a proteinaceous capsule-like structure on the outside of the Y. pestis 
when the bacteria are grown at 37°C under oxygen limiting conditions (Perry and 
Fetherston, 1997). The requirement of Caf1 in pathogenesis is disputed in the literature; 
however, very few natural isolates lack the genes encoding caf1, suggesting that there is a 
natural selection in for its maintenance (Meka-Mechenko, 2003; Sebbane et al., 2009; 
Winter et al., 1960). Recent evidence suggests that the role of Caf1 in pathogenesis is 
dependent on the animal model that is used in the study (Weening et al., 2011). The 
capsule has been shown to inhibit phagocytosis by macrophages in tissue culture, but it 
may have additional roles in masking PAMP recognition during Y. pestis infection (Du et 
al., 2002; Weening et al., 2011). Additionally, Caf1 has been widely used as a candidate 
for vaccine development (see below).  
Although the majority of virulence factors currently studied are required for 
mammalian infection, Ymt has been shown to be important in flea infections. Ymt is a 
phospholipase D (PLD) that was originally identified for its ability to cause septic shock 
in mice but has recently been shown to be dispensable for mammalian infection 
(Hinnebusch et al., 2000). Ymt has been shown to protect Y. pestis in the flea gut from 
cytotoxic digestion products of digested blood (Hinnebusch et al., 2002). The acquisition 
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of Ymt by Y. pestis may have been a determining factor in allowing for Y. pestis to use an 
arthropod vector as a route of transmission.           
The genes encoding the dominant adhesins/invasins found in Y. enterocolitica and 
Y. pseudotuberculosis, inv and yadA, are pseudogenes in Y. pestis (Simonet et al., 1996; 
Skurnik and Wolf-Watz, 1989). Intimate contact with the host plasma membrane is 
thought to be required for use of the Ysc-Yop T3SS, and because the two predominate 
Yersinia adhesins are lacking in Y. pestis, many studies have looked for additional 
adhesins in Y. pestis that are required for T3SS translocation. Many potential adhesins 
have been identified, most of which are chromosomally encoded. One potential adhesin is 
encoded by the chaperon-usher operon psa (PsaA is also known as the pH6 antigen), 
which encodes a pilus that is thermally induced at low pH. When induced, the pilus 
mediated adhesion to tissue culture cells, and mutants lacking psaA are attenuated in 
mouse models of infection (Cathelyn et al., 2006; Leo and Skurnik, 2011). 
Autotransporters are another class of potential adhesins that are able to mediate adhesion 
when overexpressed in E. coli (Lawrenz et al., 2009; Yen et al., 2007). Specific 
autotransporters (YadBC and YapE) are attenuated in mouse models of infection when 
inoculated subcutaneously but not when inoculated intranasally (Andrews et al., 2010; 
Forman et al., 2008; Lawrenz et al., 2009). 
Ail is another adhesin that was originally discovered and characterized in Y. 
enterocolitica (Miller and Falkow, 1988; Miller et al., 1989). There are four Ail 
homologs in both Y. pestis and Y. pseudotuberculosis but only one is Y. enterocolitica, all 
of which show a high degree of homology to each other and to OmpX in E.coli 
(Kolodziejek et al., 2007). Although there are four Ail homologs in Y. pestis, only one 
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homolog (YPO2905) is produced at appreciable levels and is able to mediate the 
functions ascribed to Ail (Bartra et al., 2008). When ail is expressed in E. coli, it 
significantly increases the attachment of E. coli to fibronectin on tissue culture cells 
(Felek and Krukonis, 2009; Tsang et al., 2010). In addition, levels of attachment to tissue 
culture cells and Yop translocation are significantly reduced in ail deletion mutants of Y. 
pestis (Felek et al., 2010). In addition to its adhesive capabilities in Y. pestis, Ail also 
mediates resistance to complement and antimicrobial peptides such as polymyxin B 
(Bartra et al., 2008). There are differing reports as to the requirement of Ail in 
pathogenesis; however when an ail mutant was engineered in fully virulent Y. pestis 
background it was attenuated in an intranasal mouse model of infection (Bartra et al., 
2008; Felek and Krukonis, 2009; Kolodziejek et al., 2010).  
Pathogenesis of Y. pestis  
Several mouse models of plague infection have been developed to study the 
pathogenesis of Y. pestis. A subcutaneous route of inoculation is used to simulate bubonic 
plague, and intranasal and aerosol routes of inoculation are primarily used simulate 
primary pneumonic plague. Although intravenous routes of inoculation are frequently 
used in literature to study plague pathogenesis, these routes are primarily used to study 
attenuated forms of Y. pestis such as strains lacking the pgm locus, which are unable to 
cause disease when inoculated subcutaneously or intranasally. Transcriptional profiling 
of Y. pestis grown in fleas or broth culture before infection has shown that fleas are able 
to prime several mammalian virulence factors, suggesting that there are certain caveats 
that accompany any artificial route of inoculation (Vadyvaloo et al., 2010).  
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Using an intranasal mouse model of infection, Lathem et al. have shown that the 
pneumonic plague syndrome progresses in two distinct phases as defined by host immune 
responses and disease pathology (Fig. 1-3)(Lathem et al., 2005). The initial 36 hours of 
infection are characterized by rapid bacterial replication in the lung without generating 
appreciable host immune responses, histological changes in infected tissue or obvious 
disease symptoms. Levels of proinflammatory cytokines/chemokines in the lung during 
this pre-inflammatory phase of infection were similar to those seen in uninfected mice 
(Lathem et al., 2007; Lathem et al., 2005). These observations have been corroborated 
using other animal models of infection including rats and non-human primates (Agar et 
al., 2009; Agar et al., 2008; Bubeck et al., 2007; Koster et al., 2010).  
   
Figure 1-3: Progression of primary pneumonic plague in mice.  
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In contrast, an abrupt switch occurs at approximately 36-48 hours post-
inoculation (hpi) when the second phase of disease begins. This pro-inflammatory phase 
is marked by the upregulation of pro-inflammatory cytokines, consolidation of the 
airways by a neutrophilic response and the onset of physical symptoms (Lathem et al., 
2005). Progression into this pro-inflammatory phase marks a critical turning point during 
infection that invariably results in death if not treated promptly. The mechanistic basis for 
the timing and the trigger(s) of the dramatic switch in host response remains unknown. 
Recently, Comer et al. reported a similar biphasic response during bubonic plague and 
noted a correlation between the onset of inflammation and bacteremia (Comer et al., 
2010).   
 Biphasic disease progression during plague highlights the complex nature of the 
interactions between Y. pestis and its host. Two current models have been suggested for 
the biphasic nature of disease. The first model is based on the observation that the switch 
to the pro-inflammatory phase of disease occurs concurrently with our ability to detect Y. 
pestis in the blood and/or spleen (Fig 1-3). This model implies that Y. pestis is able to 
maintain a localized immunosuppressive environment at the site of infection or in the 
draining lymph node, but upon dissemination to the bloodstream, an immune cascade is 
initiated, resulting in robust neutrophil migration into the lungs and lymph nodes and 
creating the characteristic inflammatory lesions that develop between 36 and 48 hpi 
(Personal observations and Comer et al., 2010).  
The second model in the literature suggests that there is a delay in the shift from 
Yop-mediated apoptosis, which is caspase-3 dependent and non-inflammatory, to Yop-
mediated pyroptosis, which mediated by inflammasome and caspase-1 activation and 
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results in inflammation. The delayed shift may be responsible for the delayed 
inflammatory response (Bergsbaken and Cookson, 2009). For a macrophage to undergo 
inflammasome-mediated pyroptosis, it needs to first become activated. Since activated 
macrophages are not present until later in infection, there is a delay in the inflammatory 
response. Central to this model is the inflammasome, which is a component of the innate 
immune system and consists of an oligomeric protein complex that assembles upon 
activation by bacterial or viral signals to promote the maturation of the inflammatory 
cytokines IL-1β and IL-18 (Reviewed in Martinon et al., 2009). Indeed, several studies 
have recently been published demonstrating Yersinia-induced inflammasome activation 
(Bergsbaken and Cookson, 2007; Brodsky et al., 2010; Zheng et al., 2011). However, 
these studies were performed mostly with Y. pseudotuberculosis or attenuated strains of Y. 
pestis, and therefore, the in vivo relevance of inflammasome activation for Y. pestis 
pathogenesis or in the biphasic nature of disease progression remains unknown.  
Macrophages are frequently used to study many of the molecular mechanisms 
involved in Yersinia pathogenesis, in particular Y. pestis pathogenesis. Phagocytic cells, 
including macrophages, neutrophils and dendritic cells, have been shown to be the 
predominant cell types with which Yersinia interacts in vivo, defined by the injection of 
T3SS effectors (Durand et al., 2010; Köberle et al., 2009; Marketon et al., 2005). These 
studies also show that the interaction with phagocytic cells is preferential over other cell 
types including B-cells and T-cells. Initial interactions with macrophages and/or dendritic 
cells are thought to mediate the trafficking of Yersinia to regional lymph nodes (Pujol and 
Bliska, 2005). During these initial interactions, the enteric Yersinia are intracellular as 
they pass through M cells lining the intestinal wall (Clark et al., 1998; Marra and Isberg, 
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1997) and extracellular as they replicate in different tissues (Balada-Llasat and Mecsas, 
2006; Bergman et al., 2009; Simonet et al., 1990). However, the need for a transient 
intracellular lifestyle in Y. pestis pathogenesis is debated, as the vast majority of bacteria 
appear to be extracellular later in infection (Pujol and Bliska, 2005). Y. pestis can 
replicate inside macrophages in vitro (Pujol and Bliska, 2003) and can be found inside 
macrophages in vivo (Finegold, 1969; Lukaszewski et al., 2005; Meyer, 1950); however, 
the necessity of a niche for intracellular replication remains controversial. Differences in 
the initial growth temperature (26°C vs. 37°C) seem to dictate resistance to phagocytosis 
in vivo (Burrows and Bacon, 1956), suggesting that flea-transmitted Y. pestis (26°C 
inoculation) or bubonic plague may have a brief intracellular lifestyle, whereas person-to-
person transmitted Y. pestis (37°C inoculation) or pneumonic plague may not. Thus, 
while the interaction between Y. pestis and phagocytic cells plays an important role in Y. 
pestis pathogenesis, the nature of their interaction in vivo needs to be elucidated further.  
Compared to other Gram-negative bacteria, the delayed inflammatory response of 
plague is unusual (Bubeck et al., 2007). As mentioned previously, the Ysc-Yop T3SS and 
several effector Yops have been implicated in suppressing cytokine and chemokine 
production during plague infection. However, Y. pestis possesses other mechanisms of 
avoiding innate immune mechanisms. Lipopolysaccharide (LPS) with tetra-acylated 
forms of lipid A weakly activates Toll-like receptor 4 (TLR-4)-mediated inflammation 
compared to LPS with hexa-acylated forms of lipid A. Y. pestis primarily produces hexa-
acylated lipid A when grown at 26°C but converts to tetra-acylated lipid A at 37°C 
(Kawahara et al., 2002; Rebeil et al., 2004). However, when a strain of Y. pestis was 
engineered to produce hexa-acylated lipid A at 37°C, it was more than 100,000-fold and 
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350-fold attenuated in mouse models of bubonic plague and pneumonic plague, 
respectively (Montminy et al., 2006; Smiley, 2008). The attenuation phenotype is 
associated with increased levels of TNF-α and is dependent on TLR-4, an innate immune 
receptor for LPS (Montminy et al., 2006). These results suggest that wild-type Y. pestis 
evades innate immune detection in part by avoiding TLR-4-mediated immune activation. 
These results are consistent with observations that increased cytokine levels during the 
initial stages of infection are detrimental to Y. pestis and to the other Yersinia species 
(Autenrieth et al., 1994; Barton et al., 2007; Bohn et al., 1994; Nakajima and Brubaker, 
1993).  
Another possible mechanism for decreased immune activation is secreted LcrV, 
which activates TLR-2-mediated IL-10 production, producing an anti-inflammatory 
effect on innate immune cells (DePaolo et al., 2008; Reithmeier-Rost et al., 2004; 
Viboud and Bliska, 2005). However, these studies have primarily been performed with 
other Yersinia species and have not correlated well with Y. pestis pathogenesis when 
examined directly (Philipovskiy et al., 2005; Reithmeier-Rost et al., 2007). In addition, 
IL-10 production is not apparent when analyzed in vivo during pneumonic or bubonic 
plague (Bubeck et al., 2007; Comer et al., 2010; Lathem et al., 2005). This example 
highlights the growing body of evidence that suggests that slight genetic differences 
between different Yersinia species may impact the function of virulence factors and 
ultimately dictate the differences in disease outcome.  
The pgm locus has long been associated with virulence defects in Y. pestis, 
especially when inoculated subcutaneously. These defects have largely been attributed to 
the HPI that encodes for the biosynthesis and bacterial utilization of yersiniabactin. 
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However, Paauw et al. have recently shown that the production of reactive oxygen 
species (ROS) by neutrophils, monocytes and macrophages is blocked by yersiniabactin 
because it reduces iron availability to these cells (Paauw et al., 2009). Iron functions as a 
catalyst during Haber-Weiss reactions, which generate ROS. The reduction in ROS by 
innate immune cells likely leads to decreased bacterial killing and decreased neutrophil 
infiltration, as the production of hydroxyl radicals has been shown to promote neutrophil 
infiltration into the lung (Brandes and Kreuzer, 2005). These observations may explain 
the disparity between the virulence defects of mutants lacking yersiniabactin biosynthesis 
genes and mutants lacking iron utilization genes during pneumonic plague (Fetherston et 
al., 2010). The combination of decreased bacterial killing and decreased neutrophil influx 
during early stages of infection may also contribute to the biphasic nature of Y. pestis 
disease progression.  
The dynamics of host/pathogen interactions are inherently complex and highly 
individualized for different pathogens and for different hosts. The dynamic interaction 
between Y. pestis and its host highlight the multifaceted nature of these interactions, as 
evidenced by the biphasic disease progression during plague. Ultimately, a number of 
synergistic mechanisms, both those discussed here and those less appreciated, likely 
contribute to the extraordinary virulence of Y. pestis.  
Diagnosis, treatment and prevention of Y. pestis 
  Laboratory diagnosis of Y. pestis can be achieved through both bacteriologic and 
serologic methods from samples derived from a variety of different sources including 
lymph node aspirates, cerebrospinal fluid, urine and sputum. In smears, Y. pestis appears 
as a pleomorphic Gram-negative rod (1.0-2.0 x 0.5 µm) and may appear as single cells or 
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in small clusters (Perry and Fetherston, 1997). Y. pestis can be cultured on many solid 
and liquid culture mediums; however, growth is slow and visible colonies appear after 48 
hr. Colonies are normally smooth and opaque with round or irregular edges. Colonies 
may also have a raised center with a flat periphery or “fried egg” appearance when 
viewed under magnification (Smego et al., 1999). The optimal growth temperature for Y. 
pestis is 28°C, and if plague is suspected, all diagnostic cultures should be made in 
duplicate, one for growth at 28°C and one at 37°C. Y. pestis is classified as a oxidase-
negative, catalase-positive, urea-negative, indole-negative, non-lactose fermenter (Smego 
et al., 1999).  
 Antibody based methods, including direct immunofluorescence and serologic 
assays, can also be used to diagnose Y. pestis infection (Guarner et al., 2002; Smego et al., 
1999). Many of these assays use or detect antibodies directed against the F1 antigen of Y. 
pestis, which is relatively abundant and immunogenic; anti-F1 antibodies appear after the 
first week of infection. Paired serum samples are normally taken, one during the acute 
infection and another during postconvalescence. Enzyme-linked immunosorbent assays 
(ELISA) are normally performed to detect F1 antigen or the serum levels of anti-F1 
antibodies. A four-fold difference in titers between the paired samples is considered 
positive for Y. pestis infection, and a titer greater than 1:10 for a single serum sample is 
also indicative of infection (Perry and Fetherston, 1997). Serum samples from suspected 
plague patients are routinely analyzed at the CDC because most microbiology clinical 
laboratories are not equipped to definitively diagnose Y. pestis (Personal experience!!).  
The mortality rate of plague is very high if untreated. Therefore, effective and 
timely antibiotic treatment is critical for recovery. Streptomycin, gentamycin, tetracycline, 
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doxycycline and chloramphenicol are the commonly used, but fluoroquinolones have also 
been shown to be effective in animal studies and may be used in treatment (Perry and 
Fetherston, 1997; Smego et al., 1999). The antibiotic administered is often determined on 
a case-by-case basis; precautions should be taken in cases where non-life-threatening 
complications may arise, such as with pregnant or child-aged patients. Multiple 
antibiotics are routinely administered intravenously and intramuscularly during the initial 
treatment and then orally after a patient is stabilized. Prophylactic use of antibiotics 
(doxycycline or ciprofloxacin) is recommended for people exposed to plague patients 
especially those who come within six to ten feet of persons with pneumonic plague 
(Inglesby et al., 2000). In addition, suspected plague patients should be maintained in 
isolation, and attending staff should use appropriate personal protective equipment until 
at least two after the start of antibiotic treatment (Inglesby et al., 2000).  
During the Black Death, plague patients who survived were effectively resistant 
to reinfection and oftentimes were the only people willing to succor those afflicted with 
the disease (Tuchman, 1978). This suggests that is should be possible to develop vaccines 
that confer protection by priming the adaptive immune system against plague. Whole-cell 
killed vaccines were commonly used in the late 1800’s to vaccinate against a wide variety 
of bacterial and viral infections, including bubonic plague. However, side effects were 
common and multiple boosters were necessary to confer only partial protection. A live 
attenuated vaccine, EV76, which lacks the pgm locus, has also been widely used in 
humans in some plague endemic areas of the world, but is not currently available 
(Williamson, 2001).   
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The protective efficacy for both these vaccines was thought to be associated with 
the development of antibodies against the F1 antigen (Titball and Williamson, 2004), and 
purified F1 antigen has been shown to be more effective in protecting against plague 
challenge than the whole-cell killed vaccine. However, vaccines that exclusively target 
F1 antigen have been unsuccessful and have lead to F1 mutations during infection 
(Friedlander et al., 1995). In addition, these vaccines also do not confer protection against 
pneumonic plague. Conversely, F1/LcrV-based subunit vaccines have shown promise 
against both pneumonic and bubonic plague challenge in cynomolgus macaques 
(Williamson et al., 2011). Additional multi-antigen subunit vaccines are also being 
developed, and multiple efforts are underway to modify the antigens, adjuvants and 
delivery platforms needed to help improve the efficacy of sub-vaccines against Y. pestis 
(Reviewed in Smiley, 2008). 
Conclusions 
 Although the relative incidence of plague is currently relatively low, epizootic 
foci are prevalent worldwide. The recent epidemics in India in 1994 and in the Republic 
of Congo in 2006 call attention to the resurgent capabilities of this disease when 
environmental and political conditions are favorable (Perry and Fetherston, 1997; WHO, 
2006). There is also a heightened threat of the use of Y. pestis as an agent of bioterrorism, 
which would not only cause severe mortality in its victims but also cause widespread 
panic and civil unrest in affected populations. Thus, a more complete mechanistic 
understanding of disease progression, including virulence factors and host-mediated 
events involved in Y. pestis pathogenesis, is needed to identify appropriate therapeutic 
options.    
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Scope of the Project   
Although our understanding of primary pneumonic plague is increasing, most 
studies have concentrated on the end stages of the disease when disease pathology is 
evident. Very few studies have examined the early events of primary pneumonic plague 
(≤ 36 hours post-inoculation) when mice are largely asymptomatic despite the large 
bacterial burden in their lungs. There are also no significant changes in lung architecture 
or in inflammatory cytokine profiles during these early stages. In addition, the bacterial 
factors that facilitate the biphasic nature of this unusual disease progression are relatively 
unknown for pneumonic plague. Therefore, my project has two major goals: characterize 
the initial bacterial/host interactions in vitro and in vivo (Chapter 2) and develop a broad, 
unbiased microarray-based negative selection technique called transposon site 
hybridization (TraSH) to identify virulence factors involved in both the pre-inflammatory 
and pro-inflammatory phases of disease (Chapters 3-4). Thus, Chapter 2 will describe the 
in vitro and ex vivo adhesion and invasion characteristics of Y. pestis and the models 
developed to study the these interactions. The adhesins required for these interactions are 
also examined in Chapter 2. The development of the TraSH methodology and its use in 
identifying essential genes in vitro and virulence factors in vivo will be the focus of 
Chapter 3. The majority of my studies have focused on verifying and characterizing the 
unusual results from the TraSH negative selection screen (Chapter 4). Although not 
included as part of this work, in Chapter 5, I have included the abstracts for collaborative 
studies in which I have participated. The final chapter (Chapter 6) will provide overall 
conclusions and implications of this work on Y. pestis pathogenesis. 
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Characterizing early bacterial/host interactions during primary pneumonic plague 
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Abstract 
Pneumonic plague is the deadliest form of plague caused by Y. pestis. After the inhalation 
of infectious droplets, Y. pestis can interact with a myriad of different cell types, but the 
initial bacterial-host cell interactions during Y. pestis pulmonary infection are largely 
uncharacterized. I adapted our animal model of pneumonic plague to specifically 
examine the interactions between Y. pestis and lung tissues. I show that Y. pestis cannot 
be lavaged from the lung during the initial stages of infection, but is freely lavageable 
during the later stages of infection. Multiple outer membrane proteins appear to 
specifically bind to tissue culture cells, implying that adhesion is mediated by more than 
one protein. Recent studies have implicated Ail as an adhesin in Y. pestis, but I found that 
Ail functions more to confer membrane stability and the proper integration of proteins 
into the outer membrane than as an adhesin. Finally, the reintroduction of two major 
Yersinia adhesins, yadA and inv, into Y. pestis reduces the virulence of Y. pestis in both 
bubonic and pneumonic animal models of infection, offering an explanation as to why 
these genes were lost during the course of Y. pestis evolution. 
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Introduction 
Pneumonic plague is the deadliest, most rapidly progressing form of plague 
caused by Y. pestis. The onset of symptoms in humans normally occurs within 48 to 60 
hours and is marked by sudden chills, high fever, severe cough, chest pain, dyspnea and 
production of copious amounts of watery, frothy and oftentimes bloody sputum (Davis et 
al., 1996). Within the next 24 to 36 hours (3-4 days post-infection), pneumonic plague 
patients develop a severe pneumonia and usually succumb to respiratory failure or acute 
respiratory insufficiency and/or septic shock.  Meanwhile, the sputum and aerosols 
produced by coughing are teeming with bacteria, which are easily transmitted to anyone 
within six to ten feet of the infected individual. 
This, however, represents the terminal stages of pneumonic plague. In stark 
contrast, the initial 36 to 48 hours of infection are characterized by a lack of appreciable 
host immune responses, histological changes in infected tissue or obvious disease 
symptoms, classifying pneumonic plague as a bi-phasic disease syndrome. The potent 
anti-inflammatory activity of the Ysc-Yop T3SS likely contributes to the relative 
quiescence of early infection; however, Y. pestis lacks the two major adhesins found in 
both Y. enterocolitica and Y. pseudotuberculosis that are thought to be required for Ysc-
Yop T3SS function (Leo and Skurnik, 2011). Additional uncharacterized adhesins likely 
mediate the intimate association required for the translocation of Yops.  
To cause disease, Y. pestis needs to circumvent the innate immune mechanisms of 
the lung, including the mucociliary clearance provided by secretory goblet cells and 
ciliated cells, phagocytosis by alveolar macrophages resident in the large and small 
airways and a myriad of proteins and peptides that have anti-microbial and 
immunomodulatory activities (Suzuki et al., 2008). In particular, the lung epithelium 
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plays a critical role in recognizing infection through pattern recognition receptors (PRRs), 
triggering localized inflammatory responses via the production and release of cytokines 
and chemokines, recruiting monocytes by upregulating cell-cell adhesion molecules and 
controlling the infection through the increased secretion of antimicrobial proteins and 
peptides. However, very little or nothing is known about how Y. pestis interacts with the 
lung epithelium or the consequences of those interactions early during the infectious 
process before macrophages and neutrophils are recruited to the site of infection. 
Characterizing these early interactions is essential in understanding early events in 
primary pneumonic plague. This chapter will outline the work I have done to characterize 
bacterial/host interactions in vitro and in vivo and my efforts to identify unknown Y. 
pestis adhesins.   
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Results and Discussion 
In vitro Y. pestis adhesion and invasion tissue culture model 
Upon entering the lung, Y. pestis has the opportunity to interact with a variety of 
cell types before it reaches the small airways. The pseudostratified and columnar 
tracheobronchial epithelium, which provide the major mechanisms for the mucocilliary 
clearance, consist of ciliated cells, secretory goblet cells and microvilliated cells. The 
bronchioles consist of cuboidal epithelium and secretory Clara cells, which are the major 
epithelial cells. Finally, the alveolar epithelium or small airways consists almost 
exclusively of alveolar type I cells and alveolar type II cells, with about 95% of the 
alveolar epithelium consisting of alveolar type I cells (squamous alveolar cells), which 
provide for gas exchange in the lung. Although alveolar type II cells (septal cells) 
comprise 60% of the cells lining alveolus, because of their shape they cover a much 
smaller surface area than alveolar type I cells (<5%). Alveolar type II cells are 
responsible for the production and secretion of surfactant, a group of phospholipids and 
small hydrophobic proteins that reduce alveolar surface tension. The ability of the lung 
epithelial surface to mount an immune response and its role during infection is only 
beginning to be truly appreciated (Hippenstiel et al., 2006). Pneumonic plague is 
primarily a disease of the small airways (Lathem et al., 2005); therefore, I established an 
in vitro model system to help determine the molecular mechanisms involved in these 
early pathogen-host cell interactions in the small airways.  
I elected to use A549 cells (ATCC #CCL-185), which are a human alveolar type 
II pneumocyte carcinoma cell line that has been used extensively as a model of the small 
airway epithelium (Liu et al., 2006). Using an MOI of 10 bacteria to 1 cell (MOI 10:1), I 
found that Y. pestis adheres to and invades these cells. On average, 17.5% of the 
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inoculating bacteria were able to adhere to A549 cells at 1 hour post-inoculation (hpi) and 
12.5% at 3 hpi, whereas only approximately 2-3% of these bacteria were able to invade 
the A549 cells at 3 hpi as determined by gentamycin protection assays (Fig. 2-1A-B). 
This appears to be specific for Y. pestis because E. coli was unable to adhere to or 
colonize this cell line. Similar observations were seen for 6 and 12 hpi (data not shown). 
Finally, I used hamster tracheal epithelial (HTE) cells, which are a homogeneous primary 
cell culture that have characteristics of both small and large airway epithelial cells 
(Baseman et al., 1980; Goldman and Baseman, 1980), to show that Y. pestis adheres to 
and invades these cells in a similar manner (data not shown). These results demonstrate 
that Y. pestis is able to adhere to epithelial tissue culture cells in vitro, and although they 
are able to invade these cells, the frequency is very low.    
 
Figure 2-1: Tissue culture model of Y. pestis adherence and invasion. (A) 
Adherence of Y. pestis and E. coli to A549 cells at various time points post-
inoculation. Bacteria were inoculated at an MOI of 10:1 (bacteria:cells). Each bar 
represents the mean percent adherence relative to the inoculum. (B) Invasion of Y. 
pestis and E. coli into A549 cells at various time points post-inoculation as 
determined by gentamicin protection assays. Bacteria were inoculated at an MOI of 
10:1. At the indicated time point (1 or 3 hr), the cells were incubated with gentamicin 
to kill extracellular bacteria. Each bar represents the mean percent invasion relative 
to the inoculum. Error bars represent standard error of the mean (SEM).   
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In vivo Y. pestis adhesion and invasion model 
Our laboratory has characterized the progression (kinetics) of disease using a 
C57BL/6J mouse model of infection (Lathem et al., 2005). As past of these same studies, 
we were able to determine that approximately 85% of the bacteria at 48 hpi could be 
extracted from the lung by bronchoalveolar lavage (BAL). However, in attempts to 
extract bacteria from the lung by BAL at 2 hpi to examine Y. pestis-interacting cell types, 
I found that BAL could extract only approximately 10% of total bacteria in the lungs. 
Using a series of different time points, I found that as the infection progressed BAL can 
extract an increasing larger number of bacteria (Fig. 2-2A). The percent of lavageable 
bacteria correlates almost directly with the number of bacteria in the lung. Additional 
experiments show that this phenotype is not dependent on the size of the initial inoculum, 
the Ysc-Yop T3SS (pCD1) or known putative adhesins of Y. pestis (Fig. 2-2B). This 
observation tends to be specific for Y. pestis because over 75% of Δbvg B. pertussis and 
over 50% K. pneumoniae can be lavaged from the lung at 4 hpi (Fig. 2-2B). Interestingly, 
similar numbers of bacteria are present in the lungs for both the 1x105 inoculum at 2 hpi 
and the 1x104 inoculum at 12 hpi, yet 4-fold more bacteria can be extracted by BAL from 
mice at 12 hpi. These data suggest that the ability of Y. pestis to remain in the lungs 
during a BAL is more dependent on time post-inoculation than the number of bacteria.  
A bacterium’s surrounding environment often determines its expression profile, 
including genes that encode virulence factors. Growth of Y. pestis in the flea has been 
shown to induce a state in which Y. pestis is more resistant to innate immune defenses 
when inoculated into a mouse (Vadyvaloo et al., 2010). To test whether my observations 
were the result of broth-grown bacteria, I designed a series of experiments in which I 
inoculated mice with bacteria harvested by BAL from mice that had been intranasally 
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inoculated 48 hours previously, when the bacteria are predominantly lavageable. The 
kinetics of infection, gross pathology and time to death for these “naturally” infected 
mice were similar to mice infected with broth-grown bacteria (data not shown). However, 
 
Figure 2-2: Adherence of Y. pestis to lung tissues during pulmonary infection. (A) 
Time course for lavagable bacteria from the lungs of intranasally infected C57BL/6J 
mice. CFU per lung of lavagable bacteria were determined at various time points 
post-inoculation. (B) Percent lavagable bacteria were compared for wild-type Y. 
pestis (YP3), pCD1- mutants (YP6), ΔpsaA mutants (YP16), K. pneumoniae 
(KPPR1) and Δbvg B. pertussis (BC39). The size of the initial inoculum was also 
evaluated, 1x104 vs. 1x105. (C) Percent lavagable bacteria were compared for wild-
type Y. pestis that had been pre-grown in broth or lavaged from the lungs of plague 
infected mice (48 hpi). (A-C) Each bar represents the mean percent lavagable 
bacteria from five mice. Percentages were calculated by comparing CFU recovered 
from BALF and lung homogenates. Error bars represent SEM. 
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when I performed BAL experiments at 4 hpi, I was unable to detect bacteria in the 
bronchoalveolar lavage fluid (BALF) (Fig. 2-2C). These data suggest that there may be 
subtle changes the infectious state of Y. pestis upon natural transmission. Although the 
ultimate outcome of the infection is the same, natural transmission may alter the initial 
infection, which may possibly lower the LD50. These observations need to be examined 
in more detail to determine whether a “natural” infection alters the initial dynamics of 
pneumonic plague. 
Y. pestis can survive and replicate inside macrophages in vitro and ex vivo. 
Although Y. pestis is predominantly extracellular during later stages of infection, an 
intracellular lifestyle has been postulated to be important during the early stages of 
infection (Bosio et al., 2005; Pujol and Bliska, 2003; Pujol and Bliska, 2005). However, 
many of these observations have been made in vitro with tissue culture cells or in vivo 
using Y. pseudotuberculosis. To test whether Y. pestis has an early facultative 
intracellular lifestyle during pulmonary infection, I performed ex vivo gentamicin 
protection assays on bronchoalveolar lavage fluid (BALF) from mice inoculated 
intranasally at 4 hpi. The results show that approximately 10% of the bacteria present in 
the BALF (~1% of the total bacteria in the lung) were resistant to gentamicin (Fig. 2-3A), 
implying that they are intracellular (Bosio et al., 2005). I also adapted my ex vivo 
gentamicin protection assays to examine the intracellular nature of Y. pestis on a whole 
lung basis (Technique adapted from Justice et al., 2006). Approximately 2-3% of Y. 
pestis were resistant to gentamycin at 4 hpi and 4-5% at 24hpi. In contrast, approximately 
85% of Y. pseudotuberculosis were resistant to gentamycin at 4 hpi (Fig. 2-3B), 
suggesting that when Y. pestis is pre-grown at 37°C and inoculated intranasally, it 
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remains predominately extracellular throughout the course of infection. However, the 
importance of the 2-3% of intracellular bacteria during infection is still unknown. 
Together, these in vivo data indicate that the majority Y. pestis are able to adhere tightly 
to the extracellular surfaces of the lung during the initial stages of infection. In contrast, 
during the later stages of infection Y. pestis can be freely associated lung tissue, which 
may facilitate person-to-person transmission.  
Potential candidates encoding Y. pestis adhesins  
Adherence to host lung cells is an essential step in the infectious process because 
the mechanical properties of the mucociliary escalator clear bacteria and other foreign 
 
Figure 2-3: Determination of intracellular and extracellular Y. pestis during 
pulmonary infection. (A) Gentamicin resistant (intracellular) bacteria present in 
BALF. BALF from the lungs of intranasally infected C57BL/6J mice was treated with 
100 µg ml-1 gentamicin or mock treated for 1 hr, and CFU per lung were then 
determined for lung homogenates and treated/untreated BALF. Percentages were 
determined from the total number of bacteria in both BALF and lung homogenates. 
Error bars represent SEM. (B) Percent intracellular bacteria were determined for 
wild-type Y. pestis (YP3) at 2 and 24 hpi and Y. pseudotuberculosis (BGY30) at 2 
hpi. Each bar represents the mean percentage of intracellular bacteria for three 
mice. Percentages were calculated by comparing CFU recovered from gentamicin-
treated lungs and mock-treated lungs.  
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particles from the lung. This mucociliary escalator plays an important part in maintaining 
the sterility of the lungs. However, many lung pathogens have adhesins that allow them 
to circumvent mechanical clearance. Additionally, the translocation of Ysc-Yop T3SS 
effector proteins (Yops) requires an intimate bacterial interaction with the host cell 
membrane. The major adhesins that mediate these processes for both Y. 
pseudotuberculosis and Y. enterocolitica, YadA and Inv, have been well characterized 
(Leo and Skurnik, 2011) but are inactivated in Y. pestis, suggesting that the major 
adhesin(s) required intimate host contact and Yop translocation in Y. pestis are unknown 
(Simonet et al., 1996; Skurnik and Wolf-Watz, 1989).  
Many studies have concentrated on identifying and characterizing adhesins in Y. 
pestis. The primary potential adhesins that have been studied include: Pla, which enables 
E. coli to adhere to and be internalized by HeLa cells (Lähteenmäki et al., 2001); Pla2, a 
chromosomally encoded homolog of Pla; the psa locus, which is responsible for forming 
individual fimbrial strands when the bacteria are grown at pH 6 (Liu et al., 2006); and Ail, 
which enables E. coli to adhere to tissue culture cells as well as conferring serum 
resistance (Bartra et al., 2008; Felek and Krukonis, 2009). However, Y. pestis mutants 
lacking both Pla and PsaA still show considerable adherence to and invasion into tissue 
culture cells, indicating the presence of additional surface molecules involved in adhesion 
and invasion (Kukkonen and Korhonen, 2004; Liu et al., 2006). I generated deletion 
mutations for each of these genes and tested the resulting mutants for adhesion defects on 
A549 cells. As observed in the literature, none of these mutations showed decreased 
levels of Y. pestis adherence to A549 cells except ail deletion mutants (YPO2905) (data 
not shown). Phenotypes for ail deletion mutants are described below.  
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The complete Y. pestis CO92 genome recently became available (Parkhill et al., 
2001). I used known adhesins from the literature to search for homologs in Y. pestis that 
may have adhesive properties. I identified seven genes/operons that encoded proteins 
with homologies to known adhesins: YPO598-599, Fha-like hemolysin/adhesin; 
YPO683-695, Tight adherence protein (Tad) operon; YPO1387-1388, Invasin-like 
adhesin; YPO2490-2491, Fha-like hemolysin/adhesin; YPO3797-3802, CfaA fimbrial 
operon; YPO3877-3882, Pilli assembly operon; and YPO3944, Invasin-like adhesin. I 
constructed deletion mutations in each individual operon and different combinations of 
operons that were homologous to each other using lambda red-based homologous 
recombination. C57BL/6J mice were infected intranasally with 1x104 of each mutant and 
 
Figure 2-4: Evaluation of potential adhesion mutants in an intranasal animal model 
of infection. C57BL/6J mice were intranasally inoculated with wild-type Y. pestis or 
potential adhesion mutants [YP3 (wild-type), YP186 (ΔYPO683-695), YP223 
(ΔYPO3797-3802), YP225 (ΔYPO3877-3882), YP234 (ΔYPO598-599/ΔYPO2490-
2491) or YP235 (ΔYPO1387-1388/ΔYPO3944)]. CFU per lung (A) and spleen (B) 
were determined at 48 hpi. Each bar represents the mean CFU recovered from 
three mice. Error bars represent SEM. 
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euthanized at 48 hpi to examine gross pathology and bacterial burden. I did not observe 
any statistically significant differences in lung or spleen bacterial burdens or gross 
histopathology for any of these mutants compared to wild-type Y. pestis (Fig. 2-4A-B). 
Subsequent to these studies, Forman et al. showed that mutants lacking YPO1388 have 
an increased LD50 when inoculated subcutaneously but not intranasally (Forman et al., 
2008). The differences in LD50 between the different routes of inoculation emphasize the 
apparent necessity for specific virulence factors at particular cites of inoculation, where 
the repertoire of immune cells and their immunologic responses to infection can vary 
considerably.   
Biotinylation of Y. pestis surface proteins   
Pull-down assays are extensively used to identify specific protein-protein 
interactions in a complex mixture of proteins. This approach has been used to isolate 
biotinylated bacterial proteins that specifically interact with components on eukaryotic 
cell surfaces (Castañeda-Roldán et al., 2006). For this technique, bacterial outer 
membranes are biotinylated using Sulfo-NHS-LC-Biotin, which readily dissolves in polar 
solutions and does not permeate cellular membranes, biotinylating only surface 
components. I used this technique to biotinylate Y. pestis surface proteins. Outer 
membrane fractions from biotinylated Y. pestis were then purified, solubilized and 
incubated with A549 cells for one hour. The cells were then extensively washed to 
remove any residual or loosely adherent proteins. Biotinylated bacterial proteins that 
remained adherent to the A549 cells were then detected on far-western blots that were 
probed with streptavidin-HRP. Four major bands (2 kDa, ~36 kDa, ~50 kDa and ~80 
kDa) were present whole cell exacts were probed (Fig. 2-5A). Importantly, none of these 
 58 
 
  
Figure 2-5: Biotinylation of Y. pestis surface proteins and evaluation of potential 
adhesins during infection. (A) Far-western blots of Y. pestis outer membrane 
proteins that were mock-biotinylated (lane 1) or biotinylated (lane 3 – 1/10 dilution). 
Biotinylated Y. pestis outer membrane proteins were then incubated with A549 cells 
for 1 hr (lane 2). (B-C) C57BL/6J mice were intranasally infected with wild-type Y. 
pestis or potential adhesion mutants [YP3 (wild-type), YP356 (ΔompA), YP357 
(ΔkatY) or YP362 (ΔompA/ΔkatY)]. CFU per lung (B) and spleen (C) were 
determined at 48 hpi. Each bar represents the mean CFU recovered from three 
mice. Error bars represent SEM. 
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bands were the predicted molecular weight for any of the putative Y. pestis adhesins, 
including Ail, Pla or PsaA, indicating that they do not specifically bind to A549 cells 
under these assay conditions. However, when I used streptavidin affinity resins to 
specifically isolate these proteins, I was unable to isolate sufficient quantities for positive 
identification via mass spectrometry.  
Fortunately, Myers-Morales et al. conducted a series of biotinylation experiments 
to identify possible protective antigens on the surface of Y. pestis (Myers-Morales et al., 
2007). From their data, I postulated that the ~36 kDa and ~80 kDa proteins from my 
biotinylation pull-down experiments could be OmpA and KatY, respectively. Therefore, I 
constructed ΔompA, ΔkayY and ΔompA/ΔkatY Y. pestis mutants to determine their 
adhesive properties. Repeated biotinylation experiments with ΔompA and ΔkayY pCD1- 
mutants indicated that my assumptions were correct, as there was a corresponding loss of 
either the ~36 kDa or ~80 kDa band (data not shown) in the membrane fractions. Both 
ΔompA and ΔkayY pCD1- mutants were less autoaggregative when grown at 37°C (data 
not shown). In addition, OmpA has recently been implicated as an adhesin in certain 
strains of E. coli (Smith et al., 2007). However, both individual mutants and an 
ΔompA/ΔkatY double mutant were fully virulent when C57BL/6J mice were inoculated 
intranasally (Fig 2-5B-C). Interestingly, unlike the ΔompA and ΔkatY single mutants I 
generated in a pCD1- background, the ΔompA/ΔkatY double mutant in a pCD1+ 
background does not have an autoaggregation phenotype (data not shown). This would 
suggest that there might be additional adhesive proteins encoded on the pCD1 plasmid or 
at least induced by the presence of the T3SS. Together these data suggest that Y. pestis 
possesses multiple adhesive molecules. However, sufficient quantities of protein for mass 
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spectrometry identification from the pull-down assays are still needed to ensure that the 
~36-kDa and ~80-kDa proteins are indeed OmpA and KatY and not other proteins with 
similar masses.    
Enrichment and characterization of mutants unable to effectively colonize the lung 
As described above, Y. pestis adheres tightly to lung tissue during a BAL (Fig 2-
2A). I took advantage of this observation to devise an enrichment strategy for isolating 
mutants that are unable to effectively adhere to lung tissues and hence unable to 
efficiently colonize the lung. This strategy involved infecting mice with library of 
transposon mutagenized Y. pestis and lavaging the lungs of the infected mice two hours 
later. Bacteria that are lavaged from the lung are then used to infect additional mice. This 
process is repeated for three rounds of infection, thus, enriching for bacteria that are less 
adherent to lung tissues. One obvious caveat to this strategy is that it assumes that a 
single transposon insertion can reduce the adherence of Y. pestis to lung tissues enough to 
be enriched after multiple rounds of BAL. I performed these experiments using a Himar-
1-based transposon system, and using high throughput sequencing technology, I 
determined the transposon insertion sites for the remaining mutants after three rounds of 
enrichment (described in Chapter 3) (Table 2-1).  
Upon analyzing the list of genes with transposon insertions that were enriched in 
the mutant pool, I noticed a pattern in the type of enriched mutants. There were a large 
number of mutants that had transposon insertions in genes that are involved in sugar 
transport or sugar processing. Tim Brooks’ lab has shown that adding certain types of 
oligosaccharides to Y. pestis before measuring adherence to tissue culture cells reduces 
the ability of Y. pestis to bind to cells (Thomas and Brooks, 2006). Based on these data, it 
is very likely that a large number of the enriched mutants in this pool are the result of 
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increased levels of extracellular or periplasmic oligosaccharides inhibiting the actual 
adhesin.  
For example, the mutant that were enriched the most after the ail mutants (see 
below) had transposon insertions in the gene amiD, which is involved in recycling 
peptidoglycan in the periplasm (Uehara and Park, 2007). An amiDampG deletion mutant 
Table 2-1: Gene identification of enriched mutants. The gene ID, the relative number 
of sequences for a particular gene, the ratio of the mutant in the input vs. the output 
library and the annotation for each gene are included.   
Gene ID Sequences Output/input ratio Gene annotation 
YPO2905 332522 5733.14 (ail) attachment invasion locus protein 
YPO1715 136939 2794.67 (ybjR) probable N-acetylmuramoyl-L-alanine amidase 
YPO2287 49533 2607.00 taurine transport system permease 
YPO0655 35823 11.60 (asoB) involved in surface layer secretion 
YPO1841 35238 419.50 (flaV) flagellar hook assembly protein 
YPO1743 30203 54.32 (aroP) aromatic amino acid transporter 
YPO4068 28837 6.43 (mtlA) Mannitol-specific enzyme IIABC of PTS transport  
YPMT1.04c 25072 9.99 unknown function 
YPO3991 24514 43.85 putative insulinase family protease 
YPO1581 21639 3.27 (rafA) alpha-galactosidse 
YPO3965 21247 4.47 hybrid two component system 
YPO0698 19356 31.89 chaperone usher system 
YPO2718 18490 1155.62 (rnc) ribonuclease III 
YPO3992 18450 34.81 (dctA) C4-decarboxylate transport protein 
YPO4082 17165 572.17 (avtA) pyruvate aminotransferase 
YPO3987 17002 18.22 unknown function 
YPO3016 15223 8.59 (nanT) sialic acid transporter 
YPO3923 14610 7.09 heme receptor protein 
YPO3129 13923 14.15 (aefA/kefA) potassium efflux system 
YPCD1.29c 13909 1069.92 (yopB) T3SS translocon component 
YPO4093 12609 40.41 putative haloacid dehalogenase-like hydrolase 
YPO1254 12271 19.14 (bglA) 6-phospho-beta-glucosidase 
YPO1440 11702 229.45 putative helicase IV 
YPO0181 11580 5790.00 sodium dependent serotonin ABC transport protein 
YPO0402 11396 52.28 PTS system, IIB component 
YPO1661 10938 9.41 (mgtB) Mg(2+) transport ATPase protein B 
YPO2289 10517 24.01 (srfA) Salmonella putative virulence factor 
YPO0587 10334 41.17 (yapG) autotransporter 
YPO3087 10320 245.71 (ybaP) conserved hypothetical protein  
YPO3798 10313 5.27 fimbrial subunit precursor 
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in E. coli releases large amounts of disaccharide-peptide subunits of peptidoglycan (also 
known as TCT) into the surrounding environment. Y. pestis C092 releases small amounts 
of TCT into the media (data not shown), but mutations in amiD may increase these levels. 
Disaccharides similar to those found in the disaccharide portion of TCT have been shown 
to inhibit Y. pestis adherence to tissue culture cells (Thomas and Brooks, 2006) and may 
explain why this mutant was enriched during the screen for non-adherent mutants. These 
findings suggest that the predominant adhesins in Y. pestis utilize certain mono- or 
polysaccharides found on lung tissues for adherence.   
 Mutants with transposon insertions in the gene ail (YPO2905) were highly 
enriched during the serial enrichment strategy. As described previously, ail mutants have 
a very distinct colony morphology (Kolodziejek et al., 2007), and I initially used these 
observations to determine that mutants with transposon insertions in ail were being 
highly enriched. High throughput sequencing analysis of the entire pool of enriched 
mutants confirmed that mutants with transposon insertions in ail were by far the most 
enriched mutants in the pool. Ail is a 17 kDa outer membrane protein that has eight 
membrane-spanning amphipathic β-strands with four extracellular loops (Miller et al., 
1990; Plesniak et al., 2011). The Ail homolog in Y. enterocolitica, when expressed in E. 
coli, has been shown to confer a high-level of attachment and invasion to tissue culture 
cells and to confer serum resistance (Bliska and Falkow, 1992). However, Ail homologs 
in Y. pseudotuberculosis and Y. pestis only have a slight adhesive phenotype (Felek and 
Krukonis, 2009; Yang et al., 1996). A number of related proteins have been found in 
other organisms and despite their high degree of similarity, their ascribed functions vary 
widely (Baldermann et al., 1998; Cirillo et al., 1996; Mecsas et al., 1995; Miller et al., 
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1992). Although a few of these related proteins have minor phenotypes in their respective 
mouse models of infection when mutated, ail mutants in Y. enterocolitica or Y. 
pseudotuberculosis do not (Wachtel and Miller, 1995). On the other hand, when I 
constructed a clean ail deletion mutant using our standard lambda red- based homologous 
 
Figure 2-6: Kinetics of infection for a Δail Y. pestis mutant. (A-B) Kinetics of 
infection for wild-type Y. pestis (YP3 - solid circles) and Δail mutant (YP314 - open 
circles) infected intranasally in C57BL/6 mice. CFU per lung (A) and spleen (B) 
were determined at various time points of infection. Each bar represents the 
geometric mean for CFU recovered from five mice. The limit of detection is 
represented by a dotted line. (C) Adherence of pCD1- Y. pestis and Δail pCD1- 
mutant to A549 cells at 1 hpi. Bacteria were inoculated at an MOI of 10:1. Each bar 
represents the mean percent adherence relative to the inoculum. Error bars 
represent standard deviation (SD) from the mean. * p ≤ 0.05. 
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recombination protocol, it was severely attenuated in our mouse model of pneumonic 
plague (Fig. 2-6A-B) and showed a 10-fold decrease in adhesion to A549 cells (Fig. 2-
6C), which has subsequently been reported in the literature (Felek and Krukonis, 2009; 
Kolodziejek et al., 2010). However, it is unclear whether the adhesive phenotype or some 
other reported function of Ail such as serum resistance is responsible for this severe 
attenuation.  
Each mutant I generate in the laboratory undergoes a series of tests to confirm that 
all the major virulence loci (pCD1, pMT1, pPCP1 and pgm locus) are present and that 
Ysc-Yop T3SS is functional. Upon testing my clean Δail mutant, I noticed that even 
though it had the pCD1 plasmid, it failed to fully undergo a classic low calcium response 
when grown at 37°C without supplemental calcium. Instead, the Δail mutant was able to 
grow quite readily on BHI-MOX plates at 37°C although not as well as pCD1- mutants 
(data no shown). As reported in the literature (Felek and Krukonis, 2009), my Δail 
mutant was able to secrete Yops, but the secretion profile for the Δail mutant was 
surprising more similar to that of a Δpla mutant than wild-type Y. pestis (Fig. 2-7A). The 
plasminogen-activating protease Pla normally cleaves extracellular Yops and hence, a 
Δpla mutant has a very distinct Yop secretion profile. Given that modifications in the 
structure of LPS can alter the activity of Pla (Suomalainen et al., 2010), I performed 
several membrane stability assays on a Δail mutant in a pCD1- background. As reported 
by Bartra et al., my Δail mutant was 10-fold more susceptible to antimicrobial peptides 
(MIC for polymyxin B – YP6 - ≥ 250 µg ml-1 vs. YP314pCD1- - 25 µg ml-1) and human 
serum compared to pCD1- Y. pestis (data not shown)(Bartra et al., 2008). Certain cationic 
dyes also inhibit bacterial growth, and growth in the dye is often directly dependent on 
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the degree of membrane stability (Bengoechea et al., 1998). The Δail mutant showed 
increased susceptibility to crystal violet (MIC for crystal violet – YP6 - ≥ 64 µg ml-1 vs. 
YP314 pCD1- - 16 µg ml-1) compared to wild-type pCD1- Y. pestis. During assays used to 
test membrane stress, such as growing the bacteria on the detergents, I noticed that the 
unusual colony morphology of the ail mutant could be mimicked by growing wild-type 
pCD1- Y. pestis on media containing 0.1% Triton-X (data not shown), suggesting that a 
decrease in membrane stability may be responsible for the colony morphology of the Δail 
mutant. In addition, growth of a Δail mutant at 37°C results in the release of 100-fold 
more LPS into the media compared to wild-type pCD1- Y. pestis, which release can be 
 
Figure 2-7: Characterization of Yop secretions profiles in wild-type and Δail mutant 
Y. pestis. (A) Yop secretion profile after 3 hr of growth in BHI-MOX media for wild-
type Y. pestis (YP3 – lane 1), a Δail mutant (YP314 - lane 2) and a Δpla mutant 
(YP102 – lane 3). Supernatants were precipitated with trichloroacetic acid, run on a 
12% SDS-PAGE gel and stained with coomassie blue. Standard molecular weight 
markers are indicated. (B) C57BL/6 mice were infected intranasally with wild-type Y. 
pestis (YP3 - solid circles) and Δail mutant (YPI58 - open circles). CFU per lung and 
spleen were determined at 48 hpi. Each bar represents the geometric mean for 
CFU recovered from five mice.    
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ameliorated by supplementing the media with calcium. These results further suggest that 
Ail is acting to stabilize the bacterial outer membrane because excess calcium helps 
stabilize interactions between LPS molecules in the outer membrane of Gram-negative 
bacteria (Alakomi et al., 2003).   
Strikingly, Δail mutants that have been passaged fewer times, i.e., where the 
kanamycin resistance cassette has not been resolved, are almost as virulent as wild-type 
bacteria (Fig. 2-7B). These data suggest that while Ail may not be in and of itself be an 
adhesin for Y. pestis, the loss of Ail in the outer membrane may lead to membrane 
instability and secondary compensatory mutations may affect other outer membrane 
proteins, such as Pla and putative adhesins. In agreement with this hypothesis, Pierson 
conducted a transposon mutant screen in Y. enterocolitica to identify genes whose 
inactivation resulted in increased Ail production and identified mutants with transposon 
insertions in genes involved in LPS biosynthesis (Pierson, 1994). Remarkably, many of 
these same genes, which are involved in O-antigen biosynthesis, are pseudogenes in Y. 
pestis (Parkhill et al., 2001), suggesting that increased production of Ail may be 
compensating for the loss of membrane stability caused by the inactivation of certain LPS 
biosynthesis genes (Yethon et al., 2000), whose inactivation, coincidently, is required for 
the proteolytic activity of Pla (Kukkonen et al., 2004; Pouillot et al., 2005). Further 
investigation is needed to test this hypothesis, and genomic or proteomic comparisons 
between these two Δail mutant strains may be useful in determining which proteins in the 
outer membrane may act as the actual adhesins. These data also suggest that the severe 
animal phenotype seen for the Δail mutant lacking the kanamycin resistance cassette may 
be partially due to decreased Pla activity (Compare with Lathem et al., 2007). 
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inv or yadA expression in Y. pestis and their in vivo effect on pathogenesis 
 The evolution of Y. pestis from Y. pseudotuberculosis involved the acquisition, 
loss and modification of several genes including predominant virulence factors. The 
slight modification of several genes has been implicated in virulence in Y. pestis 
including changes to the structure of LPS (Montminy et al., 2006) and reductions in the 
secretion of a type-three effector (Zauberman et al., 2009). As mentioned previously, the 
major adhesins for both Y. pseudotuberculosis and Y. enterocolitica, YadA and Inv, are 
both inactivated in Y. pestis. I introduced functional versions of these genes from Y. 
pseudotuberculosis into Y. pestis to determine whether their loss was the result of 
selective pressures or random mutation. These experiments were approved by the 
Biological Safety Officer and Institutional Biological & Chemical (IBC) Safety 
Committee at Washington University in St. Louis. 
Previously, Rosqvist et al. reported that replacing the Y. pestis virulence plasmid 
(pCD1) with the virulence plasmid from Y. pseudotuberculosis (pYV) reduces the 
virulence of Y. pestis (Rosqvist et al., 1988). They also showed that wild-type levels of 
virulence were restored when YadA was disrupted but failed to characterize these results 
further. I similarly reintroduced yadA into Y. pestis by exchanging the entire pCD1 
plasmid for pYV to create a pCD1- pYV+ mutant of Y. pestis. [Please note that the 
following observations were attributed to YadA only after the bulk of these analyses were 
completed; therefore the appropriate controls with defined pCD1- pYV+ΔyadA mutants 
were limited.] I infected C57BL/6J mice intranasally with a pCD1- pYV+ mutant of Y. 
pestis and observed some unusual alterations in the disease course of the plague 
syndrome. Mice infected with pCD1- pYV+ Y. pestis presented with physical signs of 
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disease much earlier than wild-type Y. pestis, where the animals showed the first signs of 
illness at 24-36 hpi compared to 36-48 hpi for wild-type-infected animals. In agreement 
with these observations, lung histology sections showed more neutrophil influx and lung 
consolidation at 48 hpi for pCD1- pYV+ Y. pestis compared to wild-type bacteria (Fig. 2-
8C-D). However, the bacterial burdens in the lungs during the time course of disease 
were not significantly different; however, there was a reproducible delay in dissemination 
to the spleen at 48 hpi for pCD1- pYV+ Y. pestis (Fig. 2-8A-B). In addition, there was an 
increase in the time to death for mice infected with this mutant, which survived 12-24 hr 
longer than their wild-type controls (Fig 2-8E). I believe that these data indicate that lung 
pathology alone cannot fully explain the rapid time of death during primary pneumonic 
plague but that bacterial dissemination and the resultant multi-organ failure induced by 
septicemia may have a significant impact on the ultimate cause of death.  
Mutants of Y. pestis that cause pathology earlier during infection are attenuated in 
a subcutaneous model of infection (Zauberman et al., 2009). Given the increased and 
early onset of pathology in the lung for the pCD1- pYV+ mutant, I used a subcutaneous 
inoculation to analyze the effect of YadA on bubonic plague. I inoculated C57BL/6J mice  
subcutaneously with pCD1- pYV+ or wild-type Y. pestis and observed a decrease in 
colonization of the lymph nodes and a delay in dissemination to the spleen at 48 hpi (Fig. 
2-9A-B). As the infection progressed, the size and weight of the lymph nodes from mice 
infected with pCD1- pYV+ Y. pestis were significantly smaller than the lymph nodes from 
mice infected with wild-type Y. pestis (Fig 2-9C). Moreover, the average time to death 
for mice infected with wild-type and pCD1- pYV+ Y. pestis was 96 and 192 hpi, 
respectively (Fig 2-9D). Interestingly, the lymph nodes of two moribund pCD1- pYV+ Y. 
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Figure 2-8: Pulmonary infection with pCD1- pYV+ Y. pestis. (A-B) Kinetics of 
infection for wild-type Y. pestis (YP3 - solid circles) and pCD1- pYV+ Y. pestis 
(YP361 - open circles) infected intranasally in C57BL/6 mice. CFU per lung (A) and 
spleen (B) were determined at various time points of infection. Each bar represents 
the geometric mean for CFU recovered from five mice. The limit of detection is 
represented by a dotted line. (C-D) Histology sections of paraffin embedded lungs 
stained with hematoxylin and eosin for mice intranasally infected with wild-type (C) 
and pCD1- pYV+ Y. pestis (D). (E) Survival analysis of wild-type and pCD1- pYV+ Y. 
pestis during pulmonary infection, in which the mean time to death was 75 and 90 
hpi, respectively. 
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pestis-infected mice at 208 hpi showed limited signs of inflammation, and the terminal 
bacterial burdens in the lymph nodes and spleens of these mice were approximately two 
logs lower than wild-type-infected mice (84 hpi). In contrast, the lungs of these moribund 
pCD1- pYV+ Y. pestis-infected mice were completely consolidated with bacterial burdens 
reaching approximately 5x1010 CFU (Fig. 2-9E). Further, I observed that symptoms of 
moribund pCD1- pYV+ Y. pestis-infected mice were more consistent with the animals 
dying of a pneumonia and not septicemia, which is believed to be the ultimate cause of 
death during bubonic plague. Together, the data for the intranasal and subcutaneous 
infections suggest that the presence of YadA leads to an increase in pathology, which 
results in an altered immune response that is able to somewhat control the infection in the 
lymphatics and spleen but not the lungs.  
Casutt-Meyer et al. have recently shown that Yersinia species induce the synthesis 
of neutrophil extracellular traps (NETs) upon contact with neutrophils. They also showed 
that Yersinia that express yadA, including when it is artificially overexpressed in Y. pestis, 
attach more readily to the collagen within NETs, which results in bacterial killing 
(Casutt-Meyer et al., 2010). However, the plasminogen activating protease Pla cleaves 
the majority of YadA from the bacterial outer membrane when yadA is expressed at 
normal levels (Kutyrev et al., 1999). I therefore constructed a Δpla deletion mutant in a 
pCD1- pYV+ Y. pestis background to test whether YadA and NET-induced killing would 
further reduce the virulence of a Δpla mutant. Contrary to my expectations of more 
killing, I observed that the introduction of YadA into a Δpla mutant was able to rescue 
three logs of bacterial replication at 48 hpi in the lungs of intranasally infected mice 
compared to Δpla mutants or pCD1- pYV+ Δpla ΔyadA mutants (Fig. 2-10A). Although 
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Figure 2-9: Bubonic infection with pCD1- pYV+ Y. pestis. (A-B) Kinetics of infection 
for wild-type Y. pestis (YP3 - solid circles) and pCD1- pYV+ Y. pestis (YP361 - open 
circles) in C57BL/6 mice infected subcutaneously. CFU per lymph nodes (A) and 
spleen (B) were determined at various time points of infection. (C) Lymph node 
weights taken from subcutaneously infected mice at various time points of infection. 
(D) Survival analysis of wild-type and pCD1- pYV+ Y. pestis during subcutaneous 
infection, in which the mean time to death was 96 and 192 hpi, respectively. (E) 
Terminal organ burdens were taken from moribund mice infected subcutaneously 
with wild-type Y. pestis or pCD1- pYV+ Y. pestis at 84 and 204 hpi, respectively. The 
limit of detection is represented by a dotted line. Each bar represents the geometric 
mean for CFU recovered from four to five mice. * p ≤ 0.05. 
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the pCD1- pYV+ Δpla mutants are able to partially restore bacterial replication in the lung, 
they are unable to trans-complement avirulent Y. pestis (See Chapter 4 and Fig. 2-10B).  
These findings suggest that the requirement of YadA for the virulence of Y. 
pseudotuberculosis and Y. enterocolitica in animals may have been compensated for by 
the acquisition of pPCP1, which encodes pla. The sensitivity of bacteria expressing yadA 
to NETs may provide an explanation as for why evolution selected for the inactivation of 
yadA in Y. pestis; however the timing of the acquisition of pPCP1 and the inactivation of 
yadA remains unknown. Additional experiments need to be performed to further 
investigate the evolutionary implications of these findings.  
 
Figure 2-10: Pulmonary infection with Δpla pCD1-pYV+ and Δpla pCD1-pYV+ ΔyadA 
Y. pestis. (A) C57BL/6 mice infected intranasally with Δpla (YP102), Δpla pCD1-
pYV+ (YP369) or Δpla pCD1-pYV+ ΔyadA (YP383) Y. pestis, and CFU per lung and 
spleen were determined at 48 hpi. Each bar represents the geometric mean for 
CFU recovered from four to five mice. The limit of detection is represented by a 
dotted line. (B) Individual intranasal infections (white bars) for pCD1- (BGY14) or 
Δpla pCD1-pYV+ mutants or matched co-infections (gray bars) both strains in 
C57BL/6J mice. CFU per lung were determined at 48 hpi and strains were 
differentiated on BHI agar plates containing kanamycin. Error bars represent SEM.  
* p ≤ 0.05. 
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Similar to YadA, Invasin is also inactivated in Y. pestis. I reintroduced invasin 
into Y. pestis under the control of its native promoter, which shows maximal expression 
at 26°C and minimal expression at 37°C (Ellison et al., 2003), to determine its 
contribution to Y. pestis virulence. As expected, inv+ Y. pestis was more invasive than 
wild-type Y. pestis in my tissue culture model of invasion when pre-grown at 26°C but 
not when pre-grown at 37°C (Fig. 2-11A). In my intranasal mouse model of infection, 
inv+ Y. pestis displayed similar kinetics of infection in the lung and spleen compared to 
wild-type bacteria (Fig. 2-11B-C). However, in my subcutaneous mouse model of 
infection, inv+ Y. pestis was unable to colonize the cervical lymph nodes as efficiently as 
wild-type Y. pestis at 48 hpi (Fig. 2-11D). Similar to YadA, the lymph nodes from inv+ Y. 
pestis-infected mice weighted significantly less than the lymph nodes from wild-type-
infected mice (Fig. 2-11E). Organ weights are normally indicative of the level of 
inflammation, suggesting that inv+ Y. pestis mutants produce lower levels of 
inflammation during bubonic plague. As with YadA, the decreased ability to colonize the 
lymph nodes may explain why evolution selected for the inactivation of inv in Y. pestis.                
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Figure 2-11: Analysis of inv+ expression on Y. pestis infection. (A) Invasion of wild-
type and inv+ Y. pestis into A549 cells at 3 hpi as determined by a gentamicin 
protection assay. Bacteria were pre-grown at 26°C or 37°C and inoculated at an 
MOI of 10:1. At 3 hpi, the cells were incubated with gentamicin to kill extracellular 
bacteria. Each bar represents the mean percent invasion relative to the inoculum. 
Error bars represent SEM. (B-D) Kinetics of infection for wild-type Y. pestis (YP3 - 
solid circles) and inv+ Y. pestis (YP314 - open circles) in C57BL/6 mice infected 
intranasally (B-C) or subcutaneously (D). CFU per lung (B), spleen (C-D) and lymph 
nodes (D) were determined at various time points of infection. (E) Lymph node 
weights taken from subcutaneously infected mice at 48 hpi. The limit of detection is 
represented by a dotted line. Each bar represents the geometric mean for CFU 
recovered from five mice. * p ≤ 0.05. 
 75 
Conclusions  
 Adherence to tissues is considered one of the initial steps in the infectious process 
and is particularly important for bacteria that employ T3SS to subvert immune responses 
and promote virulence. Y. pestis adhesion to host tissues has been extensively researched 
in vitro on tissue culture cells, but many of these findings have not been corroborated in 
vivo. Here, I have established a model to examine Y. pestis adhesion to host tissues and 
show that Y. pestis adheres tightly to lung tissues early during mammalian infection and 
then becomes largely non-adherent (or adherent to freely lavageable cells such as 
neutrophils) during the later stages of infection. The dynamic shift in adherence to lung 
tissues may explain why person-to-person transmission of pneumonic plague has only 
been observed for patients in the late stages of infection (Chernin, 1989). I also show that 
Y. pestis is largely extracellular during early stages of pneumonic plague, indicating that a 
facultative intracellular lifestyle likely does not occur during pneumonic plague. My 
findings suggest that there are multiple potential adhesins that mediate adherence to lung 
cells; however, I was not able to specifically identify the exact nature of these adhesins. 
Additional research is needed to identify the adhesive components in Y. pestis that allow 
for intimate host cell contacts.  
 Y. pestis lacks the two dominate adhesins, YadA and Invasin, found in its 
ancestral strain, Y. pseudotuberculosis. I show that Y. pestis mutants in which yadA and 
inv expression has been restored are attenuated in our animal model of bubonic plague 
and cause a slightly altered form of pneumonic plague. Intriguingly, YadA is required for 
virulence in Y. pseudotuberculosis and Y. enterocolitica animal models of infection but 
detrimental to the virulence of Y. pestis. Strikingly, YadA can restore the bacterial 
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proliferation in the lung of Δpla deletion strains, suggesting that the acquisition of Pla 
and its proteolytic activity by early progenitors of Y. pestis may have compensated for the 
requirement of YadA during infection. Together these data corroborate theories that the Y. 
pestis genome has undergone (is undergoing) extensive remodeling to create the highly 
virulent pathogen currently found in the world today.  
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Materials and Methods 
Reagents, bacterial strains and culture conditions  
All chemicals, unless otherwise noted, were obtained from Sigma-Aldrich, Inc. 
(St. Louis, MO). Table 2-2 provides a description of bacterial strains, plasmids and 
primers used in Chapters 2, 3 and 4. The fully virulent, wild-type Yersinia pestis strain 
CO92 (YP3) and its plasmid cured derivative CO92 pCD1- (YP6) were obtained from the 
U.S. Army, Ft. Detrick, MD. The presence or absence of pCD1, pMT1, pPCP1, and the 
pgm locus was confirmed by PCR for each strain prior to use. Y. pestis were routinely 
grown on brain-heart infusion (BHI) agar (Difco Laboratories, Detroit, MI) supplemented 
with at 26°C for 2-3 d. Liquid cultures of Y. pestis were grown in BHI broth (Difco 
Laboratories, Detroit, MI) at 26°C for 6-8 hr before being diluted to an OD620 of 0.05-0.1 
in 10 ml of BHI supplemented with 2.5 mM CaCl2 in a 125 ml Erlenmeyer flask and 
grown overnight at 37°C or 26°C on a shaker set at 250 rpm. Y. pseudotuberculosis 
IP2666c and derivatives were obtained from the laboratory of Dr. Joan Mecsas. Y. 
pseudotuberculosis 32953 and K. pneumoniae subspecies pneumoniae and derivatives 
were obtained from the laboratory of Dr. Virginia Miller. Y. pseudotuberculosis strains 
were routinely grown at 26°C on LB agar for 2 d or in LB broth for 12-14 hr. K. 
pneumoniae strains were grown at 37°C for 10-12 hr on LB agar or in LB broth. For 
animal infections, Y. pseudotuberculosis and K. pneumoniae were grown in BHI broth as 
described above for Y. pestis. B. pertussis were grown on SSM agar supplemented with 
10 ml l- sheep blood at 37°C for 3-4 d or in SSM broth at 37°C for 24 hr. Media were 
supplemented with ampicillin (100 µg ml-1), kanamycin (50 µg ml-1), rifampicin (30 µg 
ml-1), polymyxin B (25 µg ml-1), Irgasan (2 µg ml-1), streptomycin (50 µg ml-1), 
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chloramphenicol (25 µg ml-1), X-gal (50 µg ml-1), magnesium oxalate (MOX, 20 mM 
MgCl2 and 20 mM Na2C2O4), 0.1% Triton-X or 2.5 mM CaCl2 as required. 
Construction of Y. pestis deletion strains  
Y. pestis deletion strains were constructed using a modified lambda red 
recombination system described previously by Lathem et al. (Lathem et al., 2007). 
Briefly, 500 bp upstream (first two primers) and 500 bp downstream (last two primers) of 
each gene was amplified by PCR using the following primer sets: ΔyadA (yadA(pYV)3’, 
yadA(pYV)5’P1, yadA(pYV)3’P4 and yadA(pYV)5’); ΔYPO0598-599 (YPO0598-599 
KO3’, YPO0598-599 KO5’P1, YPO0598-599 KO3’P4 and YPO0598-599 KO5’); 
ΔYPO1387-1388 (YPO1387-8 3’, YPO1387-8 5’P1, YPO1387-8 3’P4 and YPO1387-8 
5’); ΔYPO3994 (YPO3994 KO3’, YPO3994 KO5’P1, YPO3994 KO3’P4 and YPO3994 
KO5’); ΔYPO2490-2491 (YPO2490-2491 KO3’, YPO2490-2491 KO5’P1, YPO2490-
2491 KO3’P4 and YPO2490-2491 KO5’); ΔYPO0684-695 (YPO0684-695 3’, YPO0684-
695 5’P1, YPO0684-695 3’P4 and YPO0684-695 5’); ΔYPO3797-3802 (YPO3797-3802 
3’, YPO3797-3802 5’P1, YPO3797-3802 3’P4 and YPO3797-3802 5’); ΔYPO3877-3882 
(YPO3877-3882 3’, YPO3877-3882 5’P1, YPO3877-3882 3’P4 and YPO3877-3882 5’); 
Δail (YPO2905 3’, YPO2905 5’P1, YPO2905 3’P4 and YPO2905 5’); ΔompA 
(YPO1435 3’, YPO1435 5’P1, YPO1435 3’P4 and YPO1435 5’); ΔkatY (YPO3319 3’, 
YPO3319 5’P1, YPO3319 3’P4 and YPO3319 5’); ΔyopH (yopH 3’+500, P1yopH 3’3, 
P4yopH 5’1406 and yopH 5’-500); ΔlacZ (YplacZUP-F, YplacZUP-R, YplacZDN-R and 
YplacZDN-F). The respective PCR products were gel-purified and combined in a SOE-
PCR with a kanR cassette flanked by FRT sites, which had previously been applied from 
the plasmid pKD13 (Datsenko and Wanner, 2000). The first and last primers in each set 
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were used in the SOE-PCR reactions. The resulting PCR products (upstream-FRT-KanR-
FRT-downstream) were gel purified and transformed into YPI54 or BGY0, Y. pestis 
strains carrying pWL204, which were grown at 26°C in the presence of 10 mM arabinose 
to induce the lambda red recombinase genes. Putative recombinants were selected on 
BHI agar plates containing kanamycin. Recombinants were passaged on BHI agar plates 
containing 5% sucrose to cure pWL204. If required, the kanR cassette was resolved by 
transforming the strains with pLH29, a plasmid carrying the FLP recombinase gene, or 
pSkippy, a plasmid carrying the FLP recombinase and sacB genes, and growing the 
strains overnight at 26°C in the presence of 1 mM IPTG. The overnight cultures were 
diluted and plated on BHI agar plates containing 5% sucrose to cure pSkippy or on BHI 
agar plates for the use of pLH29. KanS and ampS recombinants were selected and in-
frame deletions of the target gene were verified by PCR. For each strain, the presence of 
all the major virulence loci (pCD1+, pMT1+, pPCP1+ and pgm+) was confirmed by PCR. 
For stains containing multiple mutations, pWL204 was transformed into one mutant (first 
listed deletion) and the process was repeated as described above.  
Construction of Y. pestis pCD1- pYV+ strains  
Y. pestis CO92 pCD1- pYV+ strains were constructed by transforming the 
virulence plasmid from Y. pseudotuberculosis IP32953, designated pYV, into YP6, a 
pCD1- strain of Y. pestis, and YP102pCD1-. Transformants were plated on BHI agar 
plates and incubated at 26°C for 24 hr. The transformants were then replica plated onto 
BHI agar plates containing magnesium oxalate (BHI-MOX) and incubated at 37°C (BHI-
MOX) or 26°C (BHI) for an additional 24 hr. Y. pestis pCD1- pYV+ recombinants 
(YP361) were selected for their ability to grow on BHI agar plates at 26°C but were 
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unable to grow on BHI-MOX plates at 37°C. PCR was also used to confirm the presence 
of pYV.   
Construction of the inv+ Y. pestis  
Y. pestis CO92 inv+ strains were constructed by co-transforming pPP53 and 
pTNS2 into wild-type Y. pestis, which inserted inv under the control of its native 
promoter into the Tn7 locus between the glmS and pstS genes (Choi et al., 2005). inv was 
amplified from Y. pseudotuberculosis IP32953 using primers Inv-nativepromotor-PstI 
and Inv-Tn7-3’BamHI and ligated into the PstI and BamHI sites in pUC18R6K-mini-
Tn7T-Kan to generate pPP53.  
Construction of the Y. pestis pgm- strain  
Y. pestis CO92 pgm- strains were selected for by passaging wild-type Y. pestis 
CO92 on BHI agar plates containing 0.02% Congo red. White colonies were selected and 
isolated for pure cultures. PCR was also used to confirm the loss of pgm locus. 
Construction of pYV- Y. pseudotuberculosis strains  
Y. pseudotuberculosis IP2666c pIB1- (BGY38) and Y. pseudotuberculosis 
IP32953 pYV- (BGY21) were constructed by passaging the Y. pseudotuberculosis 
IP2666c pIB1+ (LL-89) and Y. pseudotuberculosis IP32953 (BGY30) on BHI-MOX agar 
plates and selecting large colony variants, indicating the loss of the virulence plasmid. 
The loss of the virulence plasmid was confirmed using PCR. 
Construction of Y. pseudotuberculosis deletion strains  
The ΔlacZ Y. pseudotuberculosis IP32953 strain was constructed using the 
modified lambda red recombination system, as described above.   
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Tissue culture adhesion and invasion assays  
For both adhesion and invasion assays, 50,000 A549 cells were plated in 24-well 
plates. Before inoculation, the bacteria and A549 cells were washed three times with pre-
warmed PBS, and the bacteria were resuspended in F12 media containing 10% fetal 
bovine serum (FBS) and 2mM L-glutamine. 5x105 bacteria in 250 µl were added to the 
cells and incubated at 37ºC for 1 hour. Cells were then washed three times with pre-
warmed PBS and 0.5 ml of pre-warmed F12 was added for later time points. To harvest 
the bacteria, 1 ml of ddH20 was added to the washed cells and incubated for 5 min at 
37°C to lyse the cells. The bacteria were then serially diluted and plated on BHI or LB 
agar. Percent adherence was calculated by dividing the number of adherent bacteria by 
the number of bacteria in the inoculum. Gentamicin protection assays were performed 
similarly, except that at the designated time point 0.5 ml of F12 containing 100 µg ml-1 
gentamicin was added to the cells and incubated for 1 hr. The cells were then washed, 
diluted and plated as described. The percent of intracellular bacteria was calculated by 
dividing the number of gentamicin resistant bacteria by the number of bacteria in the 
inoculum.   
Biotinylation and isolation of outer membrane proteins  
Y. pestis cultures were grown in BHI broth under standard conditions for a 37°C 
overnight incubation. 1 OD620/ml of culture were washed three times and resuspended in 
phosphate buffered saline (PBS), pH 8.0. 100 µl of a 2.0 mM EZ-Link sulfo-NHS-LC-
biotin in ddH20 were added to each sample. Mock-biotinylated control samples received 
100 µl ddH2O. The samples were incubated on ice for 40 min and inverted every ten 
minutes to ensure homogeneous biotinylation.  The samples were washed three times 
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with PBS containing 100 mM glycine to quench the reaction and remove excess biotin. 
The samples were then suspended in a lysis buffer (50 mM Tris pH 8.0) with protease 
inhibitor cocktail (Sigma). Total membrane and outer membrane fractions were 
fractionated as described by Vincent et al. (2006). Briefly, biotinylated and mock-
biotinylated samples were lysed by French Press (14,000 PSI). Lysates were centrifuged 
at 10,000 g for 10 min at 4°C to remove any large particles or unlysed cells. Total 
membrane fractions were separated from periplasmic and cytoplasmic proteins by 
ultracentrifugation at 100,000 g for 60 min at 4°C. The inner membrane proteins were 
then solubilized in 50 mM Tris, pH 8.0 containing 1% Triton-X100, 20 mM MgCl2 and 
protease inhibitor cocktail and separated from the outer membrane proteins by 
ultracentrifugation at 100,000 g for 60 min at 4°C. The pellet, which contains the outer 
membrane proteins, was then resuspended in 50mM Tris, pH 8.0 with protease inhibitor 
cocktail and 0.1% Tween-20. Samples were then sonicated using a Bransson 2200 for 30 
min on ice. Biotinylated outer membrane proteins were then incubated with 
approximately 4x106 A549 cells for 1 hr, washed six times with PBS and lysed with 1 ml 
ddH20 containing protease inhibitor. Samples were then run on SDS-PAGE gels, 
transferred on a nitrocellulose membrane and probed with streptavidin-HRP.     
Yop secretion profiles  
Yop secretion profiles were analyzed by inoculating 0.2 OD620 equivalents of an 
overnight Y. pestis culture into BHI-MOX broth. The cultures were then grown at 26°C 
for 2 hr in a 125 ml Erlenmeyer flask at 37°C on a shaker set at 250 rpm for 4 hours. 
OD620 readings were then taken and 1 ml of supernatant was precipitated with 
trichloroacetic acid and washed with 100% acetone. Pellets were resuspended in 1M Tris 
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pH 9.0 to an OD-equivalent of 1OD 10µl-1. Samples were run on a 12% SDS-PAGE gel 
and stained with “blue silver” coomassie (Candiano et al., 2004). 
Minimal inhibitory concentration (MIC) assays  
Minimal inhibitory concentrations for crystal violet, polymyxin B and gentamicin 
were assayed using clinical standards, except that the bacteria were grown in BHI broth. 
Briefly, serial dilutions of BHI broth and antibiotic were assayed for microbial growth at 
26°C. The last antibiotic concentration at which bacterial growth was inhibited was 
considered the MIC for a particular antimicrobial for that strain.  
Endotoxin measurements  
pCD1- Y. pestis strains were grown overnight at 26°C and inoculated to an 0.2 
OD620 equivalent into BHI broth with or without calcium. The cultures were grown at 
37°C for four hours and OD620 readings were taken. Culture supernatants were then filter 
sterilized and used to quantitate endotoxin units. Uninoculated BHI broth was used as a 
baseline control. Endotoxin units were measured using Pyrochrome Chromogenic 
Endotoxin Testing Reagents (Associates of Cape Cod Incorporated, East Falmouth, MA).     
Animals  
All animals studies were approved by the Washington University Animal Studies 
Committee protocol #20060154 or the University of North Carolina in Chapel Hill Office 
of Animal Care and Use protocol #09-057.0-A. Pathogen-free, six- to eight-week-old 
C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice 
were housed in a Techniplast Isocage containment system (Buguggiate, Italy) during all 
experiments. Mice were provided with food and water ad libitum and maintained on a 12-
hr light/12-hr dark cycle at 25°C and 15% humidity. Bacteria were grown in BHI broth as 
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described above, and the optical density (OD620) of the culture was used to estimate 
bacterial concentrations. Actual bacterial concentrations were determined by plating 
serial dilutions of the inoculum on BHI or LB agar plates. The bacteria were then washed 
in endotoxin-free phosphate buffered solution (PBS) and maintained at 37°C (intranasal 
infection) or 26°C (subcutaneous infection) prior to inoculation, unless otherwise 
indicated. Mice were anesthetized with a ketamine/xylazine solution (50 mg Kg-1 / 10 mg 
Kg-1) and inoculated with 20 µl or 100 µl of bacteria in PBS via an intranasal or 
subcutaneous route, respectively. Animals were monitored twice daily and sacrificed with 
an overdose of sodium pentobarbital (180 mg Kg-1) at designated time points or when the 
animal was clearly moribund.  
Animal infections  
For both the individual infection and co-infection experiments (equal ratios of 1 
mutant : 1 WT), groups of 3-5 mice were inoculated intranasally (i.n.) with 1 x 104 CFU 
of Y. pestis, Y. pseudotuberculosis, B. pertussis and/or K. pneumoniae. Groups of 4-5 
mice were inoculated subcutaneously (s.c.) in the front neck with 1000 CFU of Y. pestis. 
At the indicated times post-inoculation, mice were euthanized, lungs and spleen (after i.n. 
inoculation) or lymph nodes, spleen, and lungs (after s.c. inoculation) were surgically 
removed, weighed, and homogenized in 0.5 ml PBS. Serial dilutions for each organ were 
plated on BHI or LB agar as appropriate for growth. For co-infections, antibiotic 
sensitivity was used to differentiate between co-inoculated strains. Bacterial burdens are 
reported as CFU/tissue.  
Animal survival  
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Groups of 10 mice were inoculated intranasally with 1 x 104 CFU or 
subcutaneously with 200 CFU of Y. pestis. Animals were monitored every 12 hr for 
survival. Animals that were clearly moribund were euthanized with an overdose of 
sodium pentobarbital and counted as having died in the next twelve hours. Animals 
inoculated intranasally with pCD1- pYV+ Y. pestis were monitored every six hours 
starting at 60 hpi. The average time to death was calculated using Prism v4.0c software 
(GraphPad Software, Inc., La Jolla, CA). 
“Natural” animal infections  
The “natural” infection model of infection denotes animal infections in which 
mice were infected with bacteria harvested from the lungs of plague-infected mice. In 
brief, BAL was performed on a mouse showing sign of pneumonic plague at 48 hpi. 
BALF was maintained at 37°C and diluted to an appropriate concentration prior to 
infection, assuming that the bacterial burden of the lung was 5x108. The actual inoculum 
was subsequently determined by plating the inoculum. Matched infections with broth-
grown Y. pestis were conducted simultaneously.   
Bronchoalveolar lavage (BAL) experiments  
BAL experiments were performed as described in (Lathem et al., 2005). In brief, 
groups of 3 mice were inoculated intranasally with 1 x 104 CFU of Y. pestis. At the 
designated time points post-inoculation, the mice were euthanized and the sternum and 
rib cage were surgically removed to provide sufficient space for the lungs to expand upon 
inflation. Tracheal cannulation was used to lavage the lungs three times with 1 ml PBS. 
BALF was centrifuged at 21,000 x g to pellet the bacteria and cell debris and then 
resuspended in 200 µl BALF. The remaining BALF was routinely tested for residual 
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bacteria, which were rarely encountered. The lungs were removed from the mouse and 
homogenized in 0.25 ml PBS. Serial dilutions were used to determine CFU/lungs. 
Percent lavageable bacteria was calculated by dividing the CFU from BALF by the CFU 
from lungs and BALF. Results are reported as CFU/Organ or as percent lavageable 
bacteria. 
Ex vivo gentamicin protection assays  
Ex vivo gentamicin protection assays for BALF were performed on BALF from 
infected animals. In brief, gentamicin was added to BALF for a final concentration of 100 
µg ml-1 gentamicin. BALF was incubated at room temperature for 30 min and then 
pelleted (500 x g for 5 min) and washed three times. Mock treated samples were also 
conducted simultaneously. Percent survival, which is assumed to be the percent of 
intracellular bacteria, was calculated by dividing the CFU from BALF treated with 
PBS/gentamicin by the CFU from untreated BALF. Ex vivo gentamicin protection assays 
for entire lungs were adapted from protocols used for bladder tissue (Justice et al., 2006). 
In brief, groups of 3 mice were inoculated intranasally with 1 x 105 CFU of Y. pestis. At 
the designated time points post-inoculation, the mice were euthanized and the sternum 
and rib cage were surgically removed to provide sufficient space for the lungs to expand 
upon inflation. Tracheal cannulation was used to inflate the lungs with 1 ml 
PBS/gentamicin or PBS alone for 30 min. The PBS/gentamicin or PBS was removed and 
the lungs were then lavaged three times with PBS to remove any residual gentamicin. 
The lungs were removed from the mouse and homogenized in 0.25 ml PBS. Serial 
dilutions were used to determine CFU/lungs. Percent survival, which is assumed to be the 
percent of intracellular bacteria, was calculated by dividing the CFU from lungs treated 
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with PBS/gentamicin by the CFU from lungs treated with PBS alone. Results are reported 
as CFU/lungs or as percent survival.      
Enrichment of less adherent Y. pestis mutants  
See Chapter 3 for the construction of the mutant library. A group of five mice was 
intranasally infected with 1x105 transposon mutants grown at 37°C overnight. At 2 hpi, 
the animals were euthanized and BALF was extracted and plated on BHI agar containing 
kanamycin. Lungs were also harvested to determine the percent adherent bacteria as 
described above. The plates were scrapped 24 hours later and extensively vortexed in 30 
ml PBS. A 300 µl sample was then inoculated unto BHI broth and grown overnight at 
37°C overnight. The process was repeated three times. The pool of mutants was analyzed 
as described in Chapter 3 using high throughput sequencing technology.     
Histopathology  
Groups of 3-5 mice were inoculated intranasally with 1 x 104 CFU of Y. pestis. 
Mice were euthanized at various time points post-inoculation with an overdose of sodium 
pentobarbital, and their lungs were inflated with 10% neutral buffered formalin via 
tracheal cannulation. The lungs were then removed from the animal and fixed for 96 hr in 
10% neutral buffered formalin. All samples were negative for bacterial growth before 
being removed from the BSL-3 facility. The lungs were washed twice in PBS for 1 hr and 
then submerged in 70% ethanol. The lungs were then embedded in paraffin and 5-µm 
sections were stained with hematoxylin and eosin. Images were viewed under an 
Olympus BX60 fluorescence microscope (Center Valley, PA), and Spot Imaging 
software (Diagnostic Instruments Inc., Sterling Heights, MI) was used to capture the 
images. 
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Statistical Analyses  
Student’s t-test was used to determine the statistical significance of animal and 
tissue culture experiments. The product limited (Kaplan-Meier) method was used to 
determine the median survival and statistical significance of animal survival experiments. 
All statistical analyses were calculated using Prism v4.0c software (GraphPad Software, 
Inc., La Jolla, CA). 
Table 2-2. Bacterial strains, plasmids and primers used in Chapters 2, 3 and 4. 
Strains Genotype Source/Reference 
YP3 Y. pestis CO92 - pCD1+ pMT1+ pPCP1+ pgm+ Laboratory Stock 
YP6 Y. pestis CO92 pCD1- Laboratory Stock 
YP16 Y. pestis CO92 ΔpsaA (Cathelyn et al., 2006) 
YP30 Y. pestis pWL204  (Lathem et al., 2007) 
YP102 Y. pestis CO92 Δpla (Lathem et al., 2007) 
YP102pCD1- Y. pestis CO92 Δpla pCD1- (Lathem et al., 2007) 
YP138 Y. pestis CO92 Δpla carrying PN25-tetR + Ptet-pla integrated in the 
glmS-pstS intergenic region 
(Lathem et al., 2007) 
YP160 Y. pestis CO92 ΔlacZ  (Lawrenz et al., 2009) 
YP181 Y. pestis CO92 ΔYPO0598-599 This study 
YP182 Y. pestis CO92 ΔYPO2490-2491 This study 
YP184 Y. pestis CO92 ΔYPO3944 This study 
YP186 Y. pestis CO92 ΔYPO0683-695 This study 
YP221 Y. pestis CO92 ΔYPO1387-1388 This study 
YP223 Y. pestis CO92 ΔYPO3797-3802 This study 
YP225 Y. pestis CO92 ΔYPO3877-3882 This study 
YP234 Y. pestis CO92 ΔYPO0598-599ΔYPO2490-2491 This study 
YP235 Y. pestis CO92 ΔYPO1387-1388ΔYPO3944 This study 
YP337 Y. pestis CO92 pGENRFP This study 
YP313 Y. pestis CO92 inv+ This study 
YP314 Y. pestis CO92 Δail This study 
YP356 Y. pestis CO92 ΔompA This study 
YP357 Y. pestis CO92 ΔkayY This study 
YP361 Y. pestis CO92 pCD1- pYV+ This study 
YP362 Y. pestis CO92 ΔompA ΔkayY This study 
YP369 Y. pestis CO92 Δpla pCD1- pYV+ This study 
YP373 Y. pestis CO92 ΔyopH This study 
YP383 Y. pestis CO92 Δpla pCD1- pYV+ ΔyadA This study 
YPI54 Y. pestis pWL204  This study 
YPI58 Y. pestis CO92 ail:: kanR This study 
BGY0 Y. pestis CO92 pCD1- pWL204 This study 
BGY4 Y. pestis CO92 pgm- This study 
BGY14 Y. pestis CO92 pCD1- lacZ::kanR This study 
BGY21 Y. pseudotuberculosis IP32953 pYV- This study 
BGY23 Y. pestis CO92 pCD1- pGEN222 This study 
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BGY30 Y. pseudotuberculosis IP32953 (Chain et al., 2004) 
BGY39 Y. pseudotuberculosis IP32953 ΔlacZ This study 
BGY38 Y. pseudotuberculosis IP2666c pIB1- KanR This study 
LL-89 Y. pseudotuberculosis IP2666c pIB1+ yopH (NdeI) KanR (Fisher et al., 2007) 
MLF-13 Y. pseudotuberculosis IP2666c pIB1+ yopH (NdeI) ΔlacZ  KanR  (Fisher et al., 2007) 
KPPR1 K. pneumoniae subspecies pneumoniae - rifampicin-resistant, type 1 
O antigen, type 2 polysaccharide capsule 
(Lawlor et al., 2005) 
VK060 K. pneumoniae cpsB::Tn5_kanR (Lawlor et al., 2005) 
BC39 B. pertussis Δbvg (Beckett et al., 2000) 
DH5α E. coli DH5α: fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
(Taylor et al., 1993) 
S17 E. coli S17-1 λpir: TpR SmR recA, thi, pro, hsdR-M+RP4: 2-Tc:Mu: 
Km Tn7 λpir 
(Priefer and Pühler, 
1983) 
   
Plasmids Relevant features Source/Reference 
pGEN222 gfp expression and the hok sok post-segregation killing system for 
plasmid maintenance; ampR   
(Galen et al., 1999) 
pGENRFP rfp expression and the hok sok post-segregation killing system for 
plasmid maintenance; ampR  
Gift from Mary Chelsea 
Lane and Harry Mobley 
pKD13 Source of kanR cassette flanked by FRT sites; kanR (Datsenko and Wanner, 
2000) 
pLH29 Plasmid carrying IPTG-inducible FLP recombinase; cmR (Huang et al., 1997) 
pPP47 Plasmid carrying a Himar1-based transposon system with T7 
promotors oriented towards the chromosome; kanR 
This study 
pPP53 pUC18R6K-mini-Tn7T-Kan carrying inv; ampR kanR  This study 
pSkippy pFLP3 (Choi et al., 2005) derivative carrying the FLP recombinase 
and sacB genes but lacking the tetR cassette; ampR 
This study 
pTnMod-RKm Tn5 mini-transposon and transposase; kanR (Dennis and Zylstra, 
1998) 
pUC18R6K-mini-
Tn7T-Kan 
mini-Tn7 transposon with a MCS and a kanR cassette flanked by 
FRT sites; ampR kanR 
(Choi and Schweizer, 
2006) 
pWL204 Plasmid carrying the lambda red recombinase gene and sacB gene 
for sucrose counterselection; ampR 
(Lathem et al., 2007) 
   
Primers Sequence Source/Reference 
YplacZUP-F CTTTCACCAAAATTTCGCCAGCGGC This study 
YplacZDN-R TGTTATAGCCGGTTATCAGTCGTTA This study 
YplacZDN-F GGTCGACGGATCCCCGGAATGTGTCAGCCTTATTTTTGTTATGT
CTGAGG 
This study 
YplacZUP-R GAAGCAGCTCCAGCCTACACAACTGTTGGCAATACAAGGTGTAA
GGCATCGG 
This study 
yopH 3’+500 ACTACATACACACTGGGAAAATCTC This study 
yopH 5’-500 GCATCCGTCCGGTGGCCGTAGGCC This study 
P1yopH 3’3 GAAGCAGCTCCAGCCTACACCATGCTTCCCTCCTTAATTAAATA
CACGCC 
This study 
P4yopH 5’1406 GGTGCGACGGATCCCCGGAATAATGTAAATATTTATTCCTATGA
GTAAATA 
This study 
YPO0598-599 
KO3’ 
CACCACGAAGAGTAAACGAAGGC This study 
YPO0598-599 
KO5’P1 
GAAGCAGCTCCAGCCTACACCATGAGGAGTTCCCTTCCCCAAG This study 
YPO0598-599 
KO3’P4 
GGTCGACGGATCCCCGGAATGAAGAACCTCCTTTATGTAGTTTT
ATT 
This study 
YPO0598-599 
KO5’ 
CGTTGATGCTCCTTTGCTTCCAATG This study 
YPO1387-8 3’ CTGGCAACCGCCGCAAGTCACGGAG This study 
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YPO1387-8 5’P1 GAAGCAGCTCCAGCCTACACCATGTTTAATATCCATAAATGCTA
TTAGG 
This study 
YPO1387-8 3’P4 GGTCGACGGATCCCCGGAATGATCGATACCCGTCGTCCTTCAA This study 
YPO1387-8 5’ CCATCACCGACGTTCCCAAACCATGCC This study 
YPO3994 KO3’ GGTGCTTATGAAGGCTTGCGCATG This study 
YPO3994 KO5’P1 GAAGCAGCTCCAGCCTACACCATGGATACTTAACTCACAAATAG
AAATGC 
This study 
YPO3994 KO3’P4 GGTCGACGGATCCCCGGAATAGTTTGAAGGGGATAACATGGCG This study 
YPO3994 KO5’ CTGCAACCCGTGGTAGAAAATGC This study 
YPO2490-2491 
KO3’ 
GATTTCTTCAGTTTTTGTTATTGTTTAGCTTGC This study 
YPO2490-2491 
KO5’P1 
GAAGCAGCTCCAGCCTACACCAAAGAGAATGCCTCGCCTCTGC This study 
YPO2490-2491 
KO3’P4 
GGTCGACGGATCCCCGGAATAATATGGATATGCTTTCAATATCA
TATG 
This study 
YPO2490-2491 
KO5’ 
CCGGATCGGTGTCGGGATCTTACTG This study 
YPO0684-695 3’ CCCTCGACACCAAAACTCCCTGTTACGG This study 
YPO0684-695 
5’P1 
GAAGCAGCTCCAGCCTACACCATCGTCAGACCTAATAGTGAGAT
G 
This study 
YPO0684-695 
3’P4 
GGTCGACGGATCCCCGGAATGAAATTGACTTAAAAATCGATATT
GACC 
This study 
YPO0684-695 5’ CGAGCAGGGTGATTTATGGCAATGCGAATG This study 
YPO3797-3802 3’ GGCCCCTGAATAAATCTGTGTGGCTCAC This study 
YPO3797-3802 
5’P1 
GAAGCAGCTCCAGCCTACACCATAAATACCTGATAGTCCTTTAT
GTA 
This study 
YPO3797-3802 
3’P4 
GGTCGACGGATCCCCGGAATAATTTCAATGACGTTATTAATCGT
TAG 
This study 
YPO3797-3802 5’ CAAGGATTATCTGCAGTTCGTTCCTTCGC This study 
YPO3877-3882 3’ GCAACACTCGATAAGCGTTATCATACTCTTG This study 
YPO3877-3882 
5’P1 
GAAGCAGCTCCAGCCTACACCATTTAAAACCCCGATGTAATCAT
TG 
This study 
YPO3877-3882 
3’P4 
GGTCGACGGATCCCCGGAATAAGCACCTGGGGATTAATGAGCC This study 
YPO3877-3882 5’ CCAGAAGATGGTGCAGATGATAGTCCAGAAGG This study 
YPO2905 3’ CAACGATGAAGCGACCATTGAGCGTGTG This study 
YPO2905 5’P1 GAAGCAGCTCCAGCCTACACCATCCAGATTGTTATAACAATACC
TAAT 
This study 
YPO2905 3’P4 GGTCGACGGATCCCCGGAATAACGTCCTCCTAACCATGAAAAC
C 
This study 
YPO2905 5’ GCGGGAGAGTAAACCAGCACCGAGC This study 
YPO1435 3’ GGTTACCCGAATTGACGGAAGATGATCG This Study 
YPO1435 5’P1 GAAGCAGCTCCAGCCTACACCATTTTACGCCTCATTATCATCCA
AATAGGC 
This Study 
YPO1435 3’P4 GGTCGACGGATCCCCGGAATGCCAACAGCTGACTAAATCGCTT
ATCTTG 
This Study 
YPO1435 5’ GAGCTCACGATGAAATATCAACAGCTGG This Study 
YPO3319 3’ CGCCCTACGCCTTGTCCAATGTC This Study 
YPO3319 5’P1 GAAGCAGCTCCAGCCTACACCATATATAAGTCCCCTTTAACTAA
AAGGCAAC 
This Study 
YPO3319 3’P4 GGTCGACGGATCCCCGGAATAACTAAATAGAGGGGAGGATTTA
TCTTCC 
This Study 
YPO3319 5’ CCTGTCTGGAGATATATTCAATACTCCTCTATG This Study 
Inv-native 
promotor-PstI 
GATCCTGCAGGTGTCATCAAGGCAACCATCAG This Study 
Inv-Tn7-3’BamHI GATCGGATCCGTTATATTGACAGCGCACAGAG This Study 
TraSH-IR-3’MfeI GATCCAATTGCTATCTGCTGACCGATGTTCCG This Study 
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TraSH-IR-
5’PmeI/AscI 
GATCGTTTAAACGGCGCGCCGACGGCCAGTGAATTGTAATACG
AC 
This Study 
TraSH-
5’Tase(AscI) 
GATCGGCGCGCCGGATTACACATGACCAACTTCG This Study 
TraSH-TnMod-
PromII 
GCGTAGAGGATCTGAAGATCAGCAGTTC  This Study 
TraSH-Tase-
PromII-GC 
CACGAAATTCCTTTTTTTCCATGAACGTTACCATGTTAGGCAGGT
C 
This Study 
TraSH-Tase-
PromII 
GACCTGCCTAACATGGTAACGTTCATGGAAAAAAAGGAATTTCG
TG  
This Study 
TraSH-Probe-
PCRadaptor 
GTCCAGTCTCGCAGATGATAAGG (Sassetti et al., 2001) 
TraSH-Probe-
PCRtrans1 
CCCGAAAAGTGCCACCTAAATTGTAAGCG (Sassetti et al., 2001) 
TraSH-Probe-
PCRtrans2 
CGCTTCCTCGTGCTTTACGGTATCG (Sassetti et al., 2001) 
TraSH-Probe-Lig2 AGTCTCGCAGATGATAAGGTGGTCGTGGT (Sassetti et al., 2001) 
TraSH-Probe-Lig1 CGACCACGACCA /3AmM/ (Sassetti et al., 2001) 
TraSH-cDNA-
2ndstrand 
GGGTCTAGAGACCGGGGACTTATC This Study 
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Chapter 3 
Transposon site hybridization (TraSH)
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Abstract 
In vitro systems have been very useful in determining specific mechanisms of bacterial 
pathogenesis, but they often do not reflect the same physiological conditions found in 
vivo. However, the cost and appropriateness of in vivo animal models of infection often 
limit their use. Several negative selection techniques have been developed to help defray 
some of the costs associated with in vivo studies. I developed a negative selection screen 
termed transposon site hybridization (TraSH) to identify bacterial factors required for Y. 
pestis pulmonary infection. To validate the system, I defined the set of genes that are 
essential for Y. pestis viability. Similar to E. coli, 628 genes were considered essential 
using this technique. However, I was unable to identify any known virulence factors 
using TraSH, including genes involved in the Ysc type-three secretion system (T3SS), 
which are known to be essential for pulmonary infection. The finding imply that there is 
global trans-complementation of avirulent mutants by wild-type Y. pestis, emphasizing 
the need to use in vivo models to study Y. pestis pathogenesis.          
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Introduction 
 The virulence of bacterial pathogens is a complex, multifactorial process that 
requires the combined and coordinated activity of many gene products from both the 
bacteria and the host. To proliferate within a host, a pathogen needs to be able to 
circumvent the host immune system (both innate and adaptive) and obtain nutrients for 
itself. A variety of in vitro systems have been developed to simulate specific aspects of 
the infectious process, which have enabled researchers to study bacterial gene expression 
and the behavior of mutant strains in a controlled environment, which often reflects some 
physiological conditions found in vivo (DiRita and Mekalanos, 1989). These systems 
have been very useful in defining many mechanisms of bacterial pathogenesis, but they 
cannot accurately reproduce the complex nature of host-pathogen interactions found in 
vivo. A pathogen may encounter vastly different environments over the course of 
infection, each requiring a unique response. Consequently, genes that are deemed 
important during in vitro studies may not be important during an actual infection, and 
conversely, genes that seem unimportant in in vitro studies may play a vital role within a 
host.  
 On the other hand, animal models of infection can be very beneficial in 
determining many aspects of host-pathogen interactions. However, the costs associated 
with using such models and the difficulties in establishing informative and appropriate 
animal models of infection have limited their use in studying bacterial pathogenesis. 
Several methodologies have recently been developed to identify and study a wide array 
of bacterial virulence factors simultaneously in different animal models of infection. One 
such methodology uses negative selection to identify mutants that are unable to survive in 
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a host. Signature-tagged mutagenesis (STM) was an early derivative of this technology 
and was limited to studying between 50 and 100 mutants at one time (Reviewed in 
Chiang et al., 1999). Negative selection screens, like STM, are ultimately limited to the 
technologies used to distinguish between the initial pool of mutants (input pool) and the 
surviving mutants after selection (output pool). Newer technologies have been developed 
to simultaneously study entire populations of mutants, encompassing transposon insertion 
mutants for every gene in the genome. Transposon site hybridization (TraSH) couples 
RNA amplification of the sites adjacent to transposon insertions with microarray analysis 
to identify mutants at a population level and can distinguish differences between two sets 
of mutant pools (input and output) with a high degree of accuracy (Sassetti et al., 2001). 
This technique has already been used to study Mycobacterium, Salmonella, Helicobacter, 
and Francisella using animal models of infection (Lawley et al., 2006; Salama et al., 
2004; Sassetti and Rubin, 2003; Weiss et al., 2007). Currently, there is one partial STM 
negative selection screen that has been reported for bubonic plague, but there are none for 
pneumonic plague (Flashner et al., 2004). Therefore, I have adapted TraSH negative 
selection technology to screen for mutants that are unable to survive during Y. pestis 
pulmonary infection.   
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Results and Discussion 
Establishing TraSH for use with Y. pestis 
STM uses the gain or loss of a sequence tag to identify whether a single mutant 
with a specific tag is enriched or lost from the output pool compared to the input pool. 
Pools of mutants are limited by the effectiveness and efficiency of differential 
hybridization used to determine the relative ratios of the sequence tag between the input 
and output pools. Sequencing the genomic DNA adjacent to the transposon can be then 
used to identify the site of the transposon insertion. In a somewhat different approach, 
TraSH combines high-density transposon mutagenesis and microarray mapping of pools 
of mutants to identify genes required for growth under certain conditions (Sassetti et al., 
2001). The ends of the transposon are engineered with T7 polymerase promoters facing 
into the chromosome, enabling the generation of short amplified RNA (aRNA) probes 
that correspond to the area immediately adjacent to the transposon insertion. For any 
given selection condition, the aRNA probes are used measure the relative abundance of 
transposon insertions per gene between input and output pools via microarray mapping. 
Changes in the relative abundance indicate a loss or enrichment of that particular gene 
under that selection condition.  
I developed a Himar1-based transposon system with integrated T7 sites that can 
be mated into Y. pestis from E. coli. Using this transposon system, I generated a Y. pestis 
transposon insertion library consisting of 2.5x105 mutants using polymyxin B to counter 
select against E. coli. The high-density transposon insertion library corresponds to an 
approximately 1X coverage of every TA site in the chromosome, ensuring that there is a 
sufficient number of transposon insertions within the close proximity to the 
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corresponding oligonucleotide sequences used on our custom microarray. However, 
DNA-based microarrays have traditionally been used to map transposon insertions in 
TraSH, and our custom build microarray is an oligonucleotide-based array that uses 
unique ORF-specific 70-mers. The oligonucleotides are designed to specifically 
recognize only antisense RNA or mRNA. Given that aRNA generated from the insertion 
site via in vitro T7 transcription will be both sense and antisense relative to the 
oligonucleotides on the microarray, I converted my aRNA to double-stranded 
complementary DNA (dscDNA) before hybridizing them to the array. Figure 3-1 shows 
an Experion RNA Analysis plot of aRNA probes before they were generated into 
dscDNA. 
In vitro TraSH to identify essential genes in Y. pestis 
Many genes encode for proteins that are essential in producing viable, replicative 
bacteria, such as genes encoding for ribosomal proteins, RNA and DNA polymerases, 
 
Figure 3-1: Experion RNA Analysis plot for aRNA TraSH probes. Microfluidic 
analysis of aRNA where the relative fluorescence (Y-axis), which measures the 
relative abundance of RNA, is measured over time (X-axis), which corresponds to 
the average length of the RNA in the sample. The time interval between 25 and 35 
seconds roughly corresponds to aRNA species between 50 and 400 bp in length.  
 
 105 
general secretory proteins and proteins involved in cytokinesis. Bacteria cannot support 
transposon insertions into such genes and still be viable; hence, aRNA or dscDNA probes 
theoretically cannot be generated for essential genes. Therefore, to validate my system 
and approach, I comparatively hybridized dscDNA probes and sheared genomic DNA to 
identify genes that are essential for Y. pestis viability (“essential genes”). Any gene that 
showed more than a 2-fold reduction in hybridization single compared to genomic DNA 
was considered to be essential. Using these criteria, I identified 628 genes as being 
essential for Y. pestis viability. Figure 3-2 shows a breakdown of essential genes based on 
their functional classification, and Table 3-1 shows the number of Y. pestis essential  
genes in specific sub-classifications and the fold change in the hybridization signal 
between sheared genomic DNA (input pool) and dscDNA probes generated from the 
transposon mutant library (output pool) for these genes. These data are in general 
agreement with similar studies that have been done to examine essential genes in E. coli, 
which identified 620 essential genes (Gerdes et al., 2003). 
 
Table 3-1: Essential Y. pestis genes required for growth divided into functional sub-
classifications. The number of genes and the range representation between sheared 
genomic DNA (input pool) and dscDNA probes the from the transposon mutant library 
(output pool). Negative values represent an underrepresentation.  
Gene Classification Number of genes Fold Representation 
(Range) 
Ribosomal protein synthesis  54 -2.00   > -100 
DNA replication 11 -2.00   > -100 
Surface polysaccharides and 
lipopolysaccharides 
19 -2.00   > -100 
General secretory proteins 16 -2.94   > -100 
Cell Division 8 -2.50   -14.28 
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Interestingly, YPO2490 but not YPO2491 was classified as an essential gene 
based on these studies. I had previously generated a clean deletion mutation in YPO2490-
2491 (see Chapter 2), and this mutant showed no growth defects compared to wild-type 
bacteria (data not shown). Recently, Aoki et al. have discovered a two-partner secretion 
system that consists of three proteins, CdiA, CdiI and CdiB, that facilitate a process 
termed contact-dependent inhibition (CDI) (Aoki et al., 2010; Aoki et al., 2005). In this 
process, the C-terminus of CdiA inhibits the growth of or lyses other bacteria that come 
into contact with the bacteria that express CdiA on their surface. CdiI is a cytoplasmic 
protein that represses the inhibitory effects of CdiA. CdiB is a chaperone that aids CdiA 
in reaching the outer membrane. This system is present in Y. pestis, where YPO2490 
corresponds to the CdiA protein, YPO2491 corresponds to CdiB protein and a small 
unannotated open reading frame downstream of YPO2490 corresponds to CdiI protein. 
cdiA and cdiI are driven by the same promoter, suggesting that a transposon insertion in 
cdiA would prevent cdiI expression. Therefore, in a pool of mutants, like my transposon 
insertion library, mutations in cdiA (YPO2490) but not cdiB (YPO2491) would result in a 
growth restriction, which may explain why I can generate individual mutations in this 
gene but random transposon insertions in a complex mutant library cannot be generated.   
In vivo TraSH to identify virulence factors required for pneumonic plague 
Having demonstrated the viability of this approach, I next used this approach to 
identify genes that contribute to virulence in an animal model of Y. pestis pulmonary 
infection (Fig. 3-3). Theoretically, mutants with insertions in important virulence factors 
should be present in the input pool (in vitro pool) but diminished or absent from the 
output pool (in vivo pool). Consistent with similar TraSH experiments (Sassetti and 
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Rubin, 2003), I infected 
two sets of 10 mice with 
2x105 bacteria and 
harvested lungs from mice 
at 24 hpi and lungs and 
spleens from mice at 48 hpi. 
Lungs were homogenized 
and plated on BHI agar 
containing kanamycin to 
recover approximately 
5x105 bacterial colonies per 
time point. Genomic DNA 
was extracted from multiple 
independent samples of the 
pooled bacteria and 
dscDNA probes were 
generated for each sample 
as described (See Materials 
and Methods and Sassetti et 
al., 2001). The Microarray Core Facility at Washington University used the aRNA 
samples to generate dscDNA, which was then labeled and hybridized to microarray slides.  
Overall the fold change between in vitro pool and in vivo pool was very small. 
Only two genes showed more than a two-fold difference between pools, whereas 150 
   
Figure 3-3: Scheme for Transposon Site 
Hybridization (TraSH). C57BL/6 mice are intranasally 
infected with 2x105 CFU from the transposon insertion 
library. In vivo pools are collected by plating lung 
homogenates, and in vitro pools are collected by 
plating the inoculum. TraSH probes are created by 
partially digesting genomic DNA, producing aRNA via 
in vitro T7 polymerase amplification reactions and 
comparatively analyzing the differences between the 
two pools by microarray mapping. Genes that have an 
increased fold representation in the in vitro pool 
compared to the in vivo pool based on hybridization 
signals represent genes specifically required for Y. 
pestis pulmonary infection. Figure courtesy 
Christopher M. Sassetti, Ph.D., UMass Medical 
School; adapted with permission (Sassetti and Rubin, 
2003), subject to copyright restrictions. 
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genes showed a fold difference between 1.5-fold and 2.0-fold. In contrast, my initial 
experiments with non-mutagenized genomic DNA and the mutant library showed 
between 2-fold and 100-fold differences in hybridization signals. Included in the 152 
genes were a large number of metabolic genes but very few genes known to be essential 
for pathogenesis, in particular, genes encoding the type-three secretion system (T3SS) 
(Table 3-2 and Table 4-1). These data are very striking, and the full implications of these 
data are addressed in Chapter 4.  
Currently, high-throughput sequencing technology is quickly replacing 
microarray analysis to determine the location and relative abundance of the transposon 
insertions for input and output pools. This approach has several advantages including the 
ability to determine the exact location of the transposon insertion without having to rely 
on probe-array hybridizations, which can vary from slide to slide. I adapted my protocols 
to use high-throughput sequencing technology to analyze the 24 hr time point. While 
many of the individual genes were different from the 48 hr data, the types of genes were 
similar, a large number of metabolic genes and very few genes known to be essential for 
pathogenesis (Table 4-1). The combined 24 and 48 hpi data suggest that wild-type-like Y. 
pestis, or mutants with transposon insertions in gene not required for virulence, are able 
to compensate for the virulence defects of mutants that have transposon insertions in 
known virulence factors. This type of global trans-complementation has never been 
documented in the literature and is discussed in great detail in Chapter 4.   
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Table 3-2: Genes showing greater than a 1.5-fold change in the hybridization signal 
between the in vitro pool and in vivo pool at 48 hpi. Negative values represent an 
underrepresentation in the in vivo pool.  
 
Gene ID Gene description Fold Representation 
YPCD1.02 transposase/IS protein -1.70 
YPCD1.38 (tyeA) Yop secretion and targeting control protein -1.73 
YPCD1.39 (yopN) Yop secretion control protein -1.69 
YPCD1.67 (yopH) putative secreted protein-tyrosine phosphatase -1.85 
YPCD1.97c putative transposase -1.61 
YPO0034 putative membrane permease -1.69 
YPO0035 (gltS) sodium/glutamate symport carrier protein  -1.54 
YPO0041 putative DNA ligase -1.72 
YPO0137 (envZ) osmolarity sensor protein -1.63 
YPO0147 conserved hypothetical protein -1.54 
YPO0260a putative type III secretion apparatus -1.53 
YPO0275 conserved hypothetical protein -1.64 
YPO0282 (hmuS) hemin transport protein -1.63 
YPO0282 (hmuS) hemin transport protein -1.69 
YPO0308 putative oxidoreductase -1.63 
YPO0319 (qor) quinone oxidoreductase -1.84 
YPO0323 conserved hypothetical protein -1.57 
YPO0328 (rhaD) rhamnulose-1 phospahte aldolase -1.72 
YPO0352 putative lipoprotein -1.58 
YPO0369 conserved hypothetical protein -1.50 
YPO0369 conserved hypothetical protein -1.52 
YPO0373 (ymr) RNA-binding protein Hfq -1.53 
YPO0376 (hflC) hypothetical protein -1.53 
YPO0388 hypothetical protein  -1.95 
YPO0433 hypothetical protein  -1.67 
YPO0442 (seB) phosphoserine phosphatase -1.69 
YPO0470 (nhaA) sodium-proton antiporter -1.66 
YPO0483 putative LysE type translocator -2.06 
YPO0486 (folA) dihydofolate reductase -1.62 
YPO0491 (apaG) CO2 resistance -1.55 
YPO0511 hypothetical protein  -1.73 
YPO0580 (uxaB) tagaturonate reductase -1.53 
YPO0629 hypothetical protein  -1.51 
YPO0641 hypothetical protein  -1.59 
YPO0645 (rpsU) 30S ribosomal protein S21 -1.60 
YPO0655 (asoB)-putative permease involved in surface layer secretion -1.50 
YPO0660 conserved hypothetical protein -1.56 
YPO0663 (tolC) outer membrane channel precursor protein -1.50 
YPO0680 putative DedA-family membrane protein -1.66 
YPO0748 hypothetical protein  -1.60 
YPO0759 sodium:sulfate symporter-family protein -1.52 
YPO0760 conserved hypothetical protein -1.58 
YPO0782 hypothetical protein  -1.74 
YPO0801 hypothetical protein  -1.63 
YPO0802 (cheD) putative methyl-accepting chemotaxis protein -1.99 
YPO0806 prepilin peptidase -1.57 
YPO0859 sugar transport system permease -1.57 
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YPO0949 putative glutaminase -1.55 
YPO0983 conserved hypothetical protein -1.76 
YPO0985 quorum-sensing transcriptional regulator -1.69 
YPO0989 pseudogene (iucA)-E. coli aerobactin siderophore biosynthesis  -1.51 
YPO0998 hypothetical protein  -1.78 
YPO1025 membrane-bound lytic murein transglycosylase A precursor -1.79 
YPO1091 putative prophage protein -1.83 
YPO1102 conserved hypothetical protein -1.58 
YPO1109 (sdhC) succinate dehydrogenase cytochrome b556 large membrane 
subunit 
-1.59 
YPO1116 (sucD) succinyl-CoA synthetase alpha subunit -1.65 
YPO1118 (cydB) cytochrome D ubiquinol oxidase subunit II -1.61 
YPO1119 conserved hypothetical protein -1.60 
YPO1129 conserved hypothetical protein -1.59 
YPO1158 conserved hypothetical protein -1.74 
YPO1211 (eco) ecotin precurser -serine protease inhibitor -1.78 
YPO1221 hypothetical protein  -1.53 
YPO1240 putative prophage protein -1.73 
YPO1269 conserved hypothetical protein -1.71 
YPO1300 (fruA) PTS system, fructose-specific IIBC component -1.51 
YPO1305 (psaC) outer membrane usher protein PsaC precursor -1.95 
YPO1317 putative exported protein -1.65 
YPO1375 (livR) leucine-responsive regulatory protein -1.55 
YPO1395 (msbA) probable transport ATP-binding protein -1.77 
YPO1483 hypothetical protein  -1.55 
YPO1535 putative iron-siderophore transport system, transmembrane 
component 
-1.55 
YPO1537 putative iron-siderophore receptor -1.67 
YPO1639 conserved hypothetical protein -1.59 
YPO1667 (cheW) chemotaxis protein  -1.57 
YPO1669 YjgF-family lipoprotein -1.52 
YPO1689 putative lipoprotein -1.70 
YPO1708 putative chaperone protein -1.57 
YPO1723 exopolygalacturonate lyase -1.75 
YPO1725 (kduI) 5-keto-4-deoxyuronate isomerase -1.66 
YPO1760 (hpcR) homoprotocatechuate degradative operon repressor -1.55 
YPO1843 (fliA) flagellar biosynthesis sigma factor -1.51 
YPO1906 (fyuA/psn) pesticin/yersiniabactin receptor protein -1.54 
YPO1934 putative LysR-family transcriptional regulatory protein -1.58 
YPO1937 L-asparagine permease -1.66 
YPO1938 probable deoR-family transcriptional regulatory protein -1.54 
YPO1969 putative IS100 transposase -1.99 
YPO1969 putative IS100 transposase -1.65 
YPO1974 putative chlorohydrolase -1.57 
YPO1977 psedogene 3-oxoacyl-[acyl-carrier-protein] synthase III  -1.62 
YPO2004 hypothetical protein  -1.67 
YPO2064 (pykA) pyruvate kinase -1.61 
YPO2079 hypothetical protein  -1.69 
YPO2080 conserved hypothetical protein -1.60 
YPO2124 putative prophage protein -1.59 
YPO2139 putative prophage protein -1.56 
YPO2158 conserved hypothetical protein -1.70 
YPO2200 hypothetical protein  -1.55 
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YPO2276 putative prophage protein -1.51 
YPO2306 putative amino acid antiporter -1.78 
YPO2328 conserved hypothetical protein -1.64 
YPO2329 (ldhA) D-lactate dehydrogenase -1.67 
YPO2346 conserved hypothetical protein -2.07 
YPO2364 IS21 element -1.88 
YPO2364 IS21 element -1.66 
YPO2405 hypothetical protein  -1.53 
YPO2560 hypothetical protein  -1.58 
YPO2567 (pta) phosphate acetyltransferase -1.64 
YPO2681 (celD) PTS system, cellobiose-specific IIA component-cel operon 
repressor 
-1.67 
YPO2691 (kdpB) putative potassium-transporting ATPase B chain -1.56 
YPO2725 conserved hypothetical protein -1.68 
YPO2759 putative mannose-resistant/Proteus-like fimbrial protein -1.54 
YPO2807 putative LysR-family transcriptional regulatory protein -1.82 
YPO2850 conserved hypothetical protein -1.57 
YPO2905 (ail) attachment invasion locus protein -1.88 
YPO2944 putative pili chaperone protein -1.69 
YPO2955 utative luxR-family regulatory protein -1.56 
YPO2958 (sfuA) iron(III)-binding periplasmic protein -1.55 
YPO2959 (sfuB) iron(III)-transport system permease -1.59 
YPO2988 conserved hypothetical protein -1.56 
YPO3241 conserved hypothetical protein -1.60 
YPO3263 probable sugar transporter -1.50 
YPO3330 putative sugar ABC transporter, ATP-binding protein -1.54 
YPO3331 putative sugar ABC transporter, permease protein -1.96 
YPO3368 hypothetical protein  -1.54 
YPO3425 (ppdD) putative prepilin peptidase dependent protein D precursor -1.61 
YPO3454 (nrdD) anaerobic ribonucleoside-triphosphate reductase -1.67 
YPO3455 (nrdG) anaerobic ribonucleoside-triphosphate reductase activating 
protein 
-1.77 
YPO3472 putative sugar binding protein -1.56 
YPO3477 putative lipid carrier protein -1.66 
YPO3479 putative protease -1.64 
YPO3524 conserved hypothetical protein -1.60 
YPO3596 putative lipoprotein -1.52 
YPO3628 putative DNA-damage-inducible protein -1.51 
YPO3646 (pcp) outer membrane lipoprotein -1.55 
YPO3655 conserved hypothetical protein -1.68 
YPO3676 putative phage-related protein -1.53 
YPO3715 (malF) maltose transport system permease protein -1.53 
YPO3719 (lysC) lysine-sensitive aspartokinase III -1.59 
YPO3728 (purH) bifunctionalphosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase 
-1.57 
YPO3738 hypothetical protein  -1.56 
YPO3783 conserved hypothetical protein -1.72 
YPO3795 (ugpA) sn-glycerol-3-phosphate transport system, permease protein -1.59 
YPO3803 hypothetical protein  -1.57 
YPO3849 (hemC) porphobilinogen deaminase -1.81 
YPO3861 (rffH) glucose-1-phosphate thymidylyltransferase -1.73 
YPO3886 colicin (partial) -1.83 
YPO3902 putative magnesium chelatase family protein -1.55 
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YPO3951 hypothetical protein  -1.72 
YPO3954 (gntT) putative gluconate permease -1.59 
YPO3962 sugar-binding transport protein -1.73 
YPO3967 phosphate transport protein -1.62 
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Conclusions  
 Our analysis of essential genes in Y. pestis required for viability indicates that the 
technical aspects of the technology used in the TraSH analysis are functioning as 
anticipated. However, the TraSH strategy relies on the fundamental assumption that 
during an infection with a pool of isogenic strains, it will be possible to select against 
single mutants that are attenuated. My experiments with TraSH using two different 
technologies and at two different time points of infection showed little or no selection 
against any known virulence factors including the T3SS genes, a surprise considering 
previous studies have demonstrated the importance of the T3SS in pneumonic plague 
(Lathem et al., 2005). These data suggest that wild-type Y. pestis may establish a 
protective environment that allows avirulent organisms to prosper.  
 Although in vitro systems have been very important in determining many 
mechanisms in bacterial pathogenesis, they cannot truly replicate the complex nature of 
host-pathogen interactions found in vivo and often yield different findings from those 
seen in vivo. The global trans-complementation of avirulent mutants by wild-type Y. 
pestis highlights these differences, as trans-complementation is seen in vivo but not in 
vitro (G. Plano, personal communication). These data also emphasize the necessity of 
using animal models of infection and fully virulent organisms in the study of Y. pestis 
pathogenesis.  
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Materials and Methods 
Reagents, bacterial strains, strain construction and culture conditions  
See Chapter 2.  
Construction of transposon insertion mutant library  
The transposon mutant library was generated using the Himar1-based transposon 
system encoded on pPP47, which was constructed in multiple steps using the phagemid 
φMycoMarT7 (Sassetti et al., 2001) and pTnMod-RKm (Dennis and Zylstra, 1998). 
Briefly, pTnMod-RKm was digested with BglII, and blunt ends were generated using 
Klenow treatment. The resulting fragments were then digested with EcoRI, and the 
fragment corresponding to the RP4 origin of transfer was ligated to the Himar1 
transposon, which was previously amplified from φMycoMarT7 using the 
oligonucleotides TraSHHimarIR5’(PmeI/AscI) and TraSHIR3’(MfeI), and transformed 
into E. coli S17. The Himar1 transposon contains an R6K origin of replication, a KanR 
cassette and flanking T7 promotors oriented so as to promote transcription into the 
chromosomal DNA. The Tn5 promotor region (pTnMod-RKm) and the Himar1 
transposase (φMycoMarT7) were independently amplified using the oligonucleotides 
TraSH-TnModPromII and TraSH Tase-PromII and TraSHTase-PromIIGC and 
TraSH5’Tase(AscI), respectively, and then joined together by SOE-PCR. The resulting 
PCR products were cloned into the AscI site adjacent to the Himar1 transposon to create 
pPP47. E. coli S17 carrying pPP47 were mated with wild-type Y. pestis and plated on 
BHI agar containing kanamycin for Y. pestis selection and polymyxin B for E. coli 
counter-selection. Southern blot analysis of twenty randomly selected colonies indicated 
that each mutant contained a single transposon insertion (data not shown). There were 
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approximately 2.5x105 mutants in the transposon mutant library used in the subsequent 
experiments. 
Transposon Site Hybridization (TraSH)  
The transposon mutant library was used for both in vitro and in vivo experiments 
to identify genes required for bacterial growth on BHI agar and to identify genes required 
for infection during primary pneumonic plague, respectively. The protocols used in these 
experiments have been described previously (Sassetti et al., 2001; Sassetti and Rubin, 
2003). To analyze genes required for bacterial growth on nutrient rich sources, TraSH 
probes were generated as described below for the initial transposon mutant library and 
hybridized against sheared genomic DNA. In vivo selection against Y. pestis was then 
performed using C57BL/6J mice. Briefly, ten mice were inoculated with 2 x 105 CFU of 
the transposon mutant library. The in vitro pool was generated by replating the library on 
BHI agar. At 48 hpi, the mice were euthanized, and a subset of the surviving bacteria (5 x 
105 CFU) was recovered from lung homogenates by plating on BHI agar plates 
containing kanamycin. Genomic DNA was isolated from pool, and modified TraSH 
probes were generated as described (Sassetti et al., 2001). Briefly, genomic DNA was 
partially digested with HinPI and MspI. DNA fragments (500-2000bp) were gel-purified 
and ligated to adaptors generated with the primers TraSH-Probe-Lig1 and TraSH-Probe-
Lig2. Ligated DNA was used as a template in two separate PCR reactions containing the 
primers TraSH-Probe-PCRadaptor and either TraSH-Probe-PCRtrans1 or TraSH-Probe-
PCRtrans1. Gel-purified PCR products (250-500 bp) were used template for in vitro T7 
transcription reactions (Ambion, Austin, TX). Template DNA was digested with 
TurboDNase (Ambion, Austin, TX), and the rRNA was purified and used to generate ds-
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cDNA (Invitrogen, Carlsbad, CA) with the primers TraSH-Probe-PCRadaptor and 
TraSH-cDNA-2ndstrand. The in vitro and in vivo probes were then labeled with Cy3 or 
Cy5 and co-hybridized to the array as described previously (Lathem et al., 2005). Probes 
were generated from each pool three times and analyzed on duplicate microarrays for a 
total of six microarray hybridizations per experiment. Two independent experiments were 
performed, yielding consistent results. The arrays were scanned following hybridization 
and analyzed using Partek Genomics Suite (Partek Inc., St. Louis, MO). Data for each 
experiment were analyzed using multiple testing correction after 3-way ANOVA and 
reported as the fold representation in the in vivo pool compared to the in vitro pool, where 
negative values indicate a relative underrepresentation in the in vivo pool.   
Transposon site high-throughput sequencing 
  Genomic DNA was obtained as outline above and partially digested with HinPI 
and MspI. DNA fragments (500-2000bp) were gel purified and ligated to adaptors 
generated with the oligonucleotides TraSH-Probe-Lig1 and TraSH-Probe-Lig2. Ligated 
DNA was used as a template in a PCR reaction containing the primers TraSH-Probe-
PCRadaptor and TraSH-Probe-PCRtrans3. The PCR products were cleaned and 
submitted to the UNC High Throughput Sequencing Facility, where 76-bp paired-end 
Illumina sequence runs were performed for each sample. Paired sequences that contained 
both the adaptor sequence and transposon sequence within 2kb of each other were 
mapped into the genome. The total number of sequence reads per gene and the ratio 
between the in vitro and the in vivo pool were determined for each gene. Genes that failed 
to have a minimum of ten sequence reads in the in vitro pool were discarded from the 
data set.     
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Chapter 4 
Dominant suppression of early innate immune mechanisms by Y. pestis
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Abstract 
Disease progression of primary pneumonic plague is biphasic, consisting of a pre-
inflammatory and a pro-inflammatory phase. During the long pre-inflammatory phase, 
bacteria replicate to high levels, seemingly uninhibited by normal pulmonary defenses. 
Using a co-infection model of pneumonic plague, I discovered that Y. pestis quickly 
creates a localized, dominant anti-inflammatory state that allows for the survival and 
rapid growth of both itself and normally avirulent organisms. Y. pseudotuberculosis, the 
relatively recent progenitor of Y. pestis, shows no similar trans-complementation effect, 
which is unprecedented among other respiratory pathogens. Even an unbiased negative 
selection screen using a vast pool of Y. pestis mutants revealed no selection against any 
known virulence genes, demonstrating the transformation of the lung into a globally 
permissive environment during the pre-inflammatory phase of pneumonic plague.  
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Introduction 
Most lung pathogens induce a measureable inflammatory response within a few 
hours of infection, but Yersinia pestis is strikingly different: the first 36 hours of infection 
are characterized by rapid bacterial replication in the lung without generating appreciable 
levels of proinflammatory cytokines/chemokines, histological changes in infected tissue 
or outward disease symptoms. This allows the organisms to multiply rapidly before the 
inflammatory response is fully activated, typically too late to control the infection. Thus, 
disease progression for primary pneumonic plague can be subdivided into two distinct 
phases, an initial pre-inflammatory phase followed by a pro-inflammatory phase, which 
is recapitulated in both mouse and non-human primate models of infection (Agar et al., 
2008; Bubeck et al., 2007; Koster et al., 2010; Lathem et al., 2005). The absence of early 
pulmonary inflammation in response to Y. pestis could be due to the organisms avoiding 
detection by the immune system, a strategy employed by many pathogens; or it could be 
due to the organisms completely suppressing early innate immune responses, which has 
never been observed for bacterial pathogens. In this study, I evaluated the early 
consequences of Y. pestis respiratory infection and discovered that the organisms are 
responsible for a rapid and profound suppression of pulmonary defenses that allows not 
only these organisms to proliferate rapidly in the lung, but other microbes as well.  
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Results and Discussion 
Trans-complementation of avirulent mutants by wild-type Y. pestis  
Y. pestis exhibits decreased bacterial replication in the lungs of mice with a 
heightened state of immune activation induced by a latent herpesvirus infection (Barton 
et al., 2007), suggesting that pre-existing or early inflammatory responses are able to 
control and/or mitigate disease progression. A Y. pestis mutant lacking YopH, an effector 
protein of the Yersinia Ysc type III secretion system (T3SS), is immunostimulatory and 
consequently growth-inhibited during respiratory infection (Cantwell et al., 2010). Based 
on these studies, I hypothesized that the ability of Y. pestis to actively suppress early 
innate immune mechanisms may have a more significant role in primary pneumonic 
plague than any intrinsic non-stimulatory properties of the bacterium itself (Lathem et al., 
2007; Montminy et al., 2006; Reithmeier-Rost et al., 2007). I therefore designed a series 
of in vivo co-infection experiments to test the idea that Y. pestis produces a dominant 
immunosuppressive state in the lung. Using a genetically marked wild-type strain (ΔlacZ 
mutant of Y. pestis CO92 (Lawrenz et al., 2009) -YP160) to quantitatively measure 
competition, I co-infected C57BL/6J mice with a Y. pestis ΔyopH strain to see if the 
immunostimulatory response to the mutant could be “suppressed” by the wild-type 
bacteria. After intranasal inoculation of a 1:1 mixture of wild-type and ΔyopH strains, I 
observed that wild-type bacteria were able to almost fully restore the in vivo replication 
defect of a co-infecting ΔyopH mutant (Fig. 4-1A). Consistent with my hypothesis, mice 
co-infected with both wild-type and ΔyopH strains produced lower cytokine levels at 24 
hours post-inoculation (hpi) than mice infected with the ΔyopH mutant alone (Fig. 4-2).  
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Figure 4-1: Wild-type Y. pestis is able trans-complement avirulent isogenic strains 
of Y. pestis. (A) Individual intranasal infections (white bars) for ΔyopH (YP373), Δpla 
(YP102), or pCD1- (YP6) mutants or matched co-infections (gray bars) with wild-
type Y. pestis in C57BL/6J mice. CFU per lung were determined at 48 hpi using BHI 
agar plates containing X-gal. All CFU differences between individual infection and 
corresponding co-infection are statistically significant (p≤0.05). (B-C) Kinetics of 
infection for pCD1- mutants (YP6 - red), wild-type (YP160 - black) and a 1:1 co-
infection of pCD1- mutants (blue) and wild-type Y. pestis (green) infected 
intranasally. CFU per tissue were determined at various time points of infection for 
lungs (B) and spleen (C). Each bar (A) or point (B-C) represents the mean CFU 
recovered from five mice. The limit of detection is represented by a dotted line. 
Error bars represent SEM (A) and SD from the mean (B and C). 
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These results were somewhat unexpected based on previously published work 
with closely related Y. pseudotuberculosis, from which Y. pestis has rather recently 
evolved (Cover and Aber, 1989; Huang et al., 2006). Respiratory co-infection with wild-
type Y. pseudotuberculosis is unable to rescue bacterial replication defects of individual 
Yop mutants (Fisher et al., 2007). All pathogenic Yersinia harbor a nearly identical Ysc-
Yop T3SS, which directly injects into host cells a number of cytotoxins or effector 
proteins (Yops) that inhibit bacterial phagocytosis and other innate immune processes 
(Cornelis, 2002). Therefore, Y. pestis-specific evolutionary adaptions beyond the Ysc-
Yop T3SS have produced a pathogen that is not only substantially more virulent than its 
immediate ancestor, but also able to compensate for the virulence defects of a co-
infecting attenuated strain. I next tested the extent to which fully virulent Y. pestis could 
compensate for deficiencies of other attenuated isogenic mutants. In these respiratory co-
    
Figure 4-2: Cytokine production in response to individual and co-infections using 
wild-type Y. pestis and a ΔyopH mutant. Individual (white bars) and matched co-
infections (gray bars) of C57BL/6J mice infected intranasally with ΔyopH (YP373) 
and/or wild-type Y. pestis (YP160). Whole lung homogenates were probed for (A) 
TNF-α and (B) IL-6 cytokine production using ELISA. Results are represented the 
mean cytokine levels (pg/ml) recovered from five mice. Error bars represent SD 
from the mean. 
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infections, wild-type Y. pestis could also compensate for (or “trans-complement”) the 
major virulence defects of both Δpla and pCD1- mutants (Fig. 4-1A), restoring 4-6 logs 
of bacterial growth capacity during the first 48 hpi.  
The profound impact of the presence of wild-type Y. pestis on the fate of pCD1- 
mutants was particularly surprising, since the pCD1 plasmid (commonly called the 
Yersinia “virulence plasmid”) encodes the entire Ysc-Yop T3SS and its virulence-
associated Yop effectors. In our intranasal model of infection, pCD1- mutants are 
severely attenuated (Lathem et al., 2005), unable to proliferate in the lung and 
successfully cleared by innate immune mechanisms. Therefore, I examined the impact of 
wild-type Y. pestis on co-infecting pCD1- mutants in more detail. Although the kinetics 
of bacterial replication progressed as expected during pulmonary infection with either 
wild-type bacteria or pCD1- mutants when inoculated individually (Lathem et al., 2005), 
growth of the pCD1- strain increased substantially when co-inoculated at a 1:1 ratio with 
wild-type Y. pestis. As the infection progressed, this trans-complementation of pCD1- 
mutant growth continued to increase, reaching 6-8 logs at 60 hpi (Fig. 4-1B). While we 
normally do not see pCD1- mutants spreading to the spleen of mice following a 
pulmonary infection, I was able to detect 104-106 pCD1- bacteria in the spleens of mice 
co-infected with wild-type Y. pestis at 60 hpi (Fig 4-1C).   
Trans-complementation of avirulent mutants by wild-type Y. pestis during bubonic 
plague  
The lung alveoli play a critical role in respiratory gas exchange, and 
inflammation-induced edema can lead to severe lung distress. Thus, the lung has many 
innate immune mechanisms, including the mucociliary escalator and alveolar 
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macrophages, that allow for the clearance of inhaled microorganisms and foreign 
particles (Suzuki et al., 2008). These systems most likely aid in the elimination of Y. 
pestis pCD1- mutants, which are cleared without producing any appreciable inflammatory 
response from the host (Lathem et al., 2005). To determine whether unique aspects of the 
lung’s physiology contribute to the ability of Y. pestis to trans-complement avirulent 
isogenic strains, I also examined the kinetics of bacterial replication in a subcutaneous 
inoculation model that mimics the route of infection and lymphatic dissemination seen in 
bubonic plague (Fig. 4-3A and 4-3B). In the draining cervical lymph nodes, pCD1- 
mutants were able to replicate 4-5 logs more by 48 hpi when co-infected with wild-type 
bacteria than when infected individually (Fig. 4-3A). Wild-type bacteria also facilitated 
the dissemination of pCD1- mutants to the spleens of animals co-infected by the 
subcutaneous route (Fig. 4-3B). Although these results are not as pronounced as the 
phenotype I see during pulmonary infection, they reinforce my observations regarding a 
   
Figure 4-3: Wild-type Y. pestis is able trans-complement avirulent isogenic strains 
of Y. pestis during a subcutaneous infection. (A) Kinetics of infection for pCD1- 
mutants (YP6 - red), wild-type (YP160 - black) and a 1:1 co-infection of pCD1- 
mutants (blue) and wild-type Y. pestis (green) infected intranasally. CFU per tissue 
were determined at various time points of infection for lymph nodes (A) and spleen 
(B). Each bar represents the mean CFU recovered from five mice. The limit of 
detection is represented by a dotted line. Error bars represent SD from the mean. 
 128 
dominant immunosuppressive effect of wild-type bacteria and demonstrate that the 
physiology of different organ systems may determine the extent of trans-
complementation.  
The life cycle of Y. pestis between flea and mammalian hosts suggests that there 
is differential expression of virulence determinates between the two hosts. Many Yersinia 
virulence determinates are thought to be regulated by temperature: in vitro, 26°C 
incubation can mimic the growth temperature in fleas just before mammalian infection, 
and 37°C incubation can mimic the growth temperature found in most mammalian hosts 
(Perry and Fetherston, 1997). I therefore tested these two pre-incubation conditions prior 
to intranasal inoculation from 37°C to 
26°C to determine whether the initial 
growth temperature would 
significantly alter the trans-
complementation efect. C57BL/6J 
mice were individually or co-infected 
intranasally with pCD1- and wild-type 
Y. pestis grown at 26°C or 37°C. The 
co-infection results were similar under 
both conditions. Figure 4-4 shows only 
Y. pestis grown at 26°C and data for 
the 37°C bacteria were similar to the 
data presented in Fig 1A. These data 
   
Figure 4-4: The ability to trans-
complement avirulent isogenic strains is 
independent of initial growth temperature. 
Individual (white bars) and matched co-
infections (gray bars) of C57BL/6J mice 
infected intranasally with pCD1- mutants 
(YP6) and/or wild-type Y. pestis (YP160) 
pre-grown at 26°C. Each bar represents 
the mean CFU recovered from five mice. 
Error bars represent SEM. 
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indicate that the initial growth temperature of the bacteria does not significantly alter the 
ability of wild-type Y. pestis to trans-complement pCD1- mutants.   
Localization and timing of trans-complementation 
In pneumonic plague, the earliest stages of inflammation appear as distinct foci, 
and this is also where most of the multiplying bacteria are observed (Lathem et al., 2005). 
I wondered whether the trans-complementation effect is similarly localized, or whether it 
reflects immunosuppression of the entire pulmonary compartment? My first indication 
came from co-infection experiments in which I varied the ratios of avirulent to virulent Y. 
pestis (Fig. 4-5A). After the first 24 hpi, the levels of pCD1- mutants are maintained at a 
constant ratio to the levels of wild-type Y. pestis (1 pCD1- : 10 wild-type), independent of 
the initial ratio of pCD1- to wild-type in the inoculum. The tight relationship between the 
growth rate of pCD1- mutants and that of wild-type Y. pestis suggests that trans-
complementation may be a more of a tightly controlled local effect rather than a global 
effect throughout the lung. In agreement with these observations were the results of 
pulmonary co-infections with gfp-expressing pCD1- mutants and rfp-expressing wild-
type Y. pestis (1:1). Co-localization of the green and red fluorescence revealed replicating 
pCD1- mutants only in close association with wild-type Y. pestis in inflammatory foci, 
but not in regions of the lung were wild-type bacteria were not present (Fig. 4-5B). These 
data suggest that during the initial stages of infection, an avirulent mutant’s proximity to 
fully virulent Y. pestis determines whether it will proliferate or be eliminated by the 
lung’s innate immune mechanisms. 
  After the first 24 hpi, the levels of pCD1- mutants are maintained at a constant 
ratio to the levels of wild-type Y. pestis (1 pCD1- : 10 wild-type), independent of the 
 130 
 
              
Figure 4-5: Relative numbers and distribution of virulent and avirulent Y. pestis 
during pulmonary co-infections. (A) Kinetics of infection for C57BL/6J mice 
intranasally infected with varying ratios of pCD1- mutants (YP6) and wild-type Y. 
pestis (YP160) [10:1 (black), 1:1 (blue) and 1:10 (orange) pCD1- : wild-type]. CFU 
per lung were determined at various time points of infection. Each point represents 
the mean CFU recovered from five mice. The limit of detection is represented by a 
dotted line. Error bars represent SD from the mean. (B) Mice were co-inoculated 
intranasally with gfp-expressing pCD1- mutants (BGY19) and rfp-expressing wild-
type Y. pestis (YP337). At 48 hpi, lungs were fixed and cryosectioned. 
Fluorescence deconvolution images were generated from 10- m sections. The 
image is representative of multiple independent experiments. Scale bar represents 
10 µm. 
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initial ratio of pCD1- to wild-type 
in the inoculum. To examine the 
importance of the initial 24 hours 
of infection, I co-infected pCD1- 
mutants with an engineered strain 
of Y. pestis in which pla is under 
the control of a tetracycline-
inducible promoter (Lathem et al., 
2007). Intranasal inoculation of the 
pla-inducible strain results in an 
unproductive infection until 
anhydrotetracycline (ATC) is 
administered to the animal, which 
allows us to control the timing of a productive infection. These experiments show that the 
first 24 hpi are critical in establishing the trans-complementation effect, which is reduced 
by 3-4 logs if ATC is not administered until 24 hpi (Fig. 4-6). These data imply that the 
first 24 hours following infection are critical in controlling pCD1- mutants during 
pulmonary infections and that wild-type Y. pestis are able to subvert these early innate 
immune responses.  
Trans-complementation requires fully virulent Y. pestis 
The (CDC) in the United States has classified Y. pestis as a Category A Select 
Agent because it causes significant morbidity and mortality in humans and its potential 
for release as a weapon of bioterrorism. Although Biosafety Level-3 laboratory 
 
Figure 4-6: The first 24 hpi are critical in 
establishing trans-complementation. C57BL/6J 
mice were intranasally infected with pCD1- 
mutants (BGY14 – gray bars) and ATC-
inducible pla strain of Y. pestis (YP138). ATC 
was administered (2 mg kg-1) at various time 
points and CFU per lung were determined at 
48 hpi. Each bar represents the mean CFU 
recovered from three mice. Error bars 
represent SEM. 
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conditions are required for the study of fully virulent Y. pestis, two attenuated strains 
(pgm- and pCD1-) are exempt from these restrictions and can be handled under normal 
laboratory conditions. The prospect of trans-complementation of raises a significant 
biosafty question: can two different attenuated strains mutually compensate for the 
virulence defects of each other to cause disease?  
 To address this concern, I performed a series of individual and co-infection 
experiments using different attenuated strains. I individually infected or co-infected 
C57BL/6J mice intranasally with pgm- and pCD1- mutants of Y. pestis. Both the pgm- and 
pCD1- mutant bacterial burdens in the co-infected mice were similar to the bacterial 
burdens in individually infected mice (Fig. 4-7A). Similar results were seen when Δpla 
and pCD1- mutants were examined in co-infection experiments (Fig. 4-7B). Additionally, 
I was unable to observe any differences in the onset of plague symptoms or in gross lung 
 
Figure 4-7: Attenuated Y. pestis strains are unable to trans-complement avirulent 
isogenic strains. (A) Individual (white bars) and matched co-infections (gray bars) of 
C57BL/6J mice infected intranasally with (A) pCD1- mutants (BGY14) and/or pgm- 
(BGY4) and (B) pCD1- mutants (BGY14) and/or Δpla (YP102). CFU per lung were 
determined at 48 hpi using BHI agar plates with or without kanamycin. Each bar 
represents the mean CFU recovered from four to five mice. The limit of detection is 
represented by a dotted line. Error bars represent SEM. 
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pathology between mice individually infected with the pgm- or Δpla mutants and mice 
co-infected with pgm- or Δpla mutants and pCD1- mutants (data not shown). These 
results demonstrate that Y. pestis strains must be able to cause significant disease in the 
lung in order to trans-complement other attenuated strains.  
Trans-complementation is unique to Y. pestis  
The ability of a microorganism to suppress the lung’s innate immune system, 
effectively compensating for mutants missing a variety of virulence factors, is 
unprecedented among bacterial pathogens. In contrast to the trans-complementation 
phenomenon I have documented with Y. pestis, wild-type Y. pseudotuberculosis is unable 
to trans-complement isogenic mutants lacking the Yersinia virulence plasmid (designated 
pYV in Y. pseudotuberculosis) or pCD1- mutants of Y. pestis during pulmonary co-
infection (Fig. 4-8A and Ref. (Fisher et al., 2007)). Similarly, wild-type K. pneumoniae, 
which can also cause an acute bacterial pneumonia, fails to trans-complement isogenic 
strains that have mutations in predominant virulence genes (such as a ΔcpsB mutant, 
which lacks the polysaccharide capsule) or pCD1- mutants of Y. pestis (Fig 4-8B and Ref. 
(Lawlor et al., 2005)). In addition, I have observed that pulmonary infection with wild-
type Y. pestis, but not pCD1- mutants, frequently leads to secondary bacterial infections. 
These bacteria, most likely introduced during the process of intranasal inoculation, can 
reach levels of 107 bacteria/lung at 60 hpi in wild-type-infected mice (Fig. 4-9). 
Shibasaburo Kitasato likely provided the first documentation of rampant secondary 
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Figure 4-8: Specificity of bacterial trans-complementation during pulmonary 
infection. (A) Y. pseudotuberculosis, which harbors the same T3SS as Y. pestis, is 
unable to trans-complement in the lung. Individual intranasal infections (white bars) 
for pYV- Y. pseudotuberculosis mutants (BGY38), pCD1- Y. pestis mutants (BGY14-
1) and wild-type Y. pseudotuberculosis (BGY30) and matched co-infections (gray 
bars) with wild-type Y. pseudotuberculosis in C57BL/6J mice. (B) Klebsiella 
pneumoniae, another pulmonary pathogen, is unable to trans-complement in the 
lung. Individual intranasal infections (white bars) for ΔcpsB K. pneumoniae mutants 
(VK060), pCD1- Y. pestis mutants (BGY14-1) and wild-type K. pneumoniae 
(KPPR1) and matched co-infections (gray bars) with wild-type K. pneumoniae in 
C57BL/6J mice. (A and B) CFU per lung were determined at 48 hpi using LB or BHI 
agar plates with and without kanamycin. Error bars represent SEM.   
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infection when he originally published a description of the bacteria he thought caused the 
plague in 1894 but its described features resembled that of a pneumococcus (Perry and 
Fetherston, 1997). The rampant growth of secondary bacteria may necessitate the use of a 
broader spectrum of antibiotics during clinical treatment of pneumonic plague.    
Some Yop effector proteins secreted by the plasmid-encoded Ysc-Yop T3SS are 
known to have anti-inflammatory mechanisms, and the Ysc-Yop system is required for 
all three Yersinia species to cause mammalian infection. Since I observed trans- 
complementation for Y. pestis but not Y. pseudotuberculosis, I tested whether this could 
be due to Y. pestis-specific evolutionary changes in the Ysc-Yop T3SS encoded on the 
virulence plasmid. I exchanged pCD1 in Y. pestis with its corresponding Y. 
pseudotuberculosis virulence plasmid (pYV), and this Y. pestis pCD1- pYV+ strain still 
                      
Figure 4-9: Wild-type Y. pestis creates a permissive environment that allows non-
pathogenic bacteria to proliferate in the lung. Kinetics of infection for pCD1- mutants 
(red) and wild-type Y. pestis (black) in C57BL/6J mice infected intranasally. CFU 
per lung were determined at various time points of infection on both BHI (Y. pestis) 
and BHI-MOX agar plates (non-Y. pestis bacteria). Each point represents the mean 
CFU recovered from five mice. The limit of detection is represented by a dotted line. 
Error bars represent SD from the mean.   
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trans-complementated a Y. pestis pCD1- mutant (Fig. 4-10). These data suggest that 
while the Ysc-Yop T3SS is necessary for a productive infection, subtle evolutionary 
adaptions to Ysc-Yop system during the evolution of Y. pestis are not solely responsible 
for the trans-complementation effect.  
Scope of trans-complementation as evidenced by transposon site hybridization (TraSH) 
Finally, I wanted to employ a broad, unbiased approach to evaluate the scope of 
trans-complementation by Y. pestis. Negative selection screens are often used to identify 
and confirm virulence-associated genes in animal models of infection (Chiang et al., 
1999). These screens rely on the fundamental assumption that during an infection with a 
pool of isogenic mutants, it will be possible to select against and subsequently identify 
single attenuated mutants. I used the microarray-based negative selection technique 
known as transposon site hybridization (TraSH) (Sassetti and Rubin, 2003) to 
comprehensively characterize trans-complementation during experimental pneumonic 
plague (see Chapter 3). The typical expectation of TraSH is that it should reveal in vivo 
selection against mutants that lack key virulence factors; however, my Y. pestis co-
 
Figure 4-10: The ability to trans-
complement avirulent isogenic strains is 
independent on the Y. pestis-specific 
T3SS. Individual (white bars) and 
matched co-infections (gray bars) of 
C57BL/6J mice infected intranasally with 
pCD1- mutants (BGY14) and/or pCD1-
pYV+ Y. pestis (YP361). CFU per lung 
were determined at 48 hpi using BHI 
agar plates with/without kanamycin. 
Each bar represents the mean CFU 
recovered from four to five mice. Error 
bars represent SEM. 
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infection results predicted that I may not observe any in vivo selection against individual 
attenuated mutants in a mixed pool. Remarkably, all known Yersinia virulence genes 
implicated in pneumonic plague showed less than a two-fold negative selection in vivo 
(Table 4-1). In contrast, negative selection screens have been employed to identify and 
confirm virulence factors in other lung pathogens, including Pseudomonas aerginosa, 
Burkholderia pseudomallei, Burkholderia cenocepacia, Streptococcus pneumoniae and 
Mycobacterium tuberculosis (Camacho et al., 1999; Cuccui et al., 2007; Hava and 
Camilli, 2002; Hunt et al., 2004; Winstanley et al., 2009; Zhang et al., 2005).  
 
Table 4-1: TraSH screen reveals global trans-complementation during primary 
pneumonic plague. Known genes required for primary pneumonic plague and their 
representation in the in vivo pool (high-throughput sequence (HTPS) reads or TraSH 
probes for the transposon mutant library at 24 or 48 hours post-intranasal inoculation 
into C57BL/6J mice, respectively) compared to the in vitro pool (HTPS reads or TraSH 
probes for the mutant library). Negative values indicate an underrepresentation in the 
output pool. n/d indicates data that were not determined by the analysis.  
Gene Reference Fold Representation 
48 hpi (microarray) 
Fold Representation  
24 hpi (HTPS) 
yopH (Bubeck and Dube, 
2007) 
-1.85 n/d 
yopD  (Cornelis, 2002) -1.33 n/d 
pla (Lathem et al., 
2007) 
-1.32 -1.33 
lcrF (T3SS) (Perry and 
Fetherston, 1997) 
-1.26 -1.63 
ail (Kolodziejek et al., 
2010) 
-1.88 1.05 
psn 
(Yersiniabactin) 
(Fetherston et al., 
2010) 
-1.54 n/d 
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Conclusions  
The concept of trans-complementation has always been hypothesized as a 
potential caveat for negative selection screens. Examples of individual secreted proteins 
have been shown to produce this effect, however it has never been seen on a global level. 
The in vivo TraSH results suggest that Y. pestis is able to trans-complement all known 
virulence factors during a pneumonic co-infection with wild-type organisms. These 
observations suggest that Y. pestis is able to create a dominant, localized anti-
inflammatory state early during lung infection, and this establishes a unique protective 
environment that even allows non-pathogenic organisms to prosper. Y. pestis rather 
recently evolved from a food-borne pathogen (Y. pseudotuberculosis) to become an 
arthropod-borne pathogen, and this is thought to have strongly favored the coevolution of 
increased virulence for mammals (Lorange et al., 2005). Poor arthropod vector 
competence imposed the need to generate very high levels of bacteremia from very few 
inoculating bacteria in order to efficiently maintain the natural route of transmission 
between arthropods and their mammalian hosts. Thus, an early anti-inflammatory state at 
the site of infection would be biologically advantageous in ensuring that Y. pestis can 
replicate unfettered until its numbers are sufficient for transmission. When finally 
recognized by the immune system, the bacteria are at such a high titer that they trigger an 
overly robust inflammatory response. In the case of a lung infection, the switch from 
unrestricted bacterial growth to overwhelming inflammation results in rapid decline in 
pulmonary function and the corresponding fatalities associated with primary pneumonic 
plague. 
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Materials and Methods 
Reagents, bacterial strains, strain construction and culture conditions  
See Chapter 2.  
Animals  
All animals studies were approved by the Washington University Animal Studies 
Committee protocol #20060154 or the University of North Carolina in Chapel Hill Office 
of Animal Care and Use protocol #09-057.0-A. Pathogen-free, six- to eight-week-old 
C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice 
were housed in a Techniplast Isocage containment system (Buguggiate, Italy) during all 
experiments. Mice were provided with food and water ad libitum and maintained on a 12-
hr light/12-hr dark cycle at 25°C and 15% humidity. Bacteria were grown in BHI broth as 
described above, and the optical density (OD620) of the culture was used to estimate 
bacterial concentrations. Actual bacterial concentrations were determined by plating 
serial dilutions of the inoculum on BHI or LB agar plates. The bacteria were then washed 
in endotoxin-free phosphate buffered solution (PBS) and maintained at 37°C (intranasal 
infection) or 26°C (subcutaneous infection) prior to inoculation, unless otherwise 
indicated. Mice were anesthetized with a ketamine/xylazine solution (50 mg Kg-1 / 10 mg 
Kg-1) and inoculated with 20 µl or 100 µl of bacteria in PBS via an intranasal or 
subcutaneous route, respectively. Animals were monitored twice daily and sacrificed with 
an overdose of sodium pentobarbital (180 mg Kg-1) at designated time points or when the 
animal was clearly moribund.  
Animal infections  
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For both the individual infection and co-infection experiments, groups of 4-5 mice 
were inoculated intranasally (i.n.) with 1 x 104 CFU of Y. pestis, Y. pseudotuberculosis 
and/or K. pneumoniae for individual and co-infections with equal ratios (1 pCD1- : 1 
WT) and 1 x 105 CFU of Y. pestis for infections with varying ratios (1 pCD1- : 10 WT, 1 
pCD1- : 1 WT and 10 pCD1- : 1 WT). Groups of 4-5 mice were inoculated 
subcutaneously (s.c.) in the front neck with 1000 CFU of Y. pestis for both individual and 
co-infections. For both Y. pestis and Y. pseudotuberculosis, lacZ mutants (Fisher et al., 
2007; Lawrenz et al., 2009) were designated as my “wild-type” strain, and blue/white 
screening was used to differentiate between co-inoculated strains. Bacterial organ 
burdens were determined by plating bacteria on BHI or LB agar containing X-gal for 
experiments involving multiple Y. pestis or Y. pseudotuberculosis strains. For 
experiments involving K. pneumoniae, organ burdens were determined using LB agar 
with kanamycin (selection mutant) or without kanamycin. For mixed species experiments 
[Y. pseudotuberculosis or K. pneumoniae with Y. pestis pCD1- lacZ::kanR (BGY14-1)], 
organ burdens were determined using BHI agar with kanamycin (Y. pestis pCD1- mutant 
selection) or without kanamycin. For experiments in which pla was induced with 
anhydrotetracycline (ATC), Y. pestis (YP138) was grown in the absence of ATC as 
described in Chapter 2 and inoculated intranasally into mice (three per time point). At the 
indicated time point, mice were injected intraperitoneally with ATC (2 mg kg-1 diluted in 
PBS) to promote pla expression (Lathem et al., 2007). ATC was then administered every 
twelve hours, except for the mice at the 6-hour time point, which received ATC at 6 hpi 
and then at 12 hpi. At the indicated times post-inoculation, mice were euthanized, lungs 
and spleen (after i.n. infection) or lymph nodes, spleen, and lungs (after s.c. infection) 
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were surgically removed, weighed, and homogenized in 0.5 ml PBS. Serial dilutions for 
each organ were plated on BHI or LB agar as indicated above. Bacterial burdens are 
reported as CFU/tissue.  
Histopathology  
Groups of 3-5 mice were inoculated intranasally with 1 x 104 CFU of a 1:1 ratio 
of Y. pestis [1 gfp-expressing pCD1- (BGY23) : 1 rfp-expressing WT (YP337)]. Mice 
were euthanized at 48 hours post-inoculation (hpi) with an overdose of sodium 
pentobarbital, and their lungs were inflated with 10% neutral buffered formalin via 
tracheal cannulation. The lungs were then removed from the animal and fixed for 96 hr in 
10% neutral buffered formalin. All samples were negative for bacterial growth before 
being removed from the BSL-3 facility. The lungs were washed twice in PBS for 1 hr and 
then in PBS-30% sucrose for 24 hr. Frozen sections were generated by freezing the lungs 
in Optimal Cutting Temperature (OCT) compound on dry ice for twenty minutes and 
then at -80°C overnight. Ten-µm section were mounted with Pro-Long Gold (Invitrogen, 
USA) and viewed under an Olympus BX60 fluorescence microscope (Center Valley, PA). 
iVision software v. 4.0.0 (BioVision Technologies, Exton, PA) used for Z-stack image 
collection and deconvolution.   
Cytokine analysis  
For the cytokine analysis, groups of 4-5 mice were co-infected or individually 
infected with 1 x 104 CFU of wild-type Y. pestis (YP160) and/or a ΔyopH mutant 
(YP373). At 24 hpi, the lungs were surgically removed and homogenized in 1 ml PBS 
containing protease inhibitor cocktail set III (Calbiochem, EMB Chemicals, Gibbstown, 
NJ). The homogenates were centrifuged at 21,000 rpm to remove the bacteria and cellular 
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tissues and then treated with a 1% sodium azide / 100 µg/ml gentamicin solution. 
Samples were stored at -80°C until the ELISA analysis was conducted. All samples were 
tested for the presence of viable Y. pestis before being removed from the BSL-3 facility. 
Commercially available IL-6 and TNF-α ELISA test kits (BD) were used according to the 
manufacture’s instructions to determine cytokine levels for each lung sample. Mock-
infected animals were used to control for baseline cytokine levels. Results are reported as 
pg/ml for each cytokine.   
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Abstract 
“Primary pneumonic plague is transmitted easily, progresses rapidly, and causes high 
mortality, but the mechanisms by which Yersinia pestis overwhelms the lungs are largely 
unknown. We show that the plasminogen activator Pla is essential for Y. pestis to cause 
primary pneumonic plague but is less important for dissemination during pneumonic 
plague than during bubonic plague. Experiments manipulating its temporal expression 
showed that Pla allows Y. pestis to replicate rapidly in the airways, causing a lethal 
fulminant pneumonia; if unexpressed, inflammation is aborted, and lung repair is 
activated. Inhibition of pla expression prolonged the survival of animals with the disease, 
offering a therapeutic option to extend the period during which antibiotics are effective.” 
 
Contribution 
My main contribution to this study was the development of the in vitro plasminogen 
activation assays to confirm the protease activity of Pla in wild-type strains, strains 
carrying various inactive point mutants and the ATC-inducible Pla strains. I also helped 
generated the pCD1- strains used for each of these mutants used in the in vitro 
plasminogen activation assays.   
 
Lathem, W., Price, P., Miller, V., and Goldman, W. (2007) A Plasminogen-Activating 
Protease Specifically Controls the Development of Primary Pneumonic Plague. Science 
315: 509-513. Subject to copyright restrictions. 
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Abstract 
“Cyclic di-GMP (c-di-GMP) is a signaling molecule that governs the transition between 
planktonic and biofilm states. Previously, we showed that the diguanylate cyclase HmsT 
and the putative c-di-GMP phosphodiesterase HmsP inversely regulate biofilm formation 
through control of HmsHFRS-dependent poly-β-1,6-N-acetylglucosamine synthesis. 
Here, we systematically examine the functionality of the genes encoding putative c-di-
GMP metabolic enzymes in Yersinia pestis. We determine that, in addition to hmsT and 
hmsP, only the gene y3730 encodes a functional enzyme capable of synthesizing c-di-
GMP. The seven remaining genes are pseudogenes or encode proteins that do not 
function catalytically or are not expressed. Furthermore, we show that HmsP has c-di-
GMP-specific phosphodiesterase activity. We report that a mutant incapable of c-di-GMP 
synthesis is unaffected in virulence in plague mouse models. Conversely, an hmsP mutant, 
unable to degrade c-di-GMP, is defective in virulence by a subcutaneous route of 
infection due to poly-β-1,6-N-acetylglucosamine overproduction. This suggests that c-di-
GMP signaling is not only dispensable but deleterious for Y. pestis virulence. Our results 
show that a key event in the evolution of Y. pestis from the ancestral Yersinia 
pseudotuberculosis was a significant reduction in the complexity of its c-di-GMP 
signaling network likely resulting from the different disease cycles of these human 
pathogens.” 
 
Contribution 
My main contribution to these studies was to generate mutants in the CO92 background 
of Y. pestis and test them for c-di-GMP production. I also made all of the original 
observations in animal for all of the different mutants although only those in the Kim 
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strain background were used in the publication. I also generated additional strains that 
helped clarify the role of HmsT in c-di-GMP production that were not included in the 
publication but directly lead to observation that were included. 
    
Bobrov, A.G., Kirillina, O., Ryjenkov, D.A., Waters, C.M., Price, P.A., Fetherston, J.D., 
Mack, D., Goldman, W.E., Gomelsky, M., and Perry, R.D. (2011) Systematic 
analysis of cyclic di-GMP signalling enzymes and their role in biofilm formation 
and virulence in Yersinia pestis. Mol Microbiol 79: 533-551. Subject to copyright 
restrictions.   
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Abstract 
“Yersinia pestis is a highly pathogenic Gram-negative organism and the causative agent 
of bubonic and pneumonic plague. Y. pestis is capable of causing major epidemics; thus, 
there is a need for vaccine targets and a greater understanding of the role of these targets 
in pathogenesis. Two prime Y. pestis vaccine candidates are the usher-chaperone fimbriae 
Psa and Caf. Herein we report that Y. pestis requires, in a nonredundant manner, both 
PsaA and Caf1 to achieve its full pathogenic ability in both pneumonic and bubonic 
plague in C57BL/6J mice. Deletion of psaA leads to a decrease in the organ bacterial 
burden and to a significant increase in the 50% lethal dose (LD50) after subcutaneous 
infection. Deletion of caf1 also leads to a significant decrease in the organ bacterial 
burden but more importantly leads to a significantly greater increase in the LD50 than 
was observed for the ΔpsaA mutant strain after subcutaneous infection of C57BL/6J mice. 
Furthermore, the degree of attenuation of the Δcaf1 mutant strain is mouse background 
dependent, as the Δcaf1 mutant strain was attenuated to a lesser degree in BALB/cJ mice 
by the subcutaneous route than in C57BL/6J mice. This observation that the degree of 
requirement for Caf1 is dependent on the mouse background indicates that the virulence 
of Y. pestis is dependent on the genetic makeup of its host and provides further support 
for the hypothesis that PsaA and Caf1 have different targets.” 
 
Contribution 
I generated the Δcaf1 mutant strains used in these studies and made all of the original 
observations with the Δcaf1 mutant during a pneumonic infection. Although not included 
in the publication, I was able to show that caf1 was the only gene on the pMT plasmid 
that resulted in a loss of virulence in the C57BL/6 mouse model of infection.  
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and Miller, V.L. (2011) The dependence of the Yersinia pestis capsule on 
pathogenesis is influenced by the mouse background. Infection and Immunity 79: 
644-652. Subject to copyright restrictions. 
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Conclusions and Future Directions
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Summary of the Work 
 Project Goals – Before this project began, there was very little information in the 
literature about the early stages of Y. pestis pathogenesis, especially during the initial pre-
inflammatory phase of disease. The overall goal of this project was to characterize the 
initial interactions between Y. pestis and lung tissues and to identify specific bacterial 
virulence factors that are involved in this process and in the overall pathogenesis of Y. 
pestis.  
Y. pestis adherence to lung tissues 
 Adherence to host tissues is considered one of the earliest essential steps in 
bacterial pathogenesis. Although a number of studies have been conducted to examine 
adhesion to tissue culture cells, an in vivo model of Y. pestis adhesion has never been 
developed to study specific Y. pestis-host cell interactions. I therefore adapted our animal 
model of pneumonic plague to specifically examine the extent of interactions between Y. 
pestis and lung tissues and to compare these interactions to those the interactions between 
Y. pestis and tissue culture cells. In Chapter 2, I was able to demonstrate that over 90% of 
Y. pestis remains adherent to lung tissues at 2 hpi during BAL, whereas in my tissue 
culture model only 17% of Y. pestis remains adherent. These data imply that adherence to 
tissue culture cells does not necessarily mimic what is occurring in vivo and that Y. pestis 
adheres fairly tightly to lung tissues during the initial stages of infection. This tight 
adherence may help prevent mechanical clearance of Y. pestis from the lung by the action 
of the mucociliary escalator. In contrast, Y. pestis is freely lavageable during the later 
stages of infection, which may provide evidence for why Y. pestis is only transmitted 
person-to-person during this stage of the disease.  
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 The high levels of adhesion during the initial stages of infection provide a means 
of enriching for less adherent mutants of Y. pestis. Ail was implicated as an adhesin in Y. 
pestis from this enrichment. Concurrent with these studies, Ail was found to mediate 
adhesion to tissue culture cells (Felek and Krukonis, 2009). However, my subsequent 
studies using Δail mutants suggest that Ail mediates membrane stability and/or the proper 
integration of proteins into the outer membrane and not direct adhesion. These studies 
along with the biotinylation studies imply that adhesion is likely mediated by more than 
one outer membrane protein. Given the possible role of Ail in maintaining membrane 
stability, the role of the outer membrane itself in mediating adhesion cannot be ruled out.  
Aberrant adhesion to host tissues may by Y. pestis appears to be detrimental to Y. 
pestis pathogenesis. Reintroduction of two major Yersinia adhesins, yadA and inv, into Y. 
pestis reduces the virulence of Y. pestis in both bubonic and pneumonic animal models of 
infection. The exact mechanism of associated with this attenuation is unknown, but 
Casutt-Meyer et al. have shown that yadA expression in Y. pestis increases its 
susceptibility to neutrophil extracellular traps (NETs) (Casutt-Meyer et al., 2010). 
However, the early and increased influx of neutrophils seen during pneumonic infection 
with yadA+ Y. pestis seems to have lead to increased bacterial burdens, not increased 
killing, implying that another mechanism of action beyond NET-mediated killing may be 
limiting Y. pestis pathogenesis when either yadA or inv is reintroduced into Y. pestis. 
Interestingly, the reintroduction of yadA into a Δpla mutant restores 3-4 logs of bacterial 
growth over a Δpla mutant during pulmonary infection. Given that YadA is required for 
full virulence in other Yersinia species (Durand et al., 2010), Pla may be compensating 
for the lack YadA in Y. pestis. The combination of the compensation by Pla and the 
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liability of having expressing YadA during a bubonic infection may explain why 
evolution selected for mutants that lack these adhesins.  
Transposon Site Hybridization (TraSH) 
In vitro systems have been great at determining specific mechanisms in bacterial 
pathogenesis, but they often do not reflect the same physiological conditions found in 
vivo. Therefore, I developed a negative selection screen termed transposon site 
hybridization (TraSH) to identify bacterial factors required for Y. pestis pulmonary 
infection (Sassetti et al., 2001). I validated the system in Chapter 3 by defining the genes 
that are essential for Y. pestis viability, which included 628 genes, similar to E. coli. 
However, I was unable to identify any known virulence factors using TraSH, including 
genes involved in the Ysc type-three secretion system (T3SS), which are known to be 
essential for pulmonary infection. These unusual data suggest that wild-type Y. pestis is 
able to globally trans-complementation of avirulent mutants in our animal model of 
pneumonic plague. 
Trans-complementation by wild-type Y. pestis          
Trans-complementation of avirulent bacteria by wild-type bacteria has been 
theorized to occur during co-infections (Chiang et al., 1999), but the global nature of 
trans-complementation I see for Y. pestis has never been described. The trans-
complementation effect may help explain the biphasic disease progression of primary 
pneumonic plague, where during the long pre-inflammatory phase, bacteria replicate to 
high levels, seemingly uninhibited by normal pulmonary defenses. Two different models 
may explain the trans-complementation and the pre-inflammatory phase of disease. The 
first model suggests that Y. pestis fails to elicit a sufficient immune response during this 
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phase of disease because it is naturally non-stimulatory, failing to trigger TLR-4- or TLR-
2-mediated immune responses (Montminy et al., 2006; Reithmeier-Rost et al., 2007). A 
second model supposes that Y. pestis creates a dominant anti-inflammatory state that 
allows for the survival and rapid growth of both itself and normally avirulent organisms. 
Using a co-infection model of pneumonic plague in which known immune-stimulatory Y. 
pestis strains are inoculated along with wild-type bacteria, I discovered that Y. pestis 
quickly creates dominant immunosuppressive state in the lung, more consistent with the 
second model.  
The protective environment is localized to the areas immediately surrounding 
wild-type Y. pestis, as evidenced by fluorescence microscopic examination of lung 
cryosections at 48 hpi. However, the overall size of these areas may be larger during the 
pre-inflammatory phase of disease, before the efflux of neutrophils into the lungs. 
Immune responses during the first 24 hpi appear to be critical in controlling the 
proliferation of avirulent bacteria, further suggesting that the pre-inflammatory phase of 
disease results from immunosuppression and not simply a failure to elicit an immune 
response.  
Neither Y. pseudotuberculosis, the relatively recent progenitor of Y. pestis, nor K. 
pneumoniae, another bacterial lung pathogen, showed a similar trans-complementation 
effect, which appears to be unprecedented among other respiratory pathogens. Thus, the 
unbiased negative selection screen approach used in TraSH, which revealed no selection 
against any known virulence genes, further demonstrates the ability of wild-type Y. pestis 
to transform the lung into a globally permissive environment during the pre-inflammatory 
phase of pneumonic plague.  
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Model for Y. pestis-specific trans-complementation  
Comparing evolutionary adaptations between Y. pestis and it recent progenitor Y. 
pseudotuberculosis may offer some insights into the mechanisms of Y. pestis 
pathogenesis, which ultimately culminate in the localized anti-inflammatory environment 
that allows for trans-complementation. Although the Ysc-Yop T3SS is undoubtedly 
important in this process, Y. pestis-specific virulence factors likely play a key role in 
enhancing immune suppression during the initial stages of disease and/or significantly 
altering the lifestyle of Y. pestis in host tissues to allow for increased pathogenesis. Figure 
6-1 depicts my current model for the life style differences that allow Y. pestis but not Y. 
pseudotuberculosis to trans-complement in vivo. This model is based on differences in 
the initial intracellular lifestyle between the two species. 
  A facultative intracellular lifestyle has been described in vivo for Y. 
pseudotuberculosis following intragastric infection, enabling Y. pseudotuberculosis to be 
trafficked to the regional lymph nodes (Pujol and Bliska, 2005). I have also shown that Y. 
pseudotuberculosis also has an intracellular lifestyle soon after intranasal infection. In 
contrast, a facultative intracellular lifestyle for Y. pestis has only been postulated. 
However, using gentamycin protection assays, I have shown that Y. pestis is 
predominantly extracellular throughout the course of disease. Examples of individual 
bacteria inside phagocytes has been demonstrated, but their importance to Y. pestis 
pathogenesis is still unknown (Pujol and Bliska, 2005). Further, ΔphoP mutants that are 
attenuated in in vitro macrophage models of infection are not attenuated in vivo, whereas 
the same ΔphoP mutation in Y. pseudotuberculosis leads to attenuation in an intranasal 
animal model of infection (Bozue et al., 2011). The intracellular lifestyle of Y. 
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Figure 6-1: Model for Y. pestis-mediated trans-complementation. Wild-type Y. 
pestis (center red circles) mediates trans-complementation of attenuated Y. pestis 
strains (green circles) by replicating extracellularly early during infection. In contrast, 
Y. pseudotuberculosis (left red circles) has an initial intracellular lifestyle, failing to 
trans-complement attenuated bacteria. (1) Attenuated bacteria are inoculated 
individually (right) or co-inoculated with wild-type Y. pestis (center) or Y. 
pseudotuberculosis (left). (2) Soon after infection professional phagocytes 
(macrophages or dendritic cells) encounter the bacterial in the small airways of the 
lung. (3) Wild-type Y. pestis is able to prevent the phagocytosis of itself and co-
inoculated attenuated mutants via combined activity of Pla, the proteinous capsule, 
Caf1, and Ysc-Yop T3SS (purple stars). Y. pseudotuberculosis is engulfed by 
phagocytic cells via a YadA-mediated mechanism. Conversely, attenuated Y. pestis 
are engulfed by macrophages when inoculated individually. (4) The harsh 
intracellular environment encountered inside macrophages limits the initial growth of 
Y. pseudotuberculosis before the macrophages undergo apoptosis. The 
macrophages are able to kill attenuated Y. pestis when inoculated individually and 
fail to undergo apoptosis, whereas wild-type Y. pestis and co-inoculated attenuated 
mutants are able to proliferate. Co-inoculated attenuated mutants will continue to 
require wild-type Y. pestis to proliferate over the entire course of the infection.  
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pseudotuberculosis is thought to be mediated by YadA and/or Inv, although there are 
differences between YadA- and Inv-mediated invasion that alter cellular responses to 
infection (Viboud and Bliska, 2005). The evidence that YadA is able to partially rescue a 
Δpla mutant during an intranasal infection further supports this idea. However, I still 
need to verify that the introduction of yadA into a Δpla mutant leads to an intracellular 
lifestyle. Although the exact proteolytic targets for Pla are unknown, it may enable Y. 
pestis to survive extracellularly over the entire course of infection.      
Our model also relies on the assumption that the intracellular environment that Y. 
pseudotuberculosis encounters is likely a much harsher environment for survival than an 
extracellular environment, decreasing the survival or restricting the growth of attenuated 
bacteria upon internalization. Additionally, the levels of Yop translocation from 
internalized bacteria appear to be lower or less frequent than the levels from extracellular 
bacteria (Durand et al., 2010), implying that extracellular bacteria have an enhanced 
ability to inhibit macrophage function. The harsher intracellular environment encountered 
by attenuated strains coupled with decreased Yop translocation by wild-type bacteria may 
prevent intracellular Y. pseudotuberculosis from achieving trans-complementation. 
Conversely, the extracellular nature of wild-type Y. pestis may enhance its ability to 
inhibit phagocytosis of both itself and attenuated strains, enabling both strains to 
proliferate. Although Y. pseudotuberculosis replicates primarily extracellularly durind the 
later stages of infection (Balada-Llasat and Mecsas, 2006), a brief intracellular lifestyle 
may be sufficient to prevent Y. pseudotuberculosis from rescuing avirulent mutants, 
given that the first 24 hpi are critical is enabling trans-complementation (Chapter 4). 
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Overall, this model implicates the acquisition of pPCP1, which encodes pla, as a major 
advance in evolution of Y. pestis pathogenesis.  
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Conclusions  
The biphasic disease progression of the pneumonic plague syndrome is unusual 
because it is characterized by rapid bacterial replication in the lung without generating 
appreciable levels of proinflammatory cytokines/chemokines, histological changes in 
infected tissue or outward disease symptoms. I have been able to show that this pre-
inflammatory phase of disease is the result of a rapid and profound suppression of 
pulmonary defenses that ultimately allows not only these organisms to proliferate rapidly 
in the lung, but other microbes as well. These observations suggest that dominant, 
localized immunosuppression plays a greater role than the inherent non-stimulatory 
nature of Y. pestis in maintaining the pre-inflammatory during primary pneumonic plague.  
Y. pestis rather recently evolved from the food-borne pathogen Y. 
pseudotuberculosis to become an arthropod-borne pathogen, and this is thought to have 
strongly favored the coevolution of increased virulence for mammals (Lorange et al., 
2005). Poor arthropod vector competence imposed the need to generate very high levels 
of bacteremia from very few inoculating bacteria in order to efficiently maintain the 
natural route of transmission between arthropods and their mammalian hosts. Thus, an 
early anti-inflammatory state at the site of infection would be biologically advantageous 
in ensuring that Y. pestis can replicate unfettered until its numbers are sufficient for 
transmission. The exact mechanistic details behind the increase immunosuppression at 
the early stages of disease are unknown; however, differences in the 
intracellular/extracellular lifestyle during the first hours 24 hours of infection may 
provide an insight into the evolution of Y. pestis from Y. pseudotuberculosis.  
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Future Directions 
I have proposed a model for Y. pestis-mediated trans-complementation that relies 
on the fundamental assumption that Y. pestis remains extracellular and Y. 
pseudotuberculosis intracellular during the initial phases of infection. I have developed 
the techniques to examine this model directly and have shown that the majority of Y. 
pestis is extracellular, whereas Y. pseudotuberculosis is intracellular. However, the 
relationship between the in vivo roles of Pla and YadA needs further characterization. 
Understanding the partial compensation of a Δpla strain by YadA will aid in this 
characterization. These studies will also greatly aid in understanding the role of Pla 
during pulmonary infection. I have developed three plausible models that may account 
for the partial rescue.  
The first model is similar to the intracellular/extracellular model presented in 
Figure 6-1. This model suggests that YadA-mediated internalization, which appears to be 
slightly mechanistically different from other means of internalization (Hudson et al., 
2005), protects bacteria during the initial stages of disease and bacterial replication. If Pla 
is acting to ensure survival in extracellular spaces and its loss decreased survival in 
extracellular spaces, this intracellular environment would now have a protective effect. 
Testing the cellular localization of a Δpla yadA+ strain during pulmonary infection will 
help clarify this model. 
The second model is fundamentally different that the first model. Yop 
translocation depends on both the binding of bacteria to host cells and activation of 
signal-transduction cascades within those cells, the later of which is triggered by ligand-
host cell receptor binding (Mejía et al., 2008). In Y. pseudotuberculosis, the activation of 
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signal-transduction cascades is mediated mainly by YadA-β1 integrin binding and to a 
lesser extent Invasin-β1 integrin binding. Both yadA and inv are pseudogenes in Y. pestis 
and hence cannot mediate Yop translocation via this signal-transduction cascade. Pla may 
engage other signaling cascades via proteolytic cleavage of cell surface components. 
Caulfield et al. have recently presented data to suggest that Pla readily cleaves Fas-ligand 
from the surface of cells to disrupt its signaling (Caulfield and Lathem, 2010). Cleavage 
of other cell-surface ligands by Pla may initiate the signaling cascades that restore Yop 
translocation. In this model, the unknown defect of a Δpla mutant may simply be its 
inability to efficiently translocate Yop effectors into host cells. YadA would then restore 
the ability of the Δpla mutant to trigger signal-transduction cascades and restore Yop 
translocation. Testing the in vivo translocation of a Δpla mutant and a Δpla yadA+ mutant 
may be able to address this model. The techniques required for these examinations are 
now widely used in the field, and I am currently adapting them for use in studying 
pneumonic plague (Durand et al., 2010; Marketon et al., 2005).  
Pla has been shown to have adhesive properties that aid in attachment and 
invasion of tissue culture cells (Lähteenmäki et al., 2001), independent of the proteolytic 
activity of Pla. The proteolytic activity of Pla is required for pulmonary infection 
(Lathem et al., 2007), but the relevant proteolytic targets of Pla in vivo remain unknown. 
Pla cleaves after basic residues in proteins, leaving the positively charged end of the 
protein attached to the cell. Considering Pla can cleave the vast majority of proteins from 
the surface of Y. pestis, robust cleavage of surface proteins may result in a positively 
charged outer membrane that can adhere more readily to host cells. In this third model, 
YadA would be able to compensate for the loss of Pla and the charged outer membrane 
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by restoring the adherence to host cells. Analyzing the overall charge of the outer 
membrane using certain cationic and anionic dyes can be used to test this model 
(Bengoechea et al., 1998a; Bengoechea et al., 1998b).  
The concept of global trans-complementation by Y. pestis lends itself to a myriad 
of different studies. Oddly enough, many of the most pressing studies involve defining 
the early events in pneumonic plague. Although not part of my dissertation, we are 
currently defining which cell types are actively translocated during the pre-inflammatory 
phase of disease and hope to continue these studies to also analyze the pro-inflammatory 
phase of disease. Simultaneously, we are monitoring changes in the host-cell repertoire in 
the lungs of mice during Y. pestis infection using flow cytometry. Although these studies 
may not identify the initial interacting cell types, they should allow us to determine which 
immune cells are responding to infection during the pre-inflammatory phase of disease. 
These studies should be able to open up new avenues of study and provide a wealth of 
information on the pre-inflammatory phase of disease.      
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